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 Summary 
With the approach of a post-antibiotic era in which the current arsenal of antibiotic compounds 
can no longer combat common bacterial infections, the search for novel compounds to fight 
against antimicrobial resistance is more important than ever.  
A group of forgotten antimicrobial peptides, termed the tyrocidines, have re-emerged as 
promising candidates for further development in clinical and industrial settings. These are basic, 
cyclic decapeptides, with the sequence cyclo(D-Phe1-L-Pro2-L-(Phe3/Trp3)-D-(Phe4/Trp4)-L-Asn5-
L-Gln6-L-(Tyr7/Phe7/Trp7)-L-Val8-L-Orn9-L-Leu10), and are naturally synthesized, together with 
the neutral, linear pentadecapeptides, the gramicidins, by the soil bacterium Brevibacillus 
parabrevis. A multitude of structurally similar tyrocidines has been found in extracts of this 
organism. This arises due to the non-ribosomal, enzymatic, synthesis of these peptides in which 
certain domains within this multi-domain enzyme system have the ability to incorporate more 
than one kind of aromatic amino acid.  The specific structural variations are at residue positions 
3, 4 and 7 in the cyclic decapeptide. These structural variations produce tyrocidines with unique 
structure-activity relationships, imbuing them with activity against a wide variety of Gram-
positive bacteria and fungi. Activity against the malarial parasite, Plasmodium falciparum, has 
also been observed. 
This study aims to make use of the variability seen for incorporation of different aromatic amino 
acid residues, specifically of phenylalanine and tryptophan, to determine if non-natural 
derivatives of these amino acids can be incorporated, to biosynthesize novel tyrocidine, 
tryptocidine and phenycidine analogues (collectively termed the Trcs), with unique structure-
activity relationships. 
The initial objective of this study was to characterise different available strains of the producer 
organism, to determine if there was a difference in the production profiles of Trcs by the 
producer organism. A clear difference was found between the Br. parabrevis 5618, 362, 10068 
and 8185 strains in terms of their production profiles, with the 5618 showing a marked 
improvement in Trc analogues rich in tryptophan. In addition to strain-determined differences in 
production profiles, differences in production as a result of altered nutrient conditions, in the 
form of nitrogen, sulphate and carbon sources, added on top of a base media, were also 
investigated. This was initially done by growth rate analysis of the producer organisms under 
different conditions, and then followed up by small scale culture to determine the effect on 
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production of Trcs. Altered productions in terms of biomass and extract mass were found, and to 
a lesser degree the Trc production profile. Urea appeared to have the most marked effect on Trc 
production, particularly for the 5618 strain. 
The next objective was to determine if the selected phenylalanine analogues 4-methyl-
phenylalanine (4-MeF), 2-flouro-phenylalanine (2-FF) and 4-trifluoro-phenylalanine (4-CF3F) 
and tryptophan analogues 5-methyl-tryptohan (5-MeW) and 1-methyl-trpyophan (1-MeW) could 
be incorporated into the Trcs. This investigation also used initial growth rate analysis of the 
strains 5618, 362 and 8185 under different supplementation concentrations of the non-natural 
and natural amino acids. With the exception of 1-MeW and CF3F, most amino acids appeared 
well tolerated by the strains tested, with a decrease in growth only being seen by most of the 
amino acids at concentrations of 22 mM. Following this, small scale cultures were done under 
selected conditions to test for their incorporation using the 5618 strain. Extensive incorporation 
was found for all the analogues, with the exception of 4-CF3F as determined by novel masses 
found using ESMS analysis. 
Finally, medium-scale cultures were done using supplementation with 2-FF and 5-MeW to 
produce enough peptide for subsequent extraction, purification and analysis. Again, extensive 
incorporation of these analogues was found, with 5-MeW substituted Trc analogues having a 
large hydrophobic shift in retention time. A tyrocidine A analogue incorporating three 2-FF 
residues was found to be the predominate peptide in the 2-FF culture, while a tryptocidine B 
analogue incorporating either one or two 5-MeW was found on the 5-MeW culture. Subsequent 
semi-preparative reverse-phase HPLC was done in an attempt to purify individual non-natural 
analogues, however, difficulties in separation owing to the large variety of Trc analogues 
produced with overlapping retention times only allowed for enrichment of certain analogues. The 
enriched analogues were tested against Microccocus luteus. The methylated tryptocidine B 
analogues appeared to have similar growth and metabolic inhibition activities to the natural 
analogues, while the fluorinated tyrocidine A analogues appeared to be more active compared to 
the natural analogue, being a more effective inhibitor of bacterial metabolism.  
The production of novel tyrocidines with unique structure-activity relationships was shown to be 
possible by supplementation of the growth media of the producer organism with non-natural 
aromatic amino acids. This provides a rapid, affordable, and scalable method to produce novel 
antimicrobial peptides. 
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Preface 
The increase in antimicrobial resistance has sparked a revival in the search for new antimicrobial 
agents. The tyrocidines, originally discovered by Rene Dubos in 1939, are a group of non-
ribosomally synthesized anti-microbial peptides showing activity against a wide variety of Gram-
positive bacteria, as well as activity against a broad range of fungal species. The tyrocidines are 
basic, cyclic, decapeptides with a strong amphipathic structure which are synthesized by the soil 
bacteria Brevibacilluus parabrevis, together with the neutral, linear gramicidins (Grcs). 
Collectively, Trcs and Grcs extracted from cultures of Br. parabrevis are known as tyrothricin 
(Tcn). The Trcs are receiving renewed interest to help combat antimicrobial resistance due to 
their rapid, membranolytic activity. Their ability to target and disrupt bacterial membranes is 
important due to the fact that these membranes contain highly conserved structures, which makes 
the development of antimicrobial resistance unlikely. The Trcs are non-ribosomally synthesized 
in an enzymatic process using a thiotemplate mechanism. Certain domains within the non-
ribosomal synthetase enzymes that incorporate amino acids into the growing Trc chain lack 
specificity for a single amino acid, and as a result domains responsible for incorporations of 
amino acids at positions 3,4 and show affinity for both phenylalanine and tryptophan, while 
position 7 also shows affinity for tyrosine. This leads to the production of a wide variety of Trcs 
with unique structure activity relationships with the sequence cyclo(Phe1-Pro2-X3-x4-Asn5-Gln6 
X7-Val8-Orn9-Leu10), where upper-case X represents variable L amino acids and the lower-case x 
represents a variable D amino acid. The lack of specificity of the variable domains, as well as the 
non-ribosomal mechanism of synthesis, provide a basis for testing for the incorporation of non-
natural aromatic amino acid derivatives into the Trcs, on which minimal work has been done. In 
addition, different strains of the producer organism as well as nutrient conditions have also been 
shown to play a role on the levels of Trc production.  
This study’s major goal was to determine the possibility of creating novel Trcs with unique 
structure-activity relationships by supplementing the growth media of the producer organisms 
with selected aromatic amino acid derivatives. In order to reach this goal a number of aims were 
set in this study as detailed below. 
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Research Aims  
Aim 1. Cultivation of Brevibacillus parabrevis strains and comparison of the production of 
tyrocidine and analogues by the producer organism 
1.1. Selection and base-line peptide production of tyrocidine producing strains from four 
available strains.  
1.2. Assessment of growth rates of three of the strains under altering nutrient conditions 
relating to urea, sodium sulphate, ammonium sulphate, glucose and glycerol content. 
1.3. Small-scale deep-well cultures using one of the strains to assess the effect of selected 
nutrient conditions determined to have largest positive effect on growth rate.  
1.4. Assessment of the effect of selected natural and non-natural amino acids on growth rate 
on three strains of the producer organism. 
1.5. Small-scale deep-well cultures using one of the strains to assess the effect of selected 
nutrient amino acids, as well as selected nutrient conditions, on the production profile of 
the Trcs.  
The results of these objectives are reported in Chapter 2 (1.1, 1.2, 1.3) and Chapter 3 (1.4, 1.5). 
Aim 2: Characterisation of peptide production profile 
2.1 High throughput organic extraction and isolation of the tyrocidines and their analogues 
from the small and medium scale cultures produced under Aim 1. 
2.2 Characterisation of the crude extract peptide production profiles via electrospray mass 
spectrometry (ESMS) and ultraperformance liquid chromatography linked to mass 
spectrometry (UPLC-MS). 
The results of these studies are reported in Chapters 2 and Chapter 3. 
Aim 3. Medium scale production using selected natural and non-natural amino acids 
3.1 Medium scale production (200 mL) and extraction of cultures supplemented with 
selected natural and non-natural amino acids. 
3.2 Purification of novel peptides using semi-preparative reverse phase high performance 
liquid chromatography (RP-HPLC) using established protocols. 
3.3 Characterisation of the purified/enriched cyclic decapeptide preparations extracts via 
ESMS and UPLC-MS. 
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3.4 Assessment of the antibacterial activity of the novel cyclic decapeptides and their natural 
analogues against Micrococcus luteus in liquid culture and in agar-based antimicrobial 
assays. 
The results of these studies are reported in the final experimental chapter, Chapter 4. 
Thesis Content 
The thesis comprises of literature background in Chapter 1 on antimicrobial peptides and the 
experimental results and discussion is given in Chapters 2-4. Chapter 5 comprises of the 
collusion and future studies. As this study refers to many different peptide structures peptide 
reference table were added to the end of the thesis for quick referencing. Independent chapter 
units were used in this thesis to ease future publication of result and some repetition was 
unavoidable, however I attempted to minimise repetitions as far as possible. 
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Overview of antimicrobial peptides focusing on the 
tyrocidines and analogues 
1.1 Introduction 
Antimicrobial resistance (AMR) is fast becoming a major burden on human health due primarily to 
their misuse within both the healthcare and agricultural sectors. A report published by the World 
Health Organisation in 2014 states that the economic burden in the US alone, as a result of 
increasing levels of AMR, amounts to between $21 and $31 billion dollars per year (1). Five or 
more of the six regions monitored by the WHO have reported over 50% resistance to commonly 
used anti-microbials by Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus. 
Resistance levels above 25 % have also been reported in some regions for Streptococcus 
pneumoniae, non-typhoidal Salmonella species, certain Shigella species and Neisseria gonorrhoea 
(1). As of 2014 the pipeline for the implementation of new antimicrobials is virtually empty, 
highlighting the need for further research and development within this field (1). 
All kingdoms of life produce compounds which provide the host with protection against invading 
microbes, of these compounds, a large group, known as antimicrobial peptides (AMPs), serve as a 
rapid-responding, non-specific defence system to the host organism, which is furthermore 
complemented by a slower acting, more specific cell-mediated response in higher eukaryotic 
organisms (2). The rapid increase in levels of AMR have sparked renewed interest in AMPs, with 
hundreds being discovered and thousands more being synthesized and designed de novo (3). AMPs 
are a promising avenue for solving the problem of AMR as they tend to target the highly conserved 
structures of microbial cell membranes, making the development of resistance unlikely (4–10). In 
addition, the large variety of AMPs makes it unlikely for target organisms to develop proteases able 
to recognize the unique epitopes of different AMPs (11). 
1.2 Diversity and categorisation of AMPs 
The diversity of AMPs can make them difficult to categorise, however there are a few 
characteristics that are shared by the majority of AMPs, namely, they mostly fall within a size of 
between 9 and 100 amino acids, have mostly L-amino acids, are amphipathic, generally have a net 
positive (cationic) charge and act on the membranes of their target organisms (3, 11). Despite their 
wide range of structures and activities against various organisms (including fungi, bacteria and 
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viruses (12)), AMPs can be grouped based on the organisms against which they have activity. The 
first major group being peptides that are non-toxic to normal mammalian cells but are toxic to 
selective microorganisms, the second group being non-toxic to mammalian cells but toxic to a 
broad range of both Gram-positive and Gram-negative bacteria, the third being non-toxic towards 
mammalian cells while being toxic towards bacteria and fungi or fungi only, and lastly peptides 
with a broad toxicity that are only slightly selective toward microbial targets (13–17).  
Epand and Vogel (18) grouped peptides by structural motifs which were common to certain groups 
of AMPs, into six categories. These groups are: peptides that form hydrophobic and amphipathic α-
helices, cyclic peptides and small proteins which form β-sheet structures, peptides possessing 
unique amino acid compositions, cyclic peptides with thio-ester groups present in the ring structure, 
and lipopeptides terminating in an amino-alcohol and macro-cyclic knotted peptides. 
1.3 Mechanisms of action  
1.3.1 Selectivity of AMPs for prokaryotic membranes 
A commonality to many AMPs is a mechanism of action which primarily involves interaction with 
the lipid bilayer of a target membrane, which is largely due to their cationic nature and subsequent 
interaction with anionic phospholipids present on the target membrane (18). This is also the main 
factor behind the preferential interaction of AMPs with bacterial membranes over the zwitterionic 
phospholipids such as phosphatidylcholine and sphingomyelin present in mammalian cell 
membranes (18, 19).  
Unlike bacterial membranes, plants and animals have their anionic components segregated into 
inner leaflet of their cell membranes (11). In addition, the presence of cholesterol in the membrane 
of multicellular animals is believed to reduce the activity of the AMPs on these membranes, either 
due to the stabilizing effect of cholesterol on the membrane or due to interaction of the AMP with 
cholesterol (20). 
1.3.2 Membrane mediated mechanisms of action 
In the context of bacteria, some AMPs may act on intracellular targets, while many act via 
disruption of cell membranes, particularly at higher concentrations. Either way, the AMPs must 
initially interact with and traverse the cell wall (consisting primarily of a peptidoglycan polymer) in 
Gram-positive bacteria and the outer membrane (and cell wall) in the case of Gram-negative 
bacteria.  
Stellenbosch University  https://scholar.sun.ac.za
1-3 
 
Many AMPs appear to readily cross the porous, 40 to 80 nm thick, cell wall of Gram-positive 
bacteria (21). In the case of Gram-negative bacteria, AMPs can rapidly traverse the outer membrane 
via a charge-exchange mechanism whereby the cationic AMPs compete with Ca2+ and Mg2+ bound 
to lipopolysaccharides. Interactions with these ions may enhance the binding of the peptides to 
outer membrane proteins, a process called the self-promoted uptake hypothesis (22). Once these 
peptides have crossed the outer membrane of Gram-negative bacteria they are free to interact with 
the cell wall and cell membrane. Studies on the interactions of AMPs with bacterial cell-walls 
(outer-most thick peptidoglycan layer on Gram-positive bacteria, and thin peptidoglycan layer 
between outer membrane and cell membrane of Gram-negative bacteria) show that there is not an 
equal distribution of bound peptides on the cell wall. Recent single-cell experiments using 
fluorescent probes have shown that AMPs are restricted to cell-wall foci associated with cell 
division, cell wall remodelling, and secretion (23, 24), with interference of these processes leading 
to cell lysis. Initial interaction of AMPs with cell walls is dependent primarily on negatively 
charged components, including lipoteichoic acids and teichoic acids. 
Once the AMPs have crossed the bacterial outer-membrane and/or cell wall, they interact with 
bacterial cell membranes (the last external barrier before the cytosol). This is likely to occur in the 
same manner as for outer-membranes and cell walls (21, 25). The amphipathic conformation of 
AMPs (resulting from their distribution of charged and hydrophobic amino acid residues) leads to 
interactions with negatively charged cell membrane components and/or insertion into the lipid-
bilayer of these membranes. There are four models typically associated with this amphipathic 
interaction of linear -helical cationic AMPs with bacterial membranes. These are the aggregate 
(26), toroidal-pore, barrel-stave and carpet models (27, 28). The conformation of an interacting 
AMP can also be altered by the specific membrane environment (29).   
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Figure 1.1 SMART model depicting interaction of AMPs (yellow and orange) with bacterial 
membranes. A, a β-sheet peptide aggregate interacting with the lipid-monolayer at its 
interface, B, random coil-string peptide forming a helical structure upon membrane 
interaction, C, helical structure peptides interacting with cell membrane. At low 
densities of peptide on the membrane surface the membrane can adapt to maintain 
membrane integrity (B), while at higher local peptide concentrations peptide-induced 
strain curvature on the lipid bilayer starts to cause transient openings (C). The 
equilibrium between the different states (shown by reversible arrows) is dependent on a 
wide variety of AMP and membrane-related factors (figure adapted from 30).  
 
 
 
 
 
 
 
 
 
 
 
 
 
A single type of AMP is likely to act through a combination of aspects of the toroidal-, barrel-stave, 
carpet-models. This is primarily due to differences in membrane structure, membrane topology, 
AMP aggregation levels, AMP-lipid interactions, AMP structure, AMP:lipid ratio and properties of 
the lipid membrane (30). This led to the proposal of a more generalised model by Bechinger (31), 
termed the SMART model (Soft Membranes Adapt and Respond, also Transiently, in the presence 
of AMPs). Bechinger (31) also proposed an additional aspect to this model due to the effect of 
AMP-induced curvature strain of bacterial membranes. Curvature strain starts at relatively low 
peptide concentrations, where AMPs lie at the interface of the cell membrane (with more 
hydrophobic peptide residues associating with hydrophobic membrane lipids, and more hydrophilic 
residues associating with the outer cell membrane surface). Curvature strain occurs as a result of the 
AMPs having an asymmetric distribution, as they do not completely fill the top lipid monolayer of 
the lipid bilayer (Figure 1.1, B). The curvature strain is initially high, but is relieved as peptides 
distribute evenly between the outer and inner surface of the membrane thanks to membrane 
transport and membrane openings (30). The ‘soft’ membranes can adjust at lower peptide 
concentrations, but as more peptide associates with the cell membrane, transient opening and 
membrane deformation begins to occur (Figure 1.1, C) (31). At even higher peptide concentrations, 
both local and global disruptions of the cell membrane begin to occur. 
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1.3.3 Receptor or non-membrane mediated mechanisms 
While interaction with target membranes is a prerequisite for all antimicrobial activity, some 
peptides, either as a function of their structure and/or concentration, translocate across target 
membranes without causing permeabilisation and act on intracellular targets (12). Cytosolic 
mechanisms of action include inhibition of nucleic acid synthesis, protein synthesis, enzyme 
activity and cell wall synthesis (32). Examples of this include the frog peptide buforin II which has 
the ability to translocate the bacterial membrane without the bacterial membrane becoming leaky or 
lysing. Once in the cytoplasm this AMP inhibits both DNA and RNA synthesis in E. coli (33). The 
proline-rich insect AMP pyrrohocidin binds to the heat shock protein DnaL, inhibiting its ATPase 
activity which ultimately leads to the accumulation of misfolded proteins and cell death (34, 35). A 
peptide which inhibits cell wall synthesis is the lantibiotic mersacidin, which interrupts the process 
of transglycosylation of lipid II, a step essential in the formation of peptidoglycan (36). 
1.4 Biosynthesis of AMPs 
The majority of AMPs synthesized by multicellular organisms are produced by traditional gene 
transcription preceded by translation via ribosomes, and will often undergo post-translational 
modification (18). An example of post-translational proteolysis is the formation of individual 
magainin peptides from a preprotein made of six copies of the peptide (37). Other peptides which 
undergo proteolytic cleavage include lactoferricin B produced in milk proteins, peptides resulting 
from denatured lysozyme, the cecropin like AMPs produced by Heliobactor pylori, bifuron I and 
parasin I (38–41). Other post-translational modification include glycosylation (42–45) and 
bromidation (46).  
When it comes to microorganisms, many of the AMPs synthesized contain non-natural or 
uncommon amino acids. This is most often due to the fact that these AMPs are synthesized non-
ribosomally in an enzymatic process, or through proteolytic cleavage following ribosomal synthesis 
(18). Non-ribosomally produced AMPs are synthesized by large, multifunctional peptide 
synthetases using a thiotemplate mechanism with multiple carrier domains, examples of peptides 
produced in this way include polymyxin B, colistin (polymyxin E or colimycin) and the tyrocidines, 
all of which have been used clinically (47–49). 
1.5 The tyrocidines 
The tyrocidines and their analogues are basic, cyclic decapeptides which form part of a group of 
antimicrobial AMPs extracted, together with neutral gramicidins, from a soil bacterium known as 
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Figure 1.2 Tyrocidine A peptide as defined by having two Phe residues at positions 3 and 4 
(making it an A analogue) and a Tyr residue at position 7 (making it a Tyrocidine). 
Numbers indicate order of incorporation of amino acids during biosynthesis. 
Residues in brackets are other possible amino acids which can be incorporated at 
these variable positions to produce the various tyrocidines and analogues as observed 
by Tang et al (62) and listed in Table 1.1. 
Brevibacillus parabrevis (Br. Parabrevis), and are produced in the late logarithmic phase of growth 
(50–53). The collective term for this antimicrobial extract is tyrothricin (Tcn), and was first isolated 
by René Dubos in 1939 who found an extract of a cultured soil bacillus to be active against Gram-
positive cocci (54). It was the first antibiotic to be used in a clinical setting but had limited use due 
to its haemolytic effect on red blood cells (55), and as such its main use was as a topical agent for 
treatment for surface wounds (56–59), as an active ingredient in throat lozenges (60) and for the 
treatment of eye ulcers (61). 
1.5.1 Structure 
The Trcs are cationic, consisting of a balance of hydrophobic and hydrophilic amino acid residues. 
There are many structural Trc analogues synthesized together by the producer organism which 
differ by one-another at specific amino acid positions within the peptide, with the sequence 
cyclo[f1P2X3x4N5Q6Y7V8X9L10] (residues depicted with a lower-case x represent variable D-amino 
while an upper-case X represents an L-amino acid). These variable amino acid residues include 
those found at positions three and four (Phe and/or Trp), seven (Tyr, Trp or Phe) and nine (ornithine 
(Orn or O) or Lys). (50, 62, 63). Figure 1.2 depicts a tyrocidine A with the relatively hydrophobic 
amino acid Phe at positions three and four.  Bearing this variability mind, a study by Tang et al 
(1992) identified the primary structures of 28 natural tyrocidine analogues, shown in Table 1.1 (62). 
While up to 72 different analogues are possible in theory, practically, only a smaller subset are 
produced, or at least at a high enough concentration to be detected (64). Tyrocidine A, A1, B, B1, C 
and C1 are produced in the highest abundance by the producer organism and can be thought of as 
the major tyrocidines, while those present in smaller amounts are considered as analogues of these 
major Trcs (62, 65). 
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Table 1.1  Tyrocidines and analogues identified and characterised from tyrothricin by Tang et 
al. (62). Standard one letter abbreviations for the L-amino acid residues are used, 
except O for ornithine. The lower-case letters depict D-amino acid residues in the 
sequence. 
Number Identity Abbreviation Sequence 
 Monoisotopic 
M
r 
Abundance 
1 Tyrocidine D * TrcD VOLfPYwNQY  1324.7 2.1 
2 Tyrocidne D1 * TrcD1 VKLfPYwNQY  1338.7 1.7 
3 - - VOLyPWwNQY  1363.7 < 1 
4 Tyrocidine E' * TrcE' VOLfPFyNQY  1285.7 < 1 
5 Tyrocidine E1' * TrcE1'  VKLfPFyNQY  1299.7 < 1 
6 Tyrocidine C TrcC VOLfPWwNQY  1347.7 100 
7 Tyrocidine C1 TrcC1 VKLfPWwNQY  1361.7 30 
8 Tryptocidine C TpcC VOLfPWwNQW  1370.7 23 
9 Tryptocidine C1* TpcC1 VKLfPWwNQW  1384.7 2.3 
10 Tyrocidine B' * TrcB' VOLfPFwNQY  1308.7 14 
11 Tyrocidine B1'* TrcB1' VKLfPFwNQY  1322.7 5.8 
12 Tyrocidine B TrcB VOLfPWfNQY  1308.7 109 
13 Tyrocidne B1 TrcB1 VKLfPWfNQY  1322.7 44 
14 Tryptocidine B TpcB VOLfPWfNQW  1331.7 26 
15 Tryptocidine B1 TpcB1 VKLfPWfNQW  1345.7 13 
16 Tyrocidine A TrcA VOLfPFfNQY  1269.7 88 
17 Tyrocidine A1 TrcA1 VKLfPFfNQY  1283.7 39 
18 Tryptocidine A TpcA VOLfPFfNQW  1292.7 15 
19 Phenycidine A ** PhcA VOLfPFfNQF  1253.7 3.1 
20 Tyrocidine E * TrcE VOLfPYfNQY  1285.7 2.2 
21 Tyrocidine E1* TrcE1 VKLfPYfNQY  1299.7 1.1 
22 - - VOLfPF(?)NQY  1336.7 4.5 
23 - - VKLfPF(?)NQY  1350.7 9.4 
24 Phenycidine B* PhcB VOLfPWfNQF  1292.7 3.7 
25 - - (L/I)OLfPWfNQY  1322.7 1.9 
26 - - (L/I)KLfPWfNQY  1336.7 2.6 
27 - - VOLfP(L/I)fNQY  1325.7 1.2 
28 - - VKLfP(L/I)fNQY  1249.7 < 1 
 * Peptides renamed in this study 
** Peptides renamed by our group 
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The secondary structure of TrcA (Figure 1.3) has been found to be composed of a two-stranded 
antiparrelel β-sheet structure which is connected by a type II β-turn on the one end and a type I β-
turn on the other end of the molecule (66–71). The residues Leu10, D-Phe1, Pro2 and Phe3 form a 
type II β-turn, and the residues Asn5, Gln6, Tyr7 and Val8 at the other end form a slightly distorted 
type 1 β-turn. 
The two strands are connected via three hydrogen bonds which lie between the backbone amide and 
carbonyl groups, with a fourth hydrogen bond between the backbone amide of Val8 and the side 
chain of Asn5. The association of the strands in TrcA are stabilised by hydrophobic interactions 
between the side chains of D-Phe4, Val8 and Leu10 (70). While these structural characteristics were 
determined for TrcA, differences in amino acid composition, particularly for the aromatic residues, 
are still believed to result in the same backbone structure among different tyrocidine analogues (72) 
From the studies of Loll et al. (70) and Munyuki et al. (71) it was  observed that the homodimer 
form TrcA is formed by a strong association between the two monomers. The β-sheets of each 
monomer align edge-on, leading to the formation of continuous four-stranded antiparallel sheet, 
which possess four hydrogens bonds between the backbones of each monomer. The dimer is also 
stabilised by hydrophobic interactions between the side chains of Val8 of one monomer with the 
Leu10 of another monomer. There is also a stabilising effect between the aromatic rings of D-Phe1 
and Tyr7 on the opposing monomers (70). The dimer form of the tyrocidine has been proposed to be 
the active conformation of these cyclic decapeptides (70). 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
1-9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5.2 Activity 
The Tcn extract from Br. parabrevis was first tested against a variety of Gram-positive and Gram-
negative bacteria by its discoverer, Dubos, who demonstrated its bactericidal effect on various 
strains of Diplococcus pneumoniae, Streptococcus hemolyticus, Streptococcus viridans and 
Streptococcus viridans but found no bactericidal effect on the Gram-negative bacteria tested (73). In 
the years since this initial research, research has shown this same extract to have a wide variety of 
activity, including, but not limited to fungi, viruses and malarial parasites. 
Antibacterial: Kretschmar et al. (75) tested several reference strains, and clinical isolates, of 
streptococci, staphylococci and enterococci against tyrothricin and found their minimum inhibitory 
concentration ranges (MICs) to be between 0.048-1.526 μg/mL, 1.562-3.125 μg/mL and 0.195-
1.562 μg/mL respectively. A study by Spathelf and Rautenbach (76) found the Tcn extract to be 
active against the Gram-positive bacteria Micrococcus luteus, as well as two different strains of 
Listeria monocytogenes, with IC50 concentration (concentration of peptide that leads to 50% 
Figure 1.3  Secondary structure of the six major tyrocidines showing the side chains of 
the variable aromatic dipeptide moiety, two turns (type II and I β turns) 
leading to the formation of an anti-parallel β-sheet structure. The differences 
in sequence of major peptides are shown above and on the left side of the 
figure. Also refer to Table 1.1 above. Figure courtesy of M. Rautenbach, 
structures created from the TrcC and TrcA models of  Munyuki et al. (71) 
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inhibition of maximum growth of the target organism) of 3.5 μg/mL, 12.0 μg/mL and 9.7 μg/mL 
respectively.  
Antifungal: Tcn was found to be active against a variety of Candida species (with both reference 
strains and clinical isolates), being C. albicans, C. tropicalis and C. glabrata, with MICs of between 
4 μg/ml and 16 μg/ml for the different strains and isolates of C. albicans tested, between 5.3 μg/ml 
and 7.8 μg/ml for the strains isolates of C. tropicalis tested and between 6.4 and 8.6 μg/ml for the 
different strains and isolates of C. glabrata tested (77, 78). Several clinical isolates of C. 
parapsilosis were also found to have their growth inhibited by tyrothricin (78). A study by Troskie 
et al. (79) showed the activity of Tcn extract (which had been treated to remove gramicidins) 
against a wide array of phytopathogenic fungi, with IC50 values ranging from 2.0 μg/mL for a strain 
of Cylindrocarpon liriodendra, to 8.9 μg/mL for a strain of Penicillium glabrum. 
Antiviral: An in vitro experiment against the parainfluenza virus (type Sendai) showed that 
tyrothricin had anti-infectious activity, with a similar anti-infective activity being shown for 
mumps, herpes and influenza viruses (80). Similar experiments using the herpes-simplex-virus 
(HSV) type 1 showed that incubating the virus with tyrothricin in suspension significantly 
decreased the lethality of the virus in a mouse model, but this effect was dependent on initial, direct 
contact with the virus and the peptide before contact with the mice (81). 
Antiplasmodial: A study by Taliaferro et al. (1944) found daily tyrothricin dosages of 0.2 mg to 
effectively rid chickens of Plasmodium gallinaceum when administered intravenously in a 9.5% 
ethanol solution. Tyrothricin acted in a parasiticidal manner, killing extracellular merozoites 
produced at the segmentation phase of growth most effectively, and to a lesser extent acting via 
inhibition of growth and reproduction of the parasite (82). A study by Rautenbach et al. (2007) 
assessed the in vitro activity of six purified Trc analogues on the malaria causing parasite 
Plasmodium falciparum (strain 3D7) and found that all the analogues tested had antiplasmodial 
activity in the nanomolar range, with the Trc analogue TrcA having the best relative activity with an 
IC50 value of 580 picomolar (83).  A study by Leussa (84) also assessed the effects of isolated Trcs 
on the growth of several strains of P. falciparum, showing a wide range of IC50 depending on both 
Trc structure and strain of target organism. These values ranged from 15 nM for PhcA against the 
3D7 strain of P. falciparum, to 1920 nM for TrcA against the Dd2 strain. 
Activity in mammalian cell infections: The Tcn complex, and both the Trcs and Grcs individually, 
have haemolytic activity (85–89), however, the haemolytic activity of the Trcs is less, particularly 
over longer periods of time (55, 87). The tyrothricin peptides have been shown to be safe when 
applied topically to skin ulcers and cutaneous infections (61, 90–93), but will lyse blood cells if 
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exposure to the blood stream occurs via deeper, sub-cutaneous wounds (88, 94). Oral administration 
of tyrothricin has been reported by some to treat microbial infections in mice (52, 95) but other 
studies showed tyrothricin to only slow infections of pathogens which typically invade the upper 
gastro intestinal tract (95). It appears that the tyrothricin peptides may be inactivated within the 
mammalian gastrointestinal tract as oral treatment of mice with these peptides showed no change in 
their intestinal microbiota (94, 96). 
1.5.3 Structure-activity 
Significant research has been done the importance of the residues D-Phe4 and Gln6, highlighting 
their role on the therapeutic ratio (the ratio between minimum haemolytic concentration and 
minimum concentration required to inhibit bacterial growth) (97–99). 
The hydrophobic amino acid D-Phe4 is important due to its role in inserting into hydrophobic core 
of lipid bi-layers, and substitution of this amino acid with other hydrophobic residues does not have 
a significant effect on Trc activity (97, 98), but substitution with basic D-amino acids leads to a 
reduction in activity (63, 97, 100), believed to be primarily due to a loss in amphipathicity. 
Replacing D-Phe4 with basic L-amino acids does not lead to a loss in activity, unlike the basic D-
amino acid, this residue has a reversed orientation of its side chain, allowing it to orientate with the 
basic face of the Trc dimer, potentially reinforcing the amphipathicity of the molecule (97).  
A wide variety of amino acid substitutions in place of Gln6, ranging in size and hydrophobicity, are 
well tolerated, with 13 out of 14 substitutions tested leading to improved antibacterial activity (98). 
It appears that irrespective of the amino acid substituted at this position, the residue will still lie at 
the interface between the hydrophobic interior of the lipid bilayer and the lipid head group 
following interaction with a bacterial membrane, allowing for more hydrophobic residues to 
associate with the nearby hydrophobic face of the molecule, and the phospholipid head groups for 
more hydrophilic residues (70). 
A study by Rautenbach et al. (2007) found that the six major tyrocidine analogues (A, A1, B, B1, C 
and C1) all showed activity in the nanomolar range against P. falciparum. An increase in the 
apparent hydrophobicity and a decrease in the side chain surface area of these analogues correlated 
well with an increase in their selective activity against this malaria parasite. In terms of amino acid 
composition, the tyrocidines with phenylalanine residues at positions 3 and 4 and ornithine at 
position 9 (TrcA) was therefore the most active against the parasite while TrcC1 was the least active, 
with tryptophan residues at positions 3 and 4 and lysine at position 9. 
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A study by Spathelf and Rautenbach (2009) looked at the same six major analogues on the Gram-
positive bacterium L. monocytogenes, a potentially deadly food-borne pathogen. Unlike malaria 
however, the more polar tyrocidines showed improved activity. TrcC showed better activity than 
TrcB while both were superior to TrcA. The presence of the more hydrophilic residues at positions 
3 and 4 in the form of tryptophan therefore appear to improve the activity of these peptides against 
this organism (76).  
A study by Leussa and Rautenbach (101) found that activity against selected strains of L. 
monocytogenes was dependant on Tyr or Phe in position 7 of the sequence, ornithine (Orn, O) as 
cationic residue at position 9, and Trp in position 3 or 4. The roles of Trp and Orn in the tyrocidines 
were confirmed with most active peptide being a TrcB containing Orn and a Trp-D-Phe in the 
aromatic dipeptide moiety. However, a modified TrcA, which typically had reduced activity against 
this target organism, was found to have an ICmax (concentration causing 100% growth inhibition) of 
18 μM, rivalling that of TrcB (16 μM) which was the most active peptide. The increased activity of 
this TrcA analogue resulted from the insertion of a trimethylated Orn residue at position 9 in place 
of the natural Orn residue. This lead to a relatively more hydrophobic peptide, which had reduced 
hydrogen bonding with the aromatic amino acids at position 3 and 4, and was likely more active due 
to deeper insertion into the target membrane. This result supports the importance and the nature of 
the interactions between aromatic amino acids present at positions 3 and 4, and interaction with the 
cationic ornithine residue at position 9. Any residue change resulting in tighter membrane 
interaction is likely to trap TrcA in the membrane and impede its mechanism of action.  
1.5.4 Mechanism of action 
Like many AMPs, the activity of the Trcs is believed primarily be mediated by their interaction 
with a target membrane largely though hydrophobic interaction (102), leading to membrane 
permeabilisation (103) and ultimately cell lysis (73). Trc dimers are likely the most active 
membrane configuration, due to their increased amphipathicity relative to monomers (70, 71).  A 
study by Loll et al. (70) used X-ray crystallography to determine the crystal structure of TrcA. It 
was found that TrcA forms strongly associated, highly amphipathic homodimers consisting of four 
β-strands that associate into a single, highly curved, anti-parallel β-sheet. The dimerisation of TrcA 
enhances the amphipathic nature of the TrcA peptides by partitioning hydrophobic and hydrophilic 
residues. In the dimer structure all of the amino acid side chains on the convex face of the dimer are 
hydrophobic, with the exception of the neutral, polar Asn5 residue, which takes part in the backbone 
hydrogen bonding of the dimer. Only a relatively hydrophilic, charged, Orn9 residue is found 
protruding off the convex face of the dimer. The backbone carbonyl oxygens of D-Phe1, Asn5 and 
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Gln6 all point outward on the convex face of the dimer. The Gln6 residue lies in an equatorial region 
between the concave and convex faces, but is also well positioned to turn towards the concave face. 
This configuration of amino acids ultimately produces a highly polar concave face, and a strongly 
non-polar convex face (Figure 1.4, A). The hydrophobic face of this amphipathic dimer is 
hypothesised to insert deeply into the lipid bilayer in target membranes, with the hydrophilic 
residues protruding outwards (Figure 1.4, B). 
 
 
 
 
 
 
 
 
 
 
Membrane-bound tyrocidines, especially at higher concentrations, appear to oligomerise to from 
pore-like structures in a manner similar to gramicidin S (50, 104–107). While hydrophobic 
interaction is essential for association with membrane lipids, hydrogen bonding and ionic 
interactions also play a role (101). In addition to membrane-mediated mechanisms of action, other 
non-lytic mechanisms have been proposed (76, 79, 83, 84). In the case of the Trcs antiplasmodial 
activity, it is suggested that there are other intracellular targets, such as the food vacuole (84) or 
regulators of the cell cycle (83). In Gram-positive bacteria the Trcs have been shown to disrupt 
glucose metabolism (85, 108). The Trcs may also inhibit replication and/or transcription (102) 
which is hypothesized partly due to the observation that it binds to DNA in the producer organism 
(109–111) where it inhibits transcription in vitro (112). 
1.5.5 Tyrocidine biosynthesis 
Unlike traditional protein and peptide synthesis, the tyrocidines produced by Br. Parabrevis are 
created without the use of ribosomes but rather enzymatically in a process known as non-ribosomal 
A B 
Figure 1.4 The dimer structure of TrcA with A the highly amphipathic structure (hydrophilic 
side chains shown in red, hydrophobic side chains shown in blue) showing the 
polar concave face and the non-polar convex face of the dimer and B showing the 
proposed mechanism of interaction of this dimer with a model bacterial 
membrane, with the hydrophobic, convex face inserting into the lipid-bilayer 
(with Phe4 at its center and Gln6 lying at the interface of the lipid layer), and the 
polar face lying at the level of the lipid head groups, extending outward (images 
from Loll et al. (70)). 
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peptide synthesis. These large modular enzymes have multiple domains and are known as non-
ribosomal peptide synthetases, which incorporate amino acids directly into a growing peptide (113). 
In the case of tyrocidines, there are three major NRPS involved, TycA, TycB and TycC, which 
activate and incorporate one, three and six amino acids respectively into the final decapeptide 
product (114). Experiments involving the purification of TycA, TycB and TycC found them to 
consist of 100, 230 and 440 kDa proteins respectively, and as a result the purified enzymes were 
commonly referred to as the light (TycA), intermediate (TycB) and heavy fractions (TycC) 
respectively (114).  
Following the incorporation of ten amino acids into a linear tyrocidine, the synthesis process is 
completed by ring closure between the Leu10 and Phe1 (114). Within each of the three tyrocidine 
synthetases there exists a number of modules, which in turn contain all the necessary domains for 
the incorporation of a single amino acid (although not always a specific amino acid), into a given 
Trc (115). The process of Trc synthesis begins with the activation of an amino acid substrate in the 
adenylation domain (A) of the enzyme module consuming ATP with dependence on Mg2+ as a 
cofactor in the process (116). The A-domain of modules three, four, seven and nine have affinity for 
more than one amino acid, allowing activation and subsequent incorporation of different amino 
acids at these positions in the peptide (117). This forms an activated aminoacyl-O-AMP.   
The Ppan-arm assists in the delivery of the aminoacyl- and peptidyl-S-PCP intermediates to the 
condensation domain (C), which catalyses the nucleophilic attack of the activated amino acid’s α-
carbon group on the thio-esterified carboxy group of an adjacent amino-acyl-S-Ppant moiety 
(another single activated amino acid) or a peptidyl-S-Ppan moiety (elongating peptide) on the 
preceding module to form a peptide bond (126). During this condensation process, all intermediates 
are covalently attached to the multienzyme complex. In summary, the biosynthesis of tyrocidine is 
mediated by the 4’PP cofactors, which assist in the ordered shuttling of carboxy activated substrates 
between the active units that constitute the peptide synthetases (115). At modules one and four there 
exists an additional epimerase (E) domain which catalyses the epimerisation of the activated amino 
acid bound there before its incorporation into the peptide (127, 128). These E-domains are found at 
the C-terminal ends of the TycA and TycB domains. A thioesterase (TE) domain catalyses the 
release of the peptide from the enzyme template and is therefore found at the C-terminal module of 
the NRPS (129). This process involves the formation of an acyl-O-TE intermediate which is 
cleaved by a regio- or stereoselective macrocyclization process, which uses an internal nucleophile 
to generate a cyclic product in the case of the tyrocidines (130, 131). The number of separate 
modules, with all the necessary enzyme domains needed for incorporation of an activated amino 
acid, as well as their order, determine the size and sequence of the produced peptide (115). We will 
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report in this research study on the elasticity of the tyrocidine synthesis machinery in terms of the 
incorporation of natural aromatic amino acids and non-natural amino acids in the four aromatic 
positions of the cyclodecapeptide structure.  
The Ppan-arm assists in the delivery of the aminoacyl- and peptidyl-S-PCP intermediates to the 
condensation domain (C), which catalyses the nucleophilic attack of the activated amino acid’s α-
carbon group on the thio-esterified carboxy group of an adjacent amino-acyl-S-Ppant moiety 
(another single activated amino acid) or a peptidyl-S-Ppan moiety (elongating peptide) on the 
preceding module to form a peptide bond (126). During this condensation process, all intermediates 
are covalently attached to the multienzyme complex. In summary, the biosynthesis of tyrocidine is 
mediated by the 4’PP cofactors, which assist in the ordered shuttling of carboxy activated substrates 
between the active units that constitute the peptide synthetases (115). At modules one and four there 
exists an additional epimerase (E) domain which catalyses the epimerisation of the activated amino 
acid bound there before its incorporation into the peptide (127, 128). These E-domains are found at 
the C-terminal ends of the TycA and TycB domains. A thioesterase (TE) domain catalyses the 
release of the peptide from the enzyme template and is therefore found at the C-terminal module of 
the NRPS (129). This process involves the formation of an acyl-O-TE intermediate which is 
cleaved by a regio- or stereoselective macrocyclization process, which uses an internal nucleophile 
to generate a cyclic product in the case of the tyrocidines (130, 131). The number of separate 
modules, with all the necessary enzyme domains needed for incorporation of an activated amino 
acid, as well as their order, determine the size and sequence of the produced peptide (115). We will 
report in this research study on the elasticity of the tyrocidine synthesis machinery in terms of the 
incorporation of natural aromatic amino acids and non-natural amino acids in the four aromatic 
positions of the cyclodecapeptide structure.  
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Tyrocidine production profile characterisation and optimisation of carbon, nitrogen 
and sulphate sources in different strains of Brevibacillus parabrevis 
2.1 Introduction 
Tyrothricin (Tcn) is an antimicrobial peptide complex produced by the gram-positive soil bacteria 
Brevibacillus parabrevis (previously known as Bacillus brevis and Bacillius aneurinolyticus) consists 
of two major peptide groups, namely the tyrocidines (Trc) and gramicidines (Grcs) (1, 2). The Trcs 
are basic, cyclic decapeptides and the Grcs are neutral, linear pentadecapeptides (2, 3). The 
tyrocidines are synthesised by multienzyme complex (Trc synthetase complex) which sequentially 
incorporates the constituent amino acids into the growing peptide, with three major enzyme 
complexes (Trc synthetases I, II and III) consisting of enzyme subunits which in turn have domains 
specific for the activation and incorporation of an amino acids into the growing peptide (4). The 
sequence variability seen between Trc analogues is largely due to the ability of the Trc synthetase 
sub-units to incorporate different amino acids at positions 3,4 and 7 within the Trc cyclic decapeptide 
(3–5).  
Trc inhibits the growth of a wide variety of Gram-positive microorganisms (6, 7), as well as the blood-
borne malaria parasite Plasmodium falciparum, and are toxic in the blood stream due to their 
haemolytic activity (2, 8).  They, however, show little toxicity when applied topically or locally, for 
example, via the subcutaneous, intramuscular or intrapleural routes (2). The Trcs have shown their 
ability to induce cell death of target organisms via lysis of the cell membrane but other mechanisms 
of action may cause or contribute to cell death, including a secondary effect of autolytic enzymes, 
inactivation of the target cell enzymes (resulting in disruption of metabolic activity) and DNA binding 
leading to non-specific repression of transcription (1, 9–13).  
The yield of Tcn was found to vary greatly depending on the composition of the growth media used 
in the initial work done on Tcn production by Dubos et al. (1). Complex nitrogen sources such as 
acid hydrolysed casein, tryptic digest of soybean meal, corn-steep liquor, tryptone and press juice 
concentrates have been found most effective in Tcn production. Using 0.2% tryptone in conjunction 
with glutamic acid, asparagine or ammonium sulphate plus citric acid or malic acid was shown to be 
moderately effective for Tcn production (14). Fermentable carbon compounds, such as glucose, 
mannitol or glycerol, were also required at levels ranging between 3% to 5% for optimal yields (14). 
A study by Okuda et al. (15) supported this, finding that a combination of tryptone, yeast extract, 
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mineral salts and glucose gave the best yield. The need for calcium and either magnesium or 
manganese was also found, particularly since the latter two compounds act as co-factors for the 
production of tyrocidine by the tyrocidine producing peptide synthetases (1, 16).   
In addition to media composition, significant variability has been found for Grc production between 
different strains of the producer organism (1). Within the total amount of Tcn produced, the ratio of 
Grcs and Trcs may also be altered (15). Okuda et al. (15) produced between 0.38 mg Grc and 1.37 
mg Trc, and 3.28 mg Grc and 9.65 mg Trc per 100 ml culture media depending on the composition 
of the media.  
Tcn production is slow during the initial phase of bacterial growth but tends to accelerate during the 
log phase where observed yields of 103 mg/100 mL Trc and 95 mg/100 mL Grc after 108 hours of 
growth in a simple Tryptone-NaCl growth media (15). Mach et al. (17) found that tyrocidine 
production occurred 26 hours after inoculation, correlating with the completion of the exponential 
growth, or log phase, in a media composition used previously by Stokes and Woodward (18), which 
contained a mixture of mineral salts, L-asparagine and glycerol.  
Little work has been done to assess and compare the variability of the growth of different strains of 
Tcn-producing Br. parabrevis. In this study, we first assessed the Trc production of four different 
strains in TGS media using medium-scale cultures then proceeded to investigate the effect of various 
nitrogen, sulphate and carbon sources, both in varying combinations and concentrations, on the 
growth of three selected strains of the producer organism. Following this, small-scale, medium 
throughput culturing was done to assess any correlation between growth rate and peptide production.  
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2.2 Materials  
The producer organisms Brevibacillus parabrevis (Br. parabrevis) 362 and 5618 originate from the 
Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) in Braunschweig, Germany. 
The Br. parabrevis 8185 and 10068 strains originate from the American Type Culture Collection 
(ATCC) based in Manassas (Virginia, USA). Micrococcus luteus (M. luteus) was sourced from the 
National Collection of Type Cultures (NCTC) in Porton Down (Salisbury, England).   
Tryptic soy broth (TSB), yeast extract, tryptone, agar, glucose (Glc), glycerol (Glr), ethanol (EtOH), 
hydrochloric acid (HCl), sodium chloride (NaCl) and ammonium sulphate ((NH4)2SO4) were from 
Merck (Darmstadt, Germany). Triflouroacetic acid (TFA, > 98% purity) was from Sigma-Aldrich 
(St. Louis, USA). Acetonitrile (ACN, far UV cut-off, > 98% purity) was obtained from Romil Ltd 
(Cambridge, UK). Analytical grade, deionised water was obtained by filtering reverse osmosis water 
through a Millipore® water purification system. Urea was obtained from ICN Biomedicals Inc 
(Aurora, USA). Sodium sulphate (Na2SO4) was from Univar (Illinois, US).  
Falcon® tubes were from SPL Life Sciences Co (Gyeonggi-do, South Korea). 0.22 μm syringe filters 
were from GVS Filter Technology (Morecambe, UK). The Acquity UPLC® BEH Phenyl column (2.1 
mm × 100 mm, 1.7 μm particle size) was from Waters (Milford, MA, USA).  Ninety-six well deep-
well plates were from Thermo Fisher Scientific (Waltham, MA, USA).     
2.3 Methods 
2.3.1 Medium-scale culturing of producer organisms 
Pre-culturing of producer organisms: The four available strains, Br. parabrevis ATCC 8185, Br. 
parabrevis ATCC 10068, Br. parabrevis DSMZ 362 and Br. parabrevis DSMZ 5618 (Note: strains 
will be referred to only by strain number throughout rest of chapter) were grown from glycerol freezer 
stocks stored at -80 °C.  A wire loop was used to scoop a dollop of the partially defrosted glycerol 
stocks onto tryptone soy agar (TSA) (3% (m/v) TSB, 1.5% (m/v) agar) petri dishes and subsequently 
streaked out and incubated at 37 °C for 48 hours to allow for the growth of individual colonies.  
Selection of producer colonies: To ensure that Tcn producing colonies were selected and used in 
subsequent experiments, a spot-on-lawn assay was done. Individual colonies were chosen and spotted 
onto a TSA agar petri dish in a grid like fashion so that the placement of each colony could be 
recorded. This plate is referred to as the seed plate. These colonies were chosen from the previously 
streaked out glycerol stocks, and were selected primarily based on size, with larger, darker coloured 
colonies being preferred. In order to determine if the selected colonies were producing tyrothricin, 
activity against M. luteus was tested for in the form of growth inhibition zones. M. luteus was grown 
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from freezer stocks on LB agar plates (1% (m/v) tryptone, 0.5 % (m/v) yeast extract, 1% (m/v) NaCl, 
1.5 % m/v agar), and a colony was used to inoculate 20 mL of Luria Bertani broth (LB) (1% (m/v) 
tryptone, 0.5 % (m/v) yeast extract, 1% (m/v) NaCl). This was then incubated at 37 °C, together with 
an LB blank, while being mixed at 150 rpm for 16 hours to allow for an OD at 595 nm of 0.6 
(representing the exponential phase of the organism’s growth) to develop relative to the LB blank. 
This was then sub-cultured by adding 200 uL of the 0.6 culture to 20 mL of fresh LB media. This was 
then incubated in the same manner but only for 5-6 hrs, to again reach an OD at 595 nm of 0.6. 
Following incubation, the sub-cultured M. luteus was mixed with warm LB agar (1% (m/v) tryptone, 
0.5 % (m/v) yeast extract, 1% (m/v) NaCl), which was allowed to cool sufficiently following 
autoclaving so as not to kill organism, at a ratio of 1:9 culture to LB agar. After this, 5 mL of the 
mixture of M. luteus and agar was added on top of a previously made LB agar petri dish and allowed 
to cool and solidify. Once cooled, colonies of the producer organism were spotted on top of the M. 
luteus using sterile pipette tips and were spotted from the same grid configuration of colonies on the 
original seed plate. These petri dishes were then incubated for 48 hours to allow for the growth of the 
colonies and the possible formation of zones of inhibition, where tyrothricin production halts the 
growth of M. luteus. The colonies with the largest inhibition zones were then used as a reference to 
find the original colony on the TSB plate, which was then used to create new glycerol freezer stocks. 
2.3.2 Production and extraction of tyrothricin 
Production of media: The previously optimised TGS (tryptone, glucose and inorganic salts) media 
was used based on a media composition developed by Lewis et al. (14). Due to an existing non-
disclosure agreement regarding a patent surrounding the production and extraction of tyrothricin, the 
details of this process will be omitted. TGS media (200 mL) was added into a 2-liter Erlenmeyer flask 
and autoclaved at 121 °C for 25 minutes at a pressure of 100 kPa. Twelve large scale cultures were 
prepared to allow for triplicate productions (n = 3) for each of the four strains used.  
Culturing and production of tyrothricin: In order to inoculate the 200 mL, medium-scale cultures, 
starter cultures were made. Glycerol stocks were streaked out onto tryptone soy agar (TSA) ( plates 
in the same manner as previously described and grown for 48 hours to allow for colony growth. Single 
colonies were then used to inoculate the starter culture, which was made using 20 mL of autoclaved 
TSB (3% (m/v)) in a 50 mL Falcon® tube. Following inoculation, the starter cultures were incubated 
(together with a blank) at 37°C for 16 hours while shaking at 150 rpm, allowing the cultures to reach 
an OD at 595 nm of between 0.6 and 0.9 relative to the TSB blank. Following incubation, 2 mL of 
the starter culture was added to the 200 mL culture (1% v/v) in a sterile manner. These medium-scale 
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cultures were then incubated, while stationary, for a period of 10 days. On the tenth day, the cultures 
were stopped by acidification. 
Extraction of tyrothricin: The initial acidification step is the first stage in tyrothricin extraction, and 
serves to both terminate bacterial growth and assist in cell lysis and precipitation of organic material. 
The details of extraction fall under the protection of a non-disclosure agreement with BIOPEP® and 
Stellenbosch University, and as such only the general principles will be briefly described. Following 
acidification, the biomass went through several extraction steps including organic solvent extraction, 
precipitation steps, and treatment with activated carbon. The aim is to maximise the concentration of 
the Trcs relative to co-extracted compounds at the end of the extraction steps. Crude extract masses 
were recorded. 
Analysis of extracts via UPLC-ESMS: Aliquots obtained from the first round of extraction with 
organic solvent were used for ultraperformance liquid chromatography (UPLC) linked to electrospray 
mass spectrometry (UPLC-MS). Freeze dried samples were made up to 50 mg/mL in 50% (v/v) 
acetonitrile diluted with deionised analytical grade water. The samples were then centrifuged at 8600 
× g for 10 minutes to remove any particulate or insoluble material from the sample. Following 
centrifugation, a 10 fold dilution was made using the supernatant and deionised water in a 200 uL 
vial insert. An injection of 3 μL was done using a Waters Acquity UPLCTM system and separation of 
Trcs and Grcs was done on an Acquity UPLC® BEH Phenyl column. The conditions for UPLC 
separation were as follows: a column temperature of 60 °C, a flow rate of 300 μL/min and a linear 
buffer gradient using two eluents, eluent A (1% (v/v) formic acid in analytical grade deionised water) 
and eluent B (ACN). Table 2.1 shows the UPLC method gradient that was used. 
 
 
 
 
 
 
The visualization of the chromatography was done via mass spectrometry utilizing a Waters Synapt 
G2 mass spectrometer. Two microliters of analyte was injected and ionised via electrospray in 
positive mode, using a Z-spray configuration. A capillary voltage of 2.5 kV was used together with a 
cone voltage of 15 V at a temperature of 120 °C at the source. Desolvation gas (N2) was applied at a 
Table 2.1  UPLC linear gradient program used for separation of peptides during the 
UPLC-MS analysis of medium and small scale culture extracts 
Step % eluent B 
Start 
% eluent B 
End 
Time interval 
(min) 
1 0 0 0 - 0.5 
2 0 30 0.5 - 1 
3 30 60 1 - 10 
4 60 80 10 - 15 
5 80 100 15 – 15.1 
6 100 100 15.1-18 
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rate of 650 L/hour and a desolvation temperature 275 °C. The data were acquired by scans covering 
a mass-to-charge (m/z) range of 300 to 2000 in continuum mode with a rate of 0.2 scans per second.   
2.3.3 Bacterial growth using variable nutrient sources  
Growth curves for nitrogen and sulphate sources: Using TGS as a base media, different nitrogen or 
sulphate sources were added over a range of concentrations and the effect on the growth rate of 
producer organism was recorded. A four times concentrated solution of TGS media was made to 
allow for dilution with analytical grade water and the variable nitrogen and/or sulphate source. For 
the nitrogen sources, stocks of 100 g/L urea (CO(NH2)2)  and ammonium sulphate ((NH4)2SO4) were 
used. The ammonium sulphate served both as a nitrogen and sulphate sources, while sodium sulphate 
(Na2SO4) was used as a sulphate source only. All stocks were sterilised by autoclaving in Falcon
® 
tubes. In a 96-well microtiter plate, 50 μL of concentrated TGS was added to all wells after which the 
stock solutions of urea, ammonium sulphate or sodium sulphate were added. In addition, a 
combination of both urea and sodium sulphate was used. A range of concentrations was used starting 
at 0.4 g/L going up to 8.0 g/L. In the case of the urea and sodium sulphate combination, one 
concentration range used a fixed urea concentration of 5 g/L urea together with variable sodium 
sulphate, while another used a fixed sodium sulphate concentration of 2.5 g/L combined with a 
variable urea concentration. TGS on its own was used as both a standard to measure growth under 
unmodified conditions and as a blank to check for contamination of the base media. To get TGS and 
the added nitrogen or sulphate sources to the correct concentration sterilised analytical grade water 
was added to the wells for a final volume of 200 uL per well. Overnight starter cultures of the 5618, 
362 and 8185 strains were made by inoculating TSB (3% (m/v) dissolved in analytical grade water) 
media with a colony of the producer organism and incubating at 37 °C for 16 hours. After reaching 
an OD at 595 nm of between 0.6 and 0.9 the starter culture was diluted with TSB to an OD of 0.2. 
Ten microliters of the diluted starter culture was added to each well with the exception of the blank, 
where 10 μL of the sterile blank was added. Three replicates were done for ammonium sulphate    (n 
= 3), four for sodium sulphate (n = 4), four for urea (n = 4), 6 for variable sodium sulphate and fixed 
urea (n = 6) and 5 for variable urea and fixed sodium sulphate (n = 5). Plates were incubated at 37 
°C and their OD at 595 nm was read every hour for the first 8 hours and then at 10 and 12 hours using 
a BioRadTM Model 680 microplate reader.  
Growth curves for carbon sources: Here the tryptone and salts from TGS were used but glucose was 
removed to allow for the addition of variable glucose (Glc) or glycerol (Glr) concentrations (or a 
combination of the two). Stock solutions of 50% (m/v) Glc and Glr were sterilised via autoclaving. A 
four times concentrated solution of tryptone and salts (TS) was made to allow for dilution with Glc 
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and/or Glr and analytical-grade water. A concentration range for Glc was used ranging from 10 g/L 
to 45 g/L while a Glr concentration range of 12.6 g/L to 94.5 g/L was used. A fixed Glc concentration 
of 30 g/L together with a variable Glr concentration range was also used as well as a fixed Glr 
concentration of 63 g/L together with a variable Glc concentration. Concentrated Glc or Glr was 
added to the appropriate wells followed by the addition of 50 μL of four times concentrated TS and 
finally analytical grade water. A final volume of 200 μL was used in each well. The growth control 
and the blank used TS together with a Glc concentration of 30 g/L. Overnight night cultures of the 
three strains were made and added to the wells in the same manner as for the nitrogen and sulphate 
sources. OD readings were taken at 595 nm for the first 8 hours then at 10 and 12 hours using a 
BioRadTM microtiter plate reader. Six replicates (n = 6) were done for Glc and five for Glr (n = 5). 
Five repeats were done for the variable Glr and fixed Glc (n = 5) and six for variable Glc and fixed 
Glr (n = 6). 
Generating growth rates from growth curves: Using the growth curves generated from change in 
optical density over time, growth rates could be calculated. The steepest, linear section of this growth 
curve, which lies between the lag phase and the stationary phase, represents the exponential growth 
rate where maximal bacterial growth occurs. For each nitrogen, sulphate or carbon source a maximum 
number of data points were chosen within the linear section of the exponential phase. After this a 
linear regression was used to generate a first-order polynomial equation (i.e. straight line) using the 
data points. The gradient of this line represents the growth rate and is expressed in change in OD at 
595 nm per hour. A growth rate was generated for each analytical repeat and the mean of the repeats 
was calculated. 
2.3.4 Small scale cultures using optimised growth conditions 
Deep well assay: To assess the correlation between growth rate and tyrothricin production, small 
scale medium-throughput stationary cultures were done in 96-well deep well plates using urea as an 
additional nitrogen source. This was chosen after determining that urea produced, overall, the most 
significant effect on growth rate for both the nitrogen and sulphate sources. Concentrations of 1 g/L, 
4 g/L and 8 g/L were chosen to represent below optimal growth rate, optimal growth rate, and above 
the concentration that produced optimal growth rate respectively. No additional sulphate source was 
used and a glucose concentration of 35 g/L was used for the 5618 strain while 30 g/L was used for 
the 8185 and 362 strains. These glucose concentrations were selected based on growth rate. Again, a 
four-fold concentrated solution of TGS was made up (with 3.5 % (m/v) Glc concentration being 
chosen for the 5618 strain). Two-hundred and fifty microliters of TGS was added to each well, 
together with glucose. Five microliters, 20 μL or 40 μL of concentrated urea stock solution (50% 
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(m/v)) was then added and finally analytical grade, deionised water was added to a final volume of 
500 μL. TGS on its own was used as a growth and peptide production control. Starter cultures were 
made as previously described and 10 μL were used to inoculate each well. The deep-well plates were 
incubated for 10 days at 37 °C while remaining stationary. On the tenth day, the cultures were 
acidified and extracted.  
Extraction and ESMS analysis of deep well extracts: Following the 10 days of incubation the cultures 
were acidified using HCl to a pH of 4. After 3 hours, the cultures were spun down for 20 minutes at 
3000 × g.  The supernatant was removed, and the pellet was freeze-dried to get the cell mass. The cell 
mass was then extracted using 50% ACN for 30 minutes while sonicating. The extracts were then 
spun down again for 30 minutes at 3000 × g after which the supernatant was collected and freeze 
dried. After freeze drying the mass was recorded. The samples were then made up to 1 mg/mL using 
50% ACN and analytical grade water and spun down to remove insoluble material and particulate. 
The supernatant was removed and placed into a glass insert for ESMS analysis on a Waters Synapt 
G2 mass spectrometer. 
 
2.4 Results  
2.4.1 Extraction and UPLC-MS analysis of different producer strains  
The two tyrocidine producer strains of Br. parabrevis used for Tcn production in our lab are Br. 
parabrevis ATCC 10068 and Br. parabrevis ATCC 8185. Two more strains, Br. parabrevis DSMZ 
362 and Br. parabrevis DSMZ 5618, became available for use in tyrocidine production. Variability 
in strain production profiles has been observed in addition to growth media composition (22). UPLC-
MS analysis was done on medium-scale culture extracts using the different strains to determine if 
there were strain-dependant differences in their production profiles.  
TGS (tryptone, glucose, inorganic salts) media was used in these experiments and has been shown to 
give tyrothricin yields in the order of 2-3 g/L for stationary, 200 mL cultures grown in 2 litre 
Erlenmeyer flasks (22). Table 2.2 shows the yields of extracts of the medium-scale cultures for the 
four strains used. The 8185 strain gave the highest yield 770.6 mg, followed by the 5618 and 362 
strains, which gave similar yields of around 650 mg, and lastly the 10068 strain, which produced 
under half the yield of the 5618 and 362 strains and just over a quarter of the 8185 strain yield. 
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Table 2.2  Three rounds of extraction using organic solvent were done for each biological 
repeat giving the mean freeze-dried extract mass and the SEM 
Strain 10068 5618 362 8185 
Extract  Extract Mass (mg)/200 mL culture (n=3; ± SEM) 
1 166.1 ± 14.9 505.7 ± 20.4 436.7 ± 96.1 557 ± 98 
2 35.6 ± 5.7 97 ± 6.6 140.4 ± 66.4 156.6 ± 15.1 
3 13.9 ± 2.8 62 ± 32.7 56.8 ± 27.4 57 ± 9 
Total 215.6 664.7 633.9 770.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
The percentage contribution of each analogue to the total area-under-curve can be seen in Table 2.3. 
This gives a clearer indication of the relative production of each tyrocidine analogue for each strain. 
Here the superior production of C-analogues by 5618 can clearly be seen, with TpcC and TrcC1 
showing the largest increase in production relative to the other tryptophan containing analogues. For 
the B-analogues there was no strain that had a clearly superior production profile.  
The 362 strain showed the best TpcB1 and TrcB1 production, perhaps indicating a preference for 
incorporation of a lysine residue over an ornithine residue. For TpcB, the 8185-strain showed a 
marginally better production over 10068 while 10068 produced the highest relative amount of TrcB. 
The 362 strain showed the best overall production of the A analogues with the exception of TrcA, 
where the 10068-strain showed the best production. 
Figure 2.1 shows the UPLC-MS chromatograms of the extracts, with ESMS and area-under-curve 
(AUC) being used to determine the relative contributions of each Trc analogue to the entire 
production profile.  
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Figure 2.1 UPLC-MS analysis of the first round of culture extraction using organic solvent. The first 
repeat was used from of the four strains as a representative base-peak intensity (BPI) UPLC 
chromatogram. Freeze-dried extracts were dissolved in 2.5% ACN and separated on a reverse 
phase BEH Phenyl column linked to ESMS to determine the m/z and subsequent peptide 
identity for each peak, which is shown above the retention time for each peak. The height of 
each peak is given as percentage signal intensity relative to the highest peak signal intensity in 
the chromatogram. Letters correspond with, A, Br. parabrevis 5618, B, Br. parabrevis 362, C 
Br. parabrevis 8185 and D Br. parabrevis 10068 
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Table 2.3  The first round of extractions was analysed via UPLC-ESMS to give the mean area-
under-curve and SEM for each of the major tyrocidine analogues detected. The 
detected m/z ratio represent ionization of the analyte by two protons. One injection was 
done for each extract. The expected theoretical mass is shown in the last column (See 
thesis addendum for complete list of theoretical Trc masses) 
Strain 10068 5618 362 8185 
Theoretical 
m/z  
(Doubly 
charged) 
P
ep
tid
e 
A
v
erag
e A
U
C
  
±
 S
E
M
 (n
=
3
)  
D
etected
 m
/z  
(D
o
u
b
ly
 ch
arg
ed
) 
A
v
erag
e A
U
C
  
±
 S
E
M
 (n
=
3
)  
D
etected
 m
/z  
(D
o
u
b
ly
 ch
arg
ed
) 
A
v
erag
e A
U
C
  
±
 S
E
M
 (n
=
3
)  
D
etected
 m
/z  
(D
o
u
b
ly
 ch
arg
ed
) 
A
v
erag
e A
U
C
  
±
 S
E
M
 (n
=
3
)  
D
etected
 m
/z  
(D
o
u
b
ly
 ch
arg
ed
) 
TpcC
1 1.1 ± 0.24 693.3624 2.5 ± 0.4 693.3624 1 ± 0.03 693.3624 1.4 ± 0.06 693.3624 693.3618 
TpcC 1.7 ± 0.09 686.3550 3.7 ± 0.52 686.3550 0.8 ± 0.02 686.3549 2.6 ± 0.1 686.3550 686.3540 
TrcC
1 3.7 ± 0.17 681.8551 6.4 ± 0.58 681.8551 2.8 ± 0.16 681.8550 3.2 ± 0.06 681.8551 681.8539 
TrcC 6.2 ± 0.21 674.8494 10.9 ± 0.91 674.8494 Trace 674.8494 6.8 ± 0.05 674.8494 674.8460 
TpcB
1 2.6 ± 0.18 673.8541 1.9 ± 0.08 673.8628 6.8 ± 0.28 673.8628 2.8 ± 0.07 673.8628 673.8564 
TpcB 8 ± 0.71 666.8533 7.3 ± 0.07 666.8533 5.5 ± 0.01 666.8533 8.2 ± 0.18 666.8533 666.8486 
TrcB
1 11.1 ± 0.86 662.3500 8.8 ± 0.23 662.3505 14.5 ± 0.48 662.3505 10.8 ± 0.17 662.3505 662.3484 
TrcB 22.4 ± 0.73 655.3342 21.5 ± 0.58 655.3453 14.8 ± 0.18 655.3453 20.6 ± 0.48 655.3453 655.3406 
TpcA
1 2.6 ± 0.24 654.3508 1.8 ± 0.11 654.3508 6.17 ± 0.21 654.3508 2.8 ± 0.15 654.3508 654.3509 
TpcA 7.9 ± 0.77 647.3439 6.9 ± 0.31 647.3439 8.49 ± 0.38 647.3439 8.3 ± 0.28 647.3493 647.3431 
TrcA
1 9.4 ± 1.22 642.8411 8 ± 0.25 642.8411 18.05 ± 0.5 642.8411 10.6 ± 0.46 642.8411 642.8430 
TrcA 21.9 ± 0.87 635.8411 19.1 ± 1.24 635.8411 18.96 ± 1.45 635.8411 20.4 ± 0.28 635.8411 635.8351 
PhcA 1.3 ± 0.07 627.8395 1.1 ± 0.09 627.8395 1.59 ± 0.1 627.8395 1.4 ± 0.03 627.8395 627.8377 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.2 Growth rate analysis of selected strains under varying nutrient conditions  
The variable nitrogen or carbon sources used were all added on top of the TGS media, which was 
used as a base media for media modification as well as a control on its own to look at the relative 
effect of the additional nitrogen source. In the case of the carbon source, the 3% glucose used in TGS 
was replaced with the variable carbon source, being glucose or glycerol.  
In terms of nitrogen and sulphate sources, three sources were tested: ammonium sulphate 
((NH4)2SO4) as a nitrogen source and sulphate source, sodium sulphate (Na2SO4) as a sulphate source, 
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and urea (CO(NH2)2) as a nitrogen source. These three compounds were tested on their own at 
different concentrations on top of the base media. In addition, varying concentrations of Na2SO4 were 
tested in conjunction with a fixed concentration of urea (5 g/L). Inversely, variable concentrations of 
urea were tested together with a fixed concentration of Na2SO4 (2.5 g/L). Glucose and glycerol were 
used at varying concentrations and their effect on growth rate recorded. In addition, a variable 
concentration of glucose was used with a fixed glycerol concentration of 63.5 g/L while a fixed 
concentration of glucose (30 g/L) was used together with a variable glycerol concentration. 
To assess the effects of altering nitrogen, sulphate and carbon sources on the available producer 
strains, growth curves were done to determine exponential-phase growth rates under a range of 
concentrations for a given nitrogen, sulphate or carbon source, represented as the natural logarithmic 
change in optical density per hour at 595 nm wavelength, or ΔlnOD595/hour. Only three 
concentrations were chosen over the range of concentrations used (8 in total). These concentrations 
represent the low, middle and high end of the concentrations range used. 
While four strains were available for use it was decided that the 10068-strain would be omitted as its 
growth and production profile has already been extensively characterised by Vosloo et al (22). The 
results of these growth curves for the 5618, 362 and 8185 strains are given below in Figure 2.2 and 
Figure 2.4. While one cannot assume that a relatively high growth rate will result in high levels of 
peptide production, it does provide a more rapid method of testing which nitrogen, sulphate or carbon 
sources and concentrations will sustain bacterial growth. It is in fact hypothesized that the highest 
yields of peptide occur when the producer organism is put under nutrient limiting conditions to mimic 
a stressful or competitive environment (24, 25). 
A large variation in concentrations of nitrogen sources appeared to be well tolerated across the 
concentration range for all three strains (Figure 2.2) with the 5618 strain showing the smallest 
deviation in growth rates (Figure 2.2, A). Overall, CO(NH2)2 produced the highest growth rates with 
the exception of the 8185-strain, where it was difficult to elucidate a clearly superior nitrogen and/or 
sulphate source. The 5618-strain responded most positively to an increase in concentration of 
CO(NH2)2 together with a fixed concentration of 2.5 g/L Na2SO4. Na2SO4 and (NH4)2SO4 alone gave 
the lowest relative growth rates, however, the 8185 strain again seemed to not show a preference for 
these compounds in terms of its growth rate. In terms of the positive control (representing the 
unmodified TGS base-media) the 8185-strain showed the clearest preference for TGS alone as a 
growth medium. This is expected as this strain was used for media optimisation (for Trc production) 
that resulted in the TGS media composition. 
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Figure 2.2 Selected growth rates calculated from exponential growth rates for each growth curve. 
Scattered points represent repeats for each concentration while the line of the same 
colour represents the mean of the repeats. Three concentrations were chosen to 
represent the low, middle and high end of the concentration range used. TGS media 
was used as a control for growth under unmodified conditions. Letters represent growth 
rates for strains, A 5618, B, 8185 and C, 362 under the same set of nutrient conditions
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For the 5618 and 362 strains, urea (CO(NH2)2) alone, and variable urea concentration together with 
2.5 g/L sodium sulphate (Na2SO4) led to the increase in growth rate relative to TGS alone. Genetic 
variation in the 5618 and 362 strains may lead to an altered metabolism and a unique ability to utilise 
these tested nitrogen and sulphate sources in a preferential manner. In most cases, the spread of 
growth rate data was clustered, indicating similar responses in the cultures (Figure 2.2). However, 
some growth rates, such as those determined with mixtures of urea and sodium sulphate, gave a large 
spread in growth rate values which made it difficult to elucidate the difference in growth rates between 
nitrogen/sulphate sources used for a given strain.  
For the 5618 strain Glc appeared to be a preferable carbons source, exemplified by the fact that the 
addition of Glr to a variable Glc concentration led to a reduced growth rate (Figure 2.3, A) (with the 
exception of the 45 g/L Glc, where the addition of Glr led to an increased growth rate), while the 
addition of Glc to a variable Glr concentration led to an increase in growth rate relative to glycerol 
alone (Figure 2.3, B). For the 362 and 8185 strains Glr again led to a reduction in growth when added 
to a variable Glc concentration, however, unlike 5618, both 362 and 8185 preferred Gly alone 
compared to the addition of a 30 g/L Glc (with the exception of the 12.6 g/L Glr for the 362-strain, 
(Figure 2.3, D). Looking at growth rates using Glc between strains we can see that the 362-strain 
appears to produce the highest growth rates, albeit with a large relatively larger spread of data points. 
The 362 strain also has the largest difference between variable Glc concentrations and variable Glc 
concentrations with the addition of Glr. The addition of Glr to Glc reduced growth rate at all Glc 
concentrations for all three strains used (Except for 45 g/L Glc mixed with Glr). In addition, a Glc 
concentration of 30 g/L (representing the middle of the concentration range used) lead to the best 
growth rates overall. 
Looking at Glr alone, a concentration of 63.5 g/L appeared to produce the best growth rate, with the 
exception of the 8185-strain where a concentration of 12.6 g/L was superior. The 8185-strain 
appeared to be the least tolerant to Glr with a steady decline in growth rate as Glr concentration 
increased. 
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Figure 2.3  Selected growth rates calculated from exponential growth rates for each growth 
curve. Scattered points represent repeats for each concentration while the line of the 
same colour represents the mean of the repeats. Three concentrations were chosen to 
represent the low, middle and high end of the concentration range used. The left 
column represents variable Glc concentrations while the right represents variable 
glycerol concentrations. TGS media was used as a control for growth under 
unmodified conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Besides the quantitative assessment of growth rate, the shape of the growth curves under varying 
conditions could was also inspected. The large difference between some of the growth rates is due to 
the fact that some of the technical repeats entered a clear logarithmic growth phase after a short lag 
phase while others showed a markedly slower growth rate over the same time period. Some repeats 
showed a growth curve more characteristic of diauxic growth. Diauxic growth can be attributed to a 
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metabolic change in nutrient preference of the growing bacteria. Eventually, the bacteria adapt to the 
media and surrounding environment after a period of slow growth, as observed by Vosloo (23). In 
these cases, bacteria will generally reach a similar OD in the stationary phase as the bacterial 
populations which showed a more typical exponential growth curve. The growth rates however 
represent the average change in optical density over a time period at which most repeats showed clear 
exponential growth. Figure 2.4, A, gives some examples of growth curves considered as having only 
one exponential phase, versus examples of growth curves showing at least two exponential phases 
(Figure 2.4, B). Table 2.4 shows the lag time and number of diauxy (as well as the number of repeats) 
following visual inspection of the growth curves under varying growth conditions.  
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Figure 2.4 Selected growth curves from Br. parabrevis 362. A, an example of a normal growth 
curves with varying glucose concentration and B growth curves with more than one 
apparent exponential growth phase showing a diauxy-type metabolic response. The 
growth curves in B was generated under varying glucose concentrations together with 
a fixed glycerol concentration of 63.5 g/L 
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Table 2.4 Summary of the conditions, number of repreats, lag times and number of exponential 
growth phases observed (represented in the Diauxy column) for selected growth 
curves. The growth rates were determined using the first apparent exponential growth 
phase following the lag phase 
5618  362 
Compound 
 added 
Concentration  
(g/L) 
n 
Lag Time  
(hrs) 
Diauxy  
Compound 
 added 
Concentration 
(g/L) 
n 
Lag Time 
(hrs) 
Diauxy 
(NH
4
)
2
SO
4 
0.8 3 2 2-3  
(NH
4
)
2
SO
4 
0.8 3 1-2 1-2 
5 3 2 2  5 3 1-2 1-2 
7 3 2 2  7 3 2-3 2 
Na
2
SO
4 
0.8 4 2 2-3  
Na
2
SO
4 
0.8 4 1-2 1-2 
5 4 2 2-3  5 4 2-3 1-2 
7 4 2-3 2-3  7 4 2-3 2 
CO(NH
2
)
2 
0.8 4 2-3 1-2  
CO(NH
2
)
2 
0.8 4 2-3 2 
5 4 2-3 1-2  5 4 2 2 
7 4 3-4 1  7 4 2-3 2 
Na
2
SO
4 
(var) + 
 CO(NH
2
)
2
  
(5 g/L) 
0.8 6 2 1-2  Na2SO4 (var) + 
 CO(NH
2
)
2 
 (5 g/L) 
0.8 6 1-2 1-2 
5 6 2 1  5 6 1-2 1 
7 6 2 1-2  7 6 2-3 1-2 
 CO(NH
2
)
2
 (5 
g/L) +  
Na2SO4 (var) 
0.8 5 2-3 1-2   CO(NH2)2  
(5 g/L) +  
Na2SO4 (var) 
0.8 5 1-2 2 
5 5 2-3 2  5 5 2-3 1-2 
7 5 2-3 1-2  7 5 2-3 2 
Glc 
10 6 3-4 1  
Glc 
10 6 0-1 1-2 
30 6 5 1-2  30 6 1-2 1-2 
45 6 7 1  45 6 2 1-2 
Glr 
12.6 5 3 1  
Glr 
12.6 5 0-1 1 
63 5 4-5 1-2  63 5 2 1 
94.5 5 4-5 1  94.5 5 1-2 1-2 
Glr (var) +  
Glc (30 g/L) 
12.6 5 4 1  
Glr (var) +  
Glc (30 g/L) 
12.6 5 0-1 1-2 
63 5 6-7 1  63 5 1-2 2 
94.5 5 7-9 1  94.5 5 5-6 1 
Glc (var) +  
Glr (63 g/L) 
10 6 5-6 1  
Glc (var) +  
Glr (63 g/L) 
10 6 0-1 2 
30 6 6-7 1   30 6 1-2 2 
45 6 7-8 1  45 6 2-3 1            
8185 
(NH
4
)
2
SO
4 
0.8 3 0-1 2  
Glc 
10 5 1 2-3 
5 3 0-1 2  30 5 1-2 1-2 
7 3 0-1 2  45 5 1-2 1-2 
Na
2
SO
4 
0.8 4 0-1 2  
Glr 
12.6 5 1 2-3 
5 4 0-1 1  63 5 1 1-2 
7 4 0-1 2  94.5 5 1 2 
CO(NH
2
)
2 
0.8 4 1-2 1  
Glr (var) +  
Glc (30 g/L) 
12.6 5 0-1 2-3 
5 4 1-2 1-2  63 5 0-1 2-3 
7 4 0-1 1  94.5 5 1 1-2 
Na
2
SO
4 
(var) +  
CO(NH
2
)
2 
(5 g/L) 
0.8 6 1-2 2  
Glc (var) +  
Glr (63 g/L) 
10 6 0-1 1-2 
5 6 0-1 1-2  30 6 0-1 1-2 
7 6 1-2 2-3  45 6 0-1 2-3 
 CO(NH
2
)
2
  
(5 g/L) +  
Na2SO4 (var) 
0.8 5 2-3 1-2       
5 5 1-2 1       
7 5 1-2 1       
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2.4.3 Small-scale culture extraction and ESMS analysis using selected nutrient conditions  
As mentioned earlier, one cannot necessarily presume that an optimised growth rate in a microtiter 
equates to increased yields of peptides under larger scale culture conditions. A medium-throughput 
assay done in deep well 96-well plates (in which peptides are eventually extracted and analysed) 
provides a better approximation of peptide production and can also be used to test different media 
compositions. Using growth rates as a preliminary indication of media composition on bacterial 
growth, one can pick a set of conditions to be used in the deep well assay. In this case both carbon 
and nitrogen concentrations were chosen at points which produce below optimal growth, optimal 
growth, and above optimal growth.   
The 5618-strain was more sensitive to an increase in urea concentration, with a decline in detected 
signal intensities as the urea concentration increased. The opposite was true for the 8185 and 362 
strains, which showed increasing peptide intensities as urea concentration increased. In terms of the 
TGS control, the 8185-strain showed a clear preference, with moderate levels of production in the 
362 and 8185-strain.  
Figure 2.5 represents the peptide production profiles of the major tyrocidines and analogues under 
growth conditions selected from the growth curve data, while Table 2.5 shows the cell and extract 
mass of the deep-well cultures. The 362-strain showed poor production under the selected conditions 
when compared to the 5618 and 8185 strains. The 5618-strain produced a more diverse production 
profile and produced and was only able to produce detectable amounts of TrcA1 at lower urea 
concentrations of 1 g/L. The 8185-strain also produced TrcA1 at 1g/L urea but preferred an increasing 
amount of urea, producing higher ESMS signal intensities.  
In terms of extract masses (Table 2.5), the 5618-strain had the best response to urea in terms of cell 
mass and extract mass, specifically with an addition of 8 g/L urea. Relative to the TGS control, the 
5618-strain produced, 34% more cell mass and 44% more extract mass at 8g/L urea. The 362-strain 
responded poorly to increasing urea concentration, with both a decrease in cell mass and extract mass. 
Only a urea concentration of 1 g/L led to an increase in extract yield over that of TGS for the 362-
strain. The 8185-strain also responded well to an increase in urea concentration, but the difference 
between TGS yields and urea at 8 g/L were not as pronounced as the 5618-strain, with the large 
standard deviation making differences insignificant. 
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Figure 2.5 Direct injection ESMS analysis of the tyrocidine analogue production profile of 
deep-well extracts. Media contained TGS together with 1 g/L, 4g/L and 8 g/L 
respectively of urea. Analysis was done in duplicate with 6 wells being combined 
and extracted together for each replicate under each growth condition. The y-axis 
represents the signal intensity produced by the tyrocidine analogue compared to 
the total signal of all compounds detected via ESMS in the sample. Letters in bold 
represent the strains used (A: 5618, B: 362, C: 8185) under the same nutrient 
conditions 
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Table 2.5 Deep-well extraction masses for the 5618, 326 and 8185 strains under varying urea 
concentrations on top of TGS together with TGS alone as a control. Six deep-well wells 
were combined per replicate for a total of two replicates per condition. Cell mass of 
culture after acidification, centrifugation and lyophilization of pellet is shown together 
with the standard deviation (SD). Extract mass represents lyophilized mass of the 
supernatant following extraction of cell mass, also shown with SD. Colour codes 
correspond with those in Figure 2.5 
Strain 5618 362 8185 
U
rea (g
/L
) 
C
ell M
ass (m
g
) 
 (n
=
2
; ±
 S
D
)* 
E
x
tract m
ass 
(m
g
)* 
R
atio
 - E
x
tract M
ass: 
C
ell m
ass 
C
ell M
ass 
(m
g
)* 
E
x
tract m
ass 
(m
g
)* 
R
atio
 - E
x
tract M
ass: 
C
ell m
ass 
C
ell M
ass 
(m
g
)* 
E
x
tract m
ass 
(m
g
)* 
R
atio
 - E
x
tract M
ass: 
C
ell m
ass 
1 
  
9.4 ± 1.9 7.4 ± 2.5 0.79 9.4 ± 1.1 7.5 ± 1.2 0.8 9.8 ± 0.3 8.3 ± 0.2 0.84 
4   8.5 ± 2.2 6.6 ± 0.2 0.77 6.7 ± 0.4 5.4 ± 0.2 0.8 10.1 ± 1.7 8.6 ± 1.8 0.85 
8   11.5 ± 1.8 10.3 ± 1.1 0.89 5.6 ± 0.3 4.5 ± 0.2 0.8 11 ± 3.3 8.8 ± 3.5 0.8 
TGS 7.5 ± 2.1 5.8 ± 2 0.78 6.9 ± 0.4 5.6 ± 0.8 0.81 11.4 ± 1.3 8.2 ± 2.5 0.72 
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2.5 Discussion 
There is a clear difference in the Trc production profiles of different strains of the producer organism, 
using TGS media, as exemplified by the UPLC chromatograms and AUC (Figure 2.1 & Table 2.2). 
Since strain differences in GS production have been observed (26, 27) , it is likely that variability in 
Trc production by different strains would occur, especially due to the similar synthesis mechanisms 
and overlapping use of common amino acids.  
In addition to production profiles using the same media between strains, the same argument for 
variable production of Trcs analogues under altered nutritional requirements can be made. This is 
clearly observed by both the growth rates of the different organisms (Figure 2.2 and Figure 2.3) and 
the production profiles determined by ESMS-analysis of deep-well extracts (Figure 2.5). Of particular 
interest is the 5618-strain, which possessed what could be describes as a good nutritional and peptide 
production flexibility. This strain utilised varying nitrogen, sulphate and carbon source compositions 
well in relation to the 8185 and 362-strains, and produced the major tyrocidines in easily detectable 
amounts for almost all growth conditions selected (Figure 2.5). 
The 5618-strain showed an increase in growth rate from the highest urea concentration to the lowest 
urea concentration, with the lowest concentration's growth rate being higher than the TGS control, 
indicating that this strain may benefit from exploration of additional nitrogen sources to improve 
yields. The 8185-strain showed an increase in growth rate from low to high urea concentrations, with 
the growth rate moving towards that of TGS. TGS produced the both the best growth rate and best 
Trc production profile in terms of signal intensities for the 8185-strain. This, together with no clear 
trend for the other nitrogen and/or sulphate sources on growth rate, indicates that there may not be 
much room for optimisation of the TGS media for peptide production in the 8185-strain. This is to be 
expected as most of the work done on optimisation of production in previous literature was done with 
this strain, with the creation of the TGS being based on such research (23). While it was difficult to 
observe a clear growth rate trend for either urea or the nitrogen and sulphate sources used for the 362-
strain, the increase in urea concentration showed a marked effect on the Trc production profile, 
producing increased signal intensities as urea concentration increased.  
The extract yields for 5618, for both cell mass and following extraction with 50% ACN, were 
improved at the highest urea concentration of 8 g/L. This and the TGS yields for the 8185 strain, were 
the top producing strains and conditions.  
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The importance of a complex nitrogen source described by previous investigators is supported (14, 
28). In this case tryptone served this role, and provided an adequate base on which to test various 
other nitrogen sources, sulphate sources and carbon sources. Glycerol served as a rather poor carbon 
source compared to glucose, which was effective in the concentration similar to that reported by 
Lewis et al (14), particularly when combined with tryptone. The concentration of 3% Glc used in the 
TGS base media is adequate and any deviation from this is unlikely to produce any significant change 
in Trc production. 
After exploring the difference occurring in both growth rate and peptide production under different 
nutrient conditions, the 5618-strain was chosen going forwards for both its good response to urea in 
terms of growth rate and peptide production, and its relatively high production of Trp containing Trc 
analogues. This was of particular interest as the first non-natural amino acid tested in the next chapter 
was the Trp derivative 5-methyl-tryptophan. 
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Determination of the incorporation of non-natural amino acids into  
the tyrocidines and analogues 
3.1 Introduction 
The tyrocidines are secondary metabolites synthesised by multi-domain enzyme complex known as 
non-ribosomal peptide synthetases. These multi-domain enzyme complex are most broadly grouped 
into three synthetases, namely TycA, TycB and TycC (1). These synthetases consist of several 
modules responsible for the activation and incorporation of an amino acid into the growing peptide 
chain (2–4). The process terminates with the cyclisation of the linear peptide to form a cyclic 
decapeptide (1, 5, 6) (refer to Figure 1.8 in Chapter 1).  
Tang et al. (7) has identified 28 tyrocidine (Trc) analogues based on the variability observed at 
residue positions 3, 4, 7, 8 and 9 (refer to Table 1.1 in Chapter 1). The enzyme domains responsible 
for incorporation of amino-acids into positions 3, 4 and 7 of the peptide show a partial lack of 
specificity, allowing for incorporation of more than one possible aromatic amino acid. It has been 
shown that the residues 3 and 4 can be Trp and/or Phe while residue 7 can be occupied by Tyr, Phe 
or Trp. Residue 9 can be either Ort or Lys (7–9). Residue 8 has a lower overall variability showing 
a preference for Val, but minor analogues containing Leu and Ile in this position was also identified 
by Tang et al. (7).  
The amino acid composition of any given Trc analogue has an effect on its hydrophobicity, mass-
to-charge ratio, as well as its side chain surface area (10). In addition, amino acid composition may 
have an effect on the tertiary structure of the peptide, altering how the hydrophobic, charged and 
polar residues interact within peptide oligomers, as well as with possible target cells, and ultimately 
effecting its antimicrobial activity (11). 
The aromatic amino acids (Phe, Trp and Tyr) content were found to play a role in the ability of the 
Trc analogue to cause inhibition of Gram-positive organisms. A study by Spathelf and Rautenbach 
(10) looked at the structure-activity relationships of six major tyrocidine analogues against three 
Gram-positive target organisms. Against Micrococcus luteus, four analogues (TrcB1, TrcC1, TrcB 
and TrcB) had similar IC50 values which were much lower than the more hydrophobic TrcA and 
TrcA1 analogues. A similar trend was observed against L. monocytogenes, but with a less 
pronounced difference, the order of IC50 values from lowest to highest here was TrcB1, TrcC, 
TrcC1, TrcB, TrcA and TrcA1 (10). For L. monocytogenes, the ascending order of the cyclic-
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decapeptides in terms of their IC50 values was TrcB1 > TrcC, and as the most active TrcB, with 
TrcC1 > TrcA and TrcA1 together having the highest relative IC50 values (most active). Overall, the 
more hydrophobic tyrocidine analogues had better activity, which appeared to correspond well with 
analytical HPLC retention times, with the order of elution from first to last being TrcC1, TrcC, 
TrcB1, TrcB, TrcA1 and TrcA (10). Amino acid composition is hypothesized to alter the Trc 
antimicrobial activity via its effect on dimerization of the peptide (12, 13).  
The importance of the amino acid composition on activity has also been highlighted by several 
experiments aimed at increasing antimicrobial activity while decreasing haemolytic activity via 
synthetic insertion of selected amino acids into the Trcs and analogues (9, 14). Increasing the 
positive charge of TrcA by the replacement of Gln6 by an Orn led to enhanced activity against 
Bacillus subtilis while simultaneously decreasing its toxic haemolytic affect (14). Insertion of a Lys 
in position 6 of TrcA led to an increase in activity against a variety of selected Gram-positive 
bacteria, also due to an increase in the positive charge relative to the unmodified TrcA (9). The 
replacement of Phe4 by a Lys4 formed a TrcA analogue with three positively charged residues that 
possessed activity against Gram-negative bacteria (9). The importance of the distribution of 
hydrophilic and hydrophobic amino acids within the Trcs, and the resultant amphipathic nature of 
the tyrocidines also plays a key role in activity. The insertion of a hydrophobic penta-fluoro-
phenylalanine residue in positions 3 and 7 (position 7 generally contain a more polar Tyr residue) 
potentially disrupts the amphipathic nature of TrcA, leading to a decrease in antibacterial activity 
(9). Enhancing the amphipathic nature of TrcA by insertions of Lys residues at position 4 and/or 6, 
together with the insertion of a penta-flouro-phenylalanine residue at position 3, led to enhanced 
activity against selected Gram-positive and Gram-negative bacteria (9).  
Due to the expensive and time-consuming nature of chemical synthesis and modification of the 
Trcs, it is of interest to investigate if the producer organisms can incorporate non-natural amino 
acids supplemented into the growth media into the Trcs, and the effect of these amino-acid 
analogues on growth and overall peptide production of the producer organism. The ability of the 
Trc producer organisms to incorporate amino acids supplemented into the growth media into the 
Trcs as well as their effect on growth and peptide production was investigated in several studies 
(15–17). Okuda et al. (15) found that β-hydroxyglutamic acid, pipecolic acid, β-2-thienylalanine, p-
flourophenyalanine and phenylglycine all selectively reduced Trc synthesis relative to non-
supplemented nutrient media while simultaneously enhancing gramicidin production. Isotopically 
labelled non-natural β-2-thienylalanine, as well as isotopically labelled isoleucine, valine, proline 
and ornithine were found to give rise to isotopically labelled Trcs (15). The supplementation of the 
nutrient media with non-natural amino acid analogues 5-methyl-tryptophan (5-MeW) and 
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thioproline exerted a generalised inhibitory effect on both growth and peptide production (15). A 
study by Mach et al. (16) found that the Phe analogues m-, o-, and p-fluorophenylalanine were 
found to inhibit Trc synthesis without a marked effect on protein synthesis. This study also found 
that β-methyltryptophan did not inhibit Trc synthesis while α-methyltryptophan did. Ruttenberg et 
al. (17) found that allo-Ile was preferentially incorporated into the Trcs over Ile. 
Given the flexibility of the tyrocidine synthetase system to incorporate different amino acids, both 
natural and non-natural, one can potentially produce a large library of Trc analogues with novel 
structures and activities. Of course, this is also dependent on the amino acid being non-toxic to the 
host organism, as an amino acid (specifically a non-natural derivative) may act as an antagonist to 
protein synthesis, or as an antagonist in peptide production. Modern experimental techniques allow 
us to easily assess both the ability of the producer organism to grow in the presence of a given 
amino acid (using growth curve analysis) and to determine the identity of the produced tyrocidines 
(using direct-injection ESMS or UPLC-ESMS). Observed experimental masses can be compared to 
expected theoretical masses to assess if non-natural amino acids were incorporated into the Trc 
analogue. 
In this chapter, we aim to determine the effect of the selected non-natural aromatic amino acids 
(Figure 3.1) and their naturally occurring analogues on the growth of three selected strains of the 
Trc producer organisms. One of these strains was then selected for medium-throughput deep-well 
cultures using the selected aromatic amino acids to allow for determination of the identity of the Trc 
analogues detected in the extract. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 The selected non-natural Trp and Phe analogues supplemented into cultures of the 
producer organism to determine their effect on growth and peptide production. 
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3.2 Materials 
The producer organisms Brevibacillus parabrevis 362 and 5618 originate from the Deutsche 
Sammlung von Mikroorganismen und Zellkulturen (DSMZ) in Braunschweig, Germany. The 
Brevibacillus parabrevis 8185 and 10068 strains originate from the American Type Culture 
Collection (ATCC) based in Manassas (Virginia, USA). Micrococcus luteus NCTC 8340 was 
sourced from the National Collection of Type Cultures (NCTC) in Porton Down (Salisbury, 
England).   
Tryptic soy broth (TSB), tryptone, agar, glucose (Glc), ethanol (EtOH), hydrochloric acid (HCl) and 
sodium chloride (NaCl) were from Merck (Darmstadt, Germany). Triflouroacetic acid (TFA, > 98% 
purity) was from Sigma-Aldrich (St. Louis, USA). Acetonitrile (ACN, far UV cut-off, > 98% 
purity) was obtained from Romil Ltd. (Cambridge, UK). Analytical grade, deionised water was 
obtained by filtering reverse osmosis water through a Milli-Q® water purification system (Merck 
Millipore, Ma, USA). The modified amino acids, 2-flourophenylalanine (2-FF), 4-triflouro-methyl-
phenylalanine (4-CF3F) and 4-methyl-phenylalanine (4-MeF) were from GL Biochem Ltd. 
(Shanghai, China). L-Tryptophan (Trp), 1-methyl-L-tryptophan (1-MeW), 5-methyl-DL-tryptophan 
(5-MeW) and L-phenylalanine (Phe) were from Sigma-Aldrich (Steinheim, Germany).  Glycerol 
(Glr, > 99.5% purity) is from Merck (Kenilworth, USA). 
Falcon® tubes were from Corning (Corning, NY, USA). The 96-well deep-well plates were sourced 
from Nunc (Roskilde, Denmark) and 96-well microtiter plates were from Corning Incorporated 
(NY, USA). Petri dishes were from Lasec (Cape Town, South Africa). The 96-well flat bottom 
microtiter plates were from Corning (NY, USA). Round bottom 96-well plates were from Greiner 
Bio-One (Kremsmünster, Austria). 
3.3 Methods 
3.3.1 Growth curve analysis of organisms using non-natural amino acids 
Growth curves using 5-methyl tryptophan and tryptophan supplementation: Here the selected 
amino acids were incubated and their effect on the growth rate of the selected producer organisms 
(5618, 362 and 8185 strains) was recorded. A five times concentrated solution of TGS was made up 
to allow for dilution with 5-MeW and Trp stocks and 1.25 concentrated (relative to final assay 
concentration) dilutions of 5-MeW were made in a 300 μL round-bottom microtiter plate. NaOH 
addition was used to improve amino acids solubility and pH was adjusted with HCl to neutrality.  
Controls with similar amounts of NaOH and HCl were used as pH growth controls to rule out the 
influence of these components on growth. The concentration ranges of the supplemented amino 
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acids were started from a 34.375 mM analytically prepared stock solution. A series of dilutions 
were made with analytical grade to a final concentration of 0.859 mM. A Trp dilution series was 
made in a similar manner with a 5-fold dilution range from 137.5 mM to 3.438 mM. Both the 
34.375 mM and 137.5 mM 5-MeW and Trp TGS stocks were sterilised by filtration through a 0.22 
μm filter. Growth curves were done in standard 96-well microtiter plates by transferring the 
concentrated amino acid solution to the final assay plate from the round bottom plate. The 
concentrated amino acid solutions were then diluted with concentrated TGS and/or analytical grade 
water to get all components to the correct concentration and a final volume of 200 μL. TGS on its 
own was used as normal culture growth control and sterility blank. Overnight cultures of the 
producer organisms were made as previously described for the growth curves in Chapter 2, and 10 
μL culture was used to inoculate the wells. Cultures were incubated at 37°C. Bacterial growth was 
monitored by recording the OD at 595 every two hours for the first eight hours then at 16 hrs, 24 hrs 
and 36 hrs on BioRadTM microtiter plate reader. 
Growth curve using 1-methyl tryptophan supplementation: Growth curves were done for 1-MeW in 
a similar manner to Trp and 5-MeW. A 27.5 mM stock of 1-MeW was dissolved in TGS and 
dilutions were made in a 300 μL round-bottom 96-well plate using TGS down to 0.69 mM. A 
volume of 200 μL was then pipetted into each well of a standard 96-well microtiter plate. TGS on 
its own was used as a control. Overnight cultures of the 5618, 362 and 8185 strains were grown up 
as previously described and 10 μL was used to inoculate each well. Growth was monitored by 
recording the change in OD at 595 nm every hour for 12 hours. 
Growth curves using phenylalanine and non-natural phenylalanine derivatives in supplementation: 
Three non-natural phenylalanine derivatives 2-FF, 4-CF3F and 4-MeF, as well as Phe as control 
were chosen to for growth curve analysis. Here, a stock solution of TGS was made containing 27.5 
mM of the selected amino acid for each amino acid. Amino acid solubility was improved by using 
NaOH and HCl as described above. Stocks were sterilised by filtration through a 0.22 μm filter.  
Normal TGS was also made up for use in growth controls and for diluting the TGS-amino acid 
stock. A range of dilutions was made in round-bottom 300 μL microtiter plates starting with the 
undiluted 27.5 mM stock going down to 0.7 mM. Dilutions of the TGS-amino acid stock were done 
with normal TGS. A volume of 200 μL of each dilution was added to a standard 96-well microtiter 
plate. Unmodified TGS was used as a sterility blank and normal culture growth control. Overnight 
starter cultures were made as previously described and 10 μL was added to the wells. Cultures were 
incubated at 37°C. Growth was measured by recording the change in OD at 595 nm every hour for 
the first eight hours then every two hours up to 14 hours using a BioRadTM microtiter plate reader. 
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Four repeats were done for phenylalanine (n=4), five were done for 2-FF (n=5), four for 4-CF3F 
(n=4) and five repeats were done for 4-MeF (n=5).  
3.3.2 Small scale cultures using selected, non-natural amino acids 
Deep well assay for tryptophan, 1-methyl tryptophan and 5-methyl tryptophan supplemented 
cultures: In order to determine the incorporation of the selected non-natural amino acids, small 
scale, medium-throughput cultures were done. The concentrations of amino acid were chosen based 
on the results from the growth curves, with a lower and a higher concentration chosen to see if 
incorporation of the amino acid increased in a dose dependant manner. Concentrations of 5 mM and 
10 mM were chosen for Trp, 5-MeW and 1-MeW in the deep well assay. Stocks of 20 mM for Trp 
and 5-MeW, and 40 mM for 1-MeW were made in analytical grade water and sterilised via 
filtration through a 0.22 μm filter. Two four times concentrated TGS stocks were made, one with a 
glucose concentration of 3% (m/v) and one with a glucose concentration of 3.5% (m/v).  In addition, 
urea and Na2SO4 stocks of 100 g/L were made and sterilised by autoclaving.  For urea and Na2SO4, 
concentration of 1 g/L and 4 g/L were chosen for use in the deep well assay. Each well consisted of 
a combination of one of the selected amino acids and either urea or Na2SO4 (with both components 
at one of two varying concentrations) together with TGS and made up to the final concentration and 
volume (500 μL) with analytical grade water. The TGS with 3% (m/v) glucose was used for 
controls with no added amino acid or urea/ Na2SO4 while the 3.5 3% (m/v) was used for the rest 
(based on the growth curve for variable glucose concentrations). Overnight starter cultures of 5618 
were made as previously described and 10 μL was used to inoculate each well. Cultures were then 
incubated at 37°C for 10 days after which they were extracted as previously described. 
Deep well assay for Phe, 2-FF, 4-CF3F and 4-MeF: The incorporation of Phe and the selected non-
natural Phe analogues were tested for using small scale, medium throughput cultures. Urea and 
Na2SO4 were also used to determine their effect on peptide production using stocks of 50.00 g/L. 
For the amino acids, stocks of 40.00 mM were made in analytical grade water and sterilised by 
filtration through a 0.22 μm filter.  Four times concentrated TGS stocks were made, one with a Glc 
concentration of 3.5% (m/v) and another with 3% (m/v). In the deep well plate each well consisted 
of either 10 or 20 mM amino acid, 1 g/L or 4 g/L urea or Na2SO4 and finally TGS with 3.5% (m/v) 
glucose (control wells only contained 3% (m/v) glucose in TGS). All wells were made up to the 
correct volume (500 μL) and concentration using analytical grade water. Overnight cultures of the 
5618-strain were made as previously described and 10 μL were used to inoculate each well. 
Cultures were incubated for 10 days and extracted as previously described.  
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Deep well culture extraction and ESMS analysis of extracts: Following the 10 days of incubation 
the cultures were acidified using HCl to a pH of 4. After 3 hours the cultures were spun down for 20 
minutes at 3000 × g.  Extraction was then done on the pellet by resuspending it in 75% ACN for 30 
minutes while sonicating. The extracts were then spun down again for 30 minutes at 3000 × g after 
which the supernatant for each duplicate repeat (combining supernatant of six wells per repeat) was 
collected and freeze dried. After freeze drying the mass was recorded. The samples were then made 
up to 1.00 mg/mL using 50% ACN and analytical grade water and spun down to remove insoluble 
material and particulate. The supernatant was removed and placed into a glass insert for ESMS 
analysis as described in Chapter 2.   
Analysis of ESMS data: For determining the % signal contribution of the Trcs and analogues in the 
deep-well extracts, an m/z spectrum was generated from ESMS analysis of the Trc extracts. This 
spectrum was then deconvoluted using the MaxEnt 3 function in MassLynx® 4.1. A mass range of 
600-2000 Da and two charges was used for the MaxEnt 3 conditions to generate a mass-spectrum 
covering the expected monomer range. The mass-spectra generated were then exported to Excel 
where the Trcs and non-natural analogues were identified using their theoretical masses. The % 
signal contribution of the identified Trcs was then calculated by dividing their signals by the sum of 
all the signals for the ionised species detected. This was done for all the deep-well extracts to 
determine the effect of the different media compositions and amino-acid supplementations on the 
relative amount of Trcs produced. A breakdown of the process of deconvolution of the m/z 
spectrum is given in the results section. In addition to this, selected deep-well extract from each of 
the amino acid supplementations used was selected to give an idea of the levels of oligomerisation 
of the Trcs in the extract as well as displaying more detailed mass-spectra for the monomers by 
these extracts. Here the MaxEnt 3 conditions covers a mass range of 600-10000 Da and six charges 
to display the expected mass range for monomers up to tetramers. Monomers were then identified 
based on theoretical masses to assess the difference between theoretical and observed masses as 
well as the putative identifications of novel Trcs.    
3.4 Results 
3.4.1 Growth curve analysis of organisms using non-natural amino acids 
For the 5618-strain, both Trp and its analogue 5-MeW appeared to be well tolerated when compared 
to TGS (Figure 3.2, A). The 1-MeW analogue was well tolerated, particularly at a lower 
concentration of 2.75 mM, however, growth was markedly inhibited at higher concentrations, with 
no growth occurring at 22 mM. Similar trends were observed for both the 362 and 8185-strains 
(Figure 3.2, B & C) with the 8185-strain appearing to be the least tolerant to both the Trp analogues 
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Figure 3.2  Growth rates for producer strains using Trp and Phe and analogues at concentrations of 
2.75, 11.0 and 22.0 mM respectively, together with a TGS control. Concentrations were 
chosen to represent low, medium and high concentrations respectively of those used in 
the growth curves. All repeats are shown under each growth condition together with the 
mean represented by the horizontal line of the same colour. Bold letters A-C represent 
growth rates for selected strains (A: 5618, B: 362, C: 8185) under varying Trp and Trp 
derivative concentrations with TGS as a control while bold letters D-F represent growth 
rates under varying concentrations of Phe and Phe derivative for selected strains (D: 
5618, E: 362, F: 8185). 
used at concentrations of 11 mM and 22 mM.  The 362-strain appeared to grow the best in the 
presence of 1-MeW, having the highest growth rate at a concentration of 11 mM, while the 5618-
strain appeared to be the most amenable to increasing 5-MeW concentrations. 
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In terms of Phe and its analogues, the 5618-strain has markedly elevated growth rates for Phe, 4-
CF3F and 4-MeF relative to TGS (Figure 3.2, D). Only the 2-FF analogue appeared to induce equal 
or slightly reduced growth rates relative to TGS for this strain (Figure 3.2, D). For all strains, the 4-
CF3F analogue appeared to drastically inhibit growth at higher concentrations of 22 mM (Figure 
3.2, D – F).  Relative to TGS, all strains had more-a-less equal or elevated growth rates for all 
amino acids and concentrations used, again with the exception of 4-CF3F at 22 mM and 2-FF at a 
concentration of 22 mM for the 5618-strain only. 
3.4.2 Analysis of direct-injection ESMS data processing 
For the discussion of the results generated from direct-injection ESMS analysis for the deep-well 
extracts, it is important to explain which assumptions were made and how results were analysed and 
interpreted using the raw output, depicted as the mass-to-charge ratio. Figure 3.3 depicts the output 
of a direct-injection ESMS analysis of a deep-well extract supplemented with Phe (expected to 
produce a higher proportion Phe containing Trc analogues (18)). The x-axis depicts the centroid 
(average mass for molecular ions detected in peak) mass-to-charge ratios of the analytes as detected 
in the Synapt G2 mass spectrometer, which was set to only detect analytes in the m/z range of 300 
to 2000. In Figure 3.3, A, four large clusters of molecular ions can be observed. The molecular ions 
detected in the highest relative % signal intensities (y-axis) in these peaks are 426.1260, 635.8792, 
922.6049 and 1270.7557 respectively. The peak cluster around m/z 426.1260 most likely represents 
contaminants extracted in the sample such as plasticisers resulting from exposure to plastics during 
the culturing, extraction and analysis process, as well as triply charged peptides. The peaks 
surrounding the m/z 635.8792 cluster represent Trcs monomers which are doubly charged with two 
protons [Trc + 2H]2+. This molecular ion represents a doubly charged TrcA monomer, which has a 
theoretical mass of 635.8351 Da. The detected molecular ion at m/z = 635.8792 has a 70 ppm error, 
which is somewhat higher than expected, possibly because of the low concentration of analytes and 
a minor problem with the calibrant Leu-enkephalin. 
The cluster of peaks around the m/z = 922.6049 molecular ion was hypothesised to represent the 
linear gramicidins. The doubly charged linear gramicidin B analogue, VGB, is the most likely 
candidate for this molecular ion, with a theoretical m/z of 922.0415. However, when the -611 ppm 
error is considered, together with previous results (19) that indicated that gramicidins are not 
produced in Phe supplemented cultures, the presence of VGB and analogues would be unlikely. 
Alternatively, this m/z cluster can be attributed to either contamination, partially synthesised Trcs or 
quadruply charged trimers.  
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Figure 3.3 Direct-injection ESMS analysis results of deep-well extract supplemented with 20 
mM Phe together with TGS base-media. Centroid mass-spectra depict m/z of 
detected analytes. A Averaged spectrum over m/z range of 350 to 2000 Da. B 
Zoomed-in spectrum of m/z range depicting singly charged monomers and doubly 
charged dimers. C Zoomed-in spectrum of m/z range typically associated with 
doubly charged monomers. D Zoomed-in spectrum of singly charged TrcA peak 
(Expected m/z = 1270.6624). E Zoomed-in spectrum of doubly charged TrcA peak 
(Expected m/z = 635.8351). 
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The next large cluster of molecular ions can be seen to be present in the highest relative signal 
intensities, and these represent both singly protonated monomers and doubly charged dimers, which 
have overlapping m/z values. In this cluster, the m/z = 1270.7295 represents a singly protonated 
TrcA ([TrcA+H]+) (52.8 ppm error). From previous studies (19) it is expected that the Trc analogue 
with the highest % signal intensity in the monomer range will also have the highest % signal 
intensity in the dimer range. 
Zooming in on the monomer m/z range (Figure 3.3, B insert), we can observe in more detail several 
more clusters of molecular ions. There are six clusters of peptides which stand out following visual 
inspection. From left to right the first cluster of molecular ions has a major monoisotopic m/z of 
1254.7567, which represents a PhcA with a theoretical mass of 1254.6675 (71 ppm error). 
Following this m/z, we come across an m/z of 1262.7570, which cannot be readily identified from 
the list of most commonly observed ionised Trc species. However, from the isotopic pattern it was 
deduced to be a doubly charge ion identified as a TrcA-PhcA heterodimer. 
If we extract the m/z range from 1269 to 1274 (Figure 3.3, D insert) it reveals the atypical isotope 
pattern of the major peptide, TrcA, in this cluster of ions. Here, the peak at m/z 1270.7557 
represents the monoisotopic mass of protonated TrcA. In general, the largest peak in such a cluster 
with the lowest m/z represents the monoisotopic mass of the singly charged monomer ([TrcA+H]+) 
or doubly charged dimer ([2TrcA+2H]2+). Trcs, particularly those with a higher Phe content, readily 
aggregate to form dimers, trimers and tetramers (19). Due to the high resolution of the Synapt G2 
mass spectrometer, one can observe isotopes pattern of TrcA. In this case the peaks at 1271.7557 
and 1272.7585 are most likely representative of a TrcA monomer and dimer with one or two 
heavier isotopes of primarily carbon-13 (C13) respectively, as these masses differ by a mass of 
1.0028 mu (mass units), which equates, to the mass of a neutron (1.008664 mu). The isotope m/z 
values of the monomeric TrcA would overlap with those of a doubly charged homodimer of TrcA, 
in which both monomers making up the dimer possess a heavier isotope of carbon. If, however, 
only one of the monomers making up the dimer has a C13 while the other does not, we observe a m/z 
ratio in-line with those observed at 1271.2562 and 1272.2581, where the mass difference from the 
preceding peak is m/z = 0.5005 (1271.2562 - 1270.7557) and m/z = 0.5009 (1272.2581 - 1271.7572 
m/z) respectively. This mass difference corresponds, with half the mass of a neutron (0.504332 mu). 
The reason that there is only half an m/z difference results from fact that the dimer is doubly 
charged. If only one of the monomers in the dimer has an extra neutron (from C13), and the dimer is 
doubly charged, then the m/z ratio difference from a dimer with two heavier TrcA isotopes that is 
doubly charged, will be half that. A similar isotope distribution pattern is observed for the doubly-
charged monomers (Figure 3.3, E insert). Here, however, the isotope pattern is a more classical 
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representation of an isotope distribution pattern for peptides, as there is little or no overlap with 
multiply charged oligomers. Here the peaks represent doubly charged isotopes of a TrcA monomer. 
The largest peak at an m/z of 635.8792 represents the doubly charged TrcA monomer. Each 
subsequent peak represents an m/z resulting from a TrcA heavier by a single neutron mass.  
Next, a cluster with major molecular ion at m/z 1278.7639 is observed. From the isotopic pattern it 
is likely a doubly charged dimer, namely TrcA-TrcA1 heterodimer. The molecular ion peak cluster  
with major monomeric m/z of 1282.7635, could be correlated with a sodium adduct of a TrcA 
dimer. TrcA1 is likely the molecular ion with m/z of 1284.7689 (not labelled) present in the same 
peak cluster, which corresponds closely with the theoretical m/z for this peptide of 1284.6781 (71 
ppm error). The next cluster has a major m/z of 1290.7627 Da, which is also not identified from the 
list of most likely ionised Trc monomers. The isotope pattern is a classical one produced by doubly 
charged ions and the monoisomeric m/z value correlating to a TrcA-TrcB heterodimer.  
As can be seen, if large-scale analysis of such spectra for many different extracts is done, it would 
be beneficial to simplify, or deconvolute the m/z spectra to ease the identification because of the 
propensity of the peptides to form dimers, as well as higher order oligomers. The deconvolution 
would also simplify the calculation of the relative contribution of Trc analogues to the tyrothricin 
(Tcn) extract within sample and within multiple samples grown, extracted and analysed under the 
same conditions. While using UPLC-MS is the standard for both accurate identification and 
quantification of Trc analogues, to analyse all the extracts from the deep-well cultures in such a 
manner would be too time consuming (due to the duration of a UPLC-MS run) and the high cost 
(time on instrument, column and solvents). As such direct-injection ESMS analysis provides a 
faster, cheaper alternative, by making use of a maximum entropy algorithm to deconvolute the m/z 
spectra to produce an accurate mass spectrum. In this case the MaxEnt 3 (built into the Waters® 
MassLynx 4.1 software suite) function designed specifically for the deconvolution of m/z spectra 
with multiply charged ions, such as peptides, was used. This algorithm produces the most likely 
distribution of masses based on a complex algorithm which makes use of the isotope pattern of 
detected peptides. As such we can determine the original mass of the uncharged oligomers from 
their charged counterparts (i.e. generate a mass using the m/z equation:   𝑚 ⁄ 𝑧 =   (𝑀𝑊 +
(𝑛 × 𝐻))/𝑛, where MW = molecular weight, n = number of charges and H = mass of a proton), as 
well as the mass of the monomers. The details of the algorithm are proprietary information in the 
MassLynx software, therefore only the MaxEnt 3 output of the sample is detailed in Figure 3.4. 
 
 
Stellenbosch University  https://scholar.sun.ac.za
3-13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 represents the MaxEnt 3 output of the m/z spectra in Figure 3.3. Figure 3.4 shows the 
deconvoluted mass spectra for the 20 mM Phe supplemented sample. The masses here 
predominantly depict the experimentally detected masses of the monomer or oligomer with the 
addition of a single hydrogen (and to a lesser degree adducts of Na and K). The masses given are 
 
Figure 3.4 Mass-spectra generated with MaxEnt 3 algorithm using the m/z spectrum of 
the 20 mM Phe supplemented deep-well sample. A Extracted mass spectrum 
of monomers in the sample. B Full mass spectrum (500 – 6000 Da) 
depicting Trc monomers, dimers and trimers. C Extracted mass spectrum of 
the peptide dimers. 
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centroid values representing the centroid monoisotopic mass (m/z with z = 1) for a given peak. In 
Figure 3.4, A, can be seen the monomeric monoisotopic mass peaks produced following the 
deconvolution by the MaxEnt 3 algorithm. All labelled mass peaks can be identified as protonated 
Trc analogues (identities not shown). In Figure 3.4, C, the accurate masses of the dimers can also be 
derived from the deconvoluted mass spectrum. Looking only at the theoretical values of the 
homodimers we can only identify the mass at 2540.4319 Da as a dimer of TrcA. The rest are 
heterodimers consisting of various combinations of monomers present in the highest % signal 
intensities in spectrum A of Figure 3.4. (Refer to addendum at end of chapter for theoretical dimer 
masses (for Phe supplemented extract) and addendum of chapter 4 for theoretical monomer 
masses). 
Figure 3.5 shows the MaxEnt output (Figure 3.5, A) and the original m/z spectrum (Figure 3.5, B). 
Here it can be seen how the algorithm gave the most likely monomer masses using the original 
isotopic-distribution patterns of the detected peptides in this range. 
 
 
 
 
 
 
 
 
 
 
 
 
From the deconvoluted mass spectra we identified the most likely peptides candidates and extracted 
the signal intensities of the monomeric species to compare the contribution of each peptide in a 
specific extract. In these calculations a general assumption was made that the monomeric peptide 
 
Figure 3.5 Comparison of 20 mM Phe supplemented deep-well extract showing, A the output of 
MaxEnt 3 algorithm over monomer-mass range versus B m/z values for molecular 
ions detected in singly charged monomer m/z range and doubly charged dimer m/z 
range. 
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signal reflected the peptide contribution in the extract and that the peptides have similar signal 
response in the mass spectrometer. 
The 5618-strain was used for all deep-well cultures as it had been first used in deep-well cultures 
with 5-MeW (due to its good production of Trp containing Trcs) and was therefore used for other 
amino acid analogues. 
3.4.2 ESMS analysis of small-scale cultures supplemented with non-natural amino acids 
For a list of theoretical monomer masses of both natural and non-natural Trc analogues identified in 
this chapter see the thesis addendum. 
A detailed ESMS analysis of deep-well cultures that were supplemented with different Phe and Trp 
analogues revealed that strain 5618 were able to incorporate different Phe and Trp derivatives into 
the Trc and Tpc peptides.  Figure 3.6 to Figure 3.12 show the mass-spectra of selected samples, 
while summaries of the possible Trc analogues which could theoretically produce the detected mass 
are given in Table 3.1 to Table 3.7. The masses shown were generated using the in-built 
MassLynx® MaxEnt 3 function to identify the most probable masses of the peptides using the 
detected mass-to-charge (m/z) ratios generated by direct-injection ESMS analyses. For the mass 
spectra, only masses (or m/z values) with % signal intensity higher than 5 % above the background 
are shown and only masses with a % signal intensity higher than 10 % were labelled if a 
corresponding theoretical mass could be identified. Mass intensities (% signal intensity) are given 
as a percentage of the maximum detected intensity for a particular spectrum. In the tables presenting 
the possible identities of the theoretical Trc analogues, the most probable peptide identity (as 
protonated peptide (mass + 1.007825 mu) and/or a sodium adduct (mass + 22.989769 mu)) is given 
above the corresponding mass. 
Figure 3.6 and Table 3.1 depict the mass spectra and possible peptide identities for a 20 mM Phe 
supplemented deep-well extract. Seven monomeric peptides were identified that met the criteria for 
identification. The majority of the identified peptides were A analogues corresponding with the 
incorporation of phenylalanine residues at positions 3 and 4. As previously found by Vosloo et al. 
(18) it was also observed that with Phe supplementation TrcA gave the highest signal intensity, 
followed by PhcA and TrcA1 in the second tier of highest signals, and  finally TpcA, PhcA1, TpcA1 
and TrcB/B' producing in the lowest, but still readily detectable amounts. Any masses not labelled 
most likely represent peptides with adducts that were not identified (i.e. an adduct other than 
sodium), partially formed or degraded peptides, or contaminants. Due to problems with the in-
analysis calibrant used in the mass-spectrometer, some samples were calibrated using the theoretical 
mass of the Trc analogue present in the highest relative amount within the sample. In these cases, 
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the difference between the detected mass and theoretical mass for this analogue was subtracted from 
all the other detected monomer masses. The Trc analogue used as the internal calibrant will 
therefore have the same detected mass as the theoretical mass, and a ppm mass error of zero. In 
addition, some of the observed masses can be produced by Trc analogues which possess the same 
molecular formula but have a different structure. For instance, in Table 3.1, any TrcB and TrcB' 
analogue have the same molecular formula, but differ structurally in that the amino acids in 
positions 3 and 4 (Phe and Trp) are swapped around. As a result, any peptide which matches the 
mass of a TrcB analogue is given the identity Trc B/B' as one cannot predict exactly which amino 
acids occupies which position (without the use of MS/MS fragmentation). However, from previous 
studies by Spathelf (8) and Tang et al. (7) it is know that TrcB’ is a minor peptide in the tyrocidine 
complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM Phe 
supplemented deep-well culture extract of strain 5618. A Full spectrum over the 
mass range from 600-6000 Da, B Extracted spectrum showing mass range (1200-
1400 Da) in which the monomeric peptides would be detected. Refer to Table 3.1 for 
the list possible peptide identities from detected masses above. 
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Figure 3.7 depicts the mass-spectra for a deep-well culture extract supplemented with 20 mM 2-FF 
on top of TGS base media. Fourteen possible peptide masses were detected. A TrcA with three 2-FF 
residues gave the highest signal. For the gramicidins, which lie in the mass range of 1882.0862 to 
1873.0858 Da, only a trace amount of protonated VGA (gramicidin A) and its sodium adduct were 
detected. Table 3.2 lists the possible peptides with theoretical masses that correspond with the 
detected masses. For the peptides identified, all have a potential incorporation of the Phe analogue 
containing a fluorine group (Table 3.2). Fluorinated analogues of PhcA, PhcA1, TrcA, TrcA1, TpcA, 
TpcA1 and TrcB/B’ are likely to be identified correctly as their natural counterparts in the 20 mM 
Phe supplemented extract were observed. The mass of 1346.6374 Da corresponds closely with that 
of a TpcB1/B1’, but given the fact that this is not observed in the Phe supplemented culture extract it 
is more likely a TrcA (3*2-FF) with a sodium adduct, as TrcA gave the largest relative signal in the 
Phe extract. The same principle can be used to eliminate the TrcC (mass at 1348.6450 Da), TrcC1 
(1362.6329 Da), TpcB/B’ (2*2-FF) (1368.6329 Da), TpcB1/B1’ (1368.6329 Da) as possible Trc 
analogues. There also appears to be less dimerization by the 2-FF extract (Figure 3.7, A), but far 
higher levels of trimers and tetramers detected (possibly explaining the loss of dimer signal).  
 
Table 3.1  List of detected masses for 20 mM supplemented Phe deep-well extracts which 
could be putatively identified based on theoretical masses. Labels correspond to 
mass-spectra in Figure 3.6, B. 
Detected Mass 
Possible 
Identities 
Theoretical Mr 
of protonated 
peptide 
ppm error 
1254.6653 PhcA 1254.6675 -2 
1268.6723 PhcA1 1268.6832 -9 
1270.6624# TrcA 1270.6624 0 
1284.6767 TrcA1 1284.6781 -1 
1293.6669 TpcA 1293.6784 -9 
1307.6721 TpcA1 1307.6941 -17 
1309.6670 TrcB/B' 1309.6733 -5 
# Detected mass of TrcA adjusted to theoretical mass. Mass difference used to adjust TrcA detected mass 
to theoretical mass used to calibrate all other masses 
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Figure 3.7  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 2-FF 
supplemented deep-well culture extract of strain 5618. A Full spectrum over the 
mass range 600-6000 Da, B Extracted spectrum showing the mass range (1280-1400 
Da) in which monomeric peptides would be detected. Refer to Table 3.2 for the list 
possible peptide identities from detected masses above. 
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Figure 3.8 represents the mass-spectra of a 20 mM 4-MeF supplemented deep-well culture, using 
TGS as a base media. Methylated analogues of PhcA, PhcA1, TrcA, TrcA1, TpcA, TpcA1 and 
TrcB/B’ (Table 3.3) are also likely to be identified correctly as their natural counterparts in the 20 
mM Phe supplemented extract were also observed. This lack of detection of TrcB1/B1’ in the Phe 
supplemented culture extract, makes TrcB1/B1’ with one 4-MeF residue (TrcB1/B1’(1*4MeF), mass 
1337.7656 Da) a less likely peptide in the 4-MeF supplemented extract. The peptides in this extract 
appeared to dimerise less (Figure 3.8, A) than those found in the Phe supplemented extract, but 
produced higher levels of trimers and tetramers.  
 
 
Table 3.2 List of detected masses for 20 mM 2-FF supplemented deep-well extracts which 
could be putatively identified based on theoretical masses. Labels correspond to 
mass-spectra in Figure 3.7, B.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1306.6460 
TrcA (2*2-FF)  
TrcA1 + Na 
1306.6436 
1306.6600 
2 
-11 
1308.6471 
PhcA (3*2-FF)  
PhcA1 (1*2-FF) + Na 
1308.6393 
1308.6557 
6 
-7 
1324.6342# 
TrcA (3*2-FF)  
TrcA1 (1*2-FF) + Na 
1324.6342 
1324.6506 
0 
-12 
1326.6336 
PhcA (4*2-FF)  
PhcA1 (2*2-FF) + Na 
1326.6298 
1326.6463 
3 
-10 
1327.6442 TrcB (1*2-FF) 1327.6639 -15 
1329.6554 
TpcA (2*2-FF) 
TpcA1 + Na 
1329.6596 
1329.6760 
-3 
-15 
1338.6521 TrcA1 (3*2-FF) 1338.6498 2 
1343.6613 TpcA1 (2*2-FF) 1343.6752 -10 
1345.6438 
TrcB/B' (2*2-FF) 
Trc B1/B1' + Na 
1345.6545 
1345.6709 
-8 
-20 
1346.6374 
TrcA (3*2-FF) + Na 
TpcB1/B1' 
1346.6161 
1346.7050 
16 
-50 
1348.6450 
TrcC 
PhcA (4*2-FF) + Na 
1348.6842 
1348.6118 
-29 
25 
1362.6329 
PhcA1 (4*2-FF) + Na 
TrcC1 
1362.6274 
1362.6999 
4 
-49 
1368.6329 
TpcB/B' (2*2-FF)  
TpcB1/B1' + Na 
1368.6705 
1368.6869 
-27 
-39 
1369.6430 TpcA (3*2-FF) +Na 1369.6321 8 
# Detected mass of TrcA (3*2-FF) adjusted to theoretical mass. Mass difference used to adjust TrcA (3*2-FF) detected mass to theoretical mass used 
to calibrate all other masses  
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Figure 3.8 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 4-MeF 
supplemented deep-well culture extract of strain 5618. A Full spectrum over the 
mass range from 600-6000 Da, B Extracted spectrum showing mass range (1280-
1400 Da) in which the monomeric peptides would be detected. Refer to Table 3.3 
for the list possible peptide identities from detected masses above. 
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Figure 3.9 and Table 3.4 represent the mass-spectra and possible peptides containing a 4-CF3F 
residue. Fifteen possible peptides were found, with only the mass 1332.6678 Da having more than 
one possible identity. Of the nine monomers identified, the masses 1338.6361 Da, 1360.6684 Da, 
1361.6549 Da, 1377.6450 Da, 1392.6464 Da and 1400.6491 Da had masses which indicated the 
possible incorporation of a single 4-CF3F residue. This signal produced by the peptides in this 
extract were relatively low compared to the background, with the highest signals being produced by 
TrcB and TrcC analogues (masses at 1309.6733, 1323.6590, 1348.6753). This indicated that the 4-
CF3F analogue of Phe might not be readily incorporated into the peptide structure. None the less 
there were possible novel TrcA and TpcA analogues detected, which would be the most likely 
candidates for incorporation when considering the high signal intensities of their natural 
counterparts in the Phe supplemented extract. There appeared to be relatively low levels of 
dimerization of these peptides compared to the Phe extract, with similar trimer levels but more 
tetramer formation (Figure 3.9, A).   
 
Table 3.3 List of detected masses for 20 mM 4-MeF supplemented deep-well culture 
extracts which could be putatively identified based on theoretical masses. Labels 
correspond to mass-spectra in Figure 3.8, B.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1284.6915 
TrcA (1*MeF) 
TrcA1 
1284.6890 
1284.6781 
2 
10 
1296.7308 
PhcA (3*MeF)  
PhcA1 (2*MeF) 
1296.7470 
1296.7363 
-12 
-4 
1298.7280 
TrcA (2*MeF)  
TrcA1 (1*MeF) 
1298.7156 
1298.7047 
10 
18 
1310.7413 
PhcA (4*MeF)  
PhcA1 (3*MeF) 
1310.7738 
1310.7629 
-25 
-16 
1312.7422# 
TrcA (3*MeF) 
TrcA1 (2*MeF) 
1312.7422 
1312.7312 
0 
8 
1318.7389 
PhcA (3*MeF) + Na 
PhcA1 (2*MeF) + Na 
1318.7292 
1318.7183 
7 
16 
1324.7448 PhcA1 (4*MeF) 1324.7895 -34 
1335.7202 
TpcA (3*MeF) 
TpcA1 (2*MeF) 
1335.7582 
1335.7472 
-28 
-20 
1337.7235 
TrcB/B' (2*MeF) 
TrcB1/B1' (1*MeF) 
1337.7265 
1337.7156 
-2 
6 
# Detected mass of TrcA (3*2-MeF) adjusted to theoretical mass. Mass difference used to adjust TrcA (3*2-MeF) detected mass to 
theoretical mass used to calibrate all other masses 
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Figure 3.9 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 4-CF3F 
supplemented deep-well culture extract of strain 5618. A Full spectrum over the 
mass range from 600-6000 Da, B Extracted spectrum showing mass range (1250-
1400 Da) in which the monomeric peptides would be detected. Refer to Table 3.4 
for the list possible peptide identities from detected masses above. 
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Figure 3.10 and Table 3.5 depict the results for 10 mM supplementation with the natural amino acid 
tryptophan (W). There were higher levels of gramicidin production relative to the Phe extract, 
possibly due to Trp-rich structure of the gramicidins. There were also lower levels of dimerization, 
but more tetramer formation observed for the cyclic decapeptides in the extract. As previously 
found by Vosloo et al. (19), we also observed only four major peptides with a clear shift towards 
the production of Trp containing analogues relative to the Phe extract. As expected from previous 
studies (19, 20), TpcC was the major peptide observeed, and generated a significantly higher signal 
compared to the other peptides in this extract. 
Table 3.4  List of detected masses for 20 mM supplemented 4-CF3F deep-well culture extracts 
which could be putatively identified based on theoretical masses. Labels correspond 
to mass-spectra in Figure 3.9, B.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1270.6355 TrcA 1270.6624 -21 
1293.6450 TrcA + Na 1293.6522 -6 
1309.6733# TrcB/B' 1309.6733 0 
1323.6590 TrcB1/B1' 1323.689 -23 
1332.6678 
TpcB/B' 
TrcB/B' + Na 
1332.6893 
1332.6631 
-16 
4 
1338.6361 TrcA (1*4-CF3F) 1338.6605 -18 
1348.6753 TrcC 1348.6842 -7 
1354.6544 TpcB/B' + Na 1354.6713 -12 
1360.6684 TrcA (1*4-CF3F) + Na 1360.6425 19 
1361.6549 TpcA (1*4-CF3F) 1361.6765 -16 
1370.6532 TrcC + Na 1370.6662 -9 
1377.6450 Trc B/B' (1*4-CF3F) 1377.6714 -19 
1392.6666 TrcAv (1*CF3F) 1392.643 17 
1393.6464 TpcC + Na 1393.6822 -26 
1400.6491 TpcB/B' (1*CF3F) 1400.6874 -27 
# Detected mass of TrcB/B’ adjusted to theoretical mass. Mass difference used to adjust TrcB/B’ detected mass to theoretical mass used to calibrate 
all other masses 
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Figure 3.10 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM Trp 
supplemented deep-well culture extract of strain 5618. A Full spectrum over the 
mass range from 600-6000 Da, B Extracted spectrum showing mass range (1280-
1450 Da) in which the monomeric peptides would be detected. Refer to Table 3.5 
for the list possible peptide identities from detected masses above. 
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Figure 3.11 and Table 3.6 represent the mass spectra and possible peptide identities found in 
cultures supplemented with the methylated tryptophan analogue 1-MeW. Eight possible peptides 
were identified. Given the production profile of the Trp supplemented extract, the mass at 
1362.6805 Da is more likely a Trc with a single 1-MeW residue incorporated than a TrcC1, which 
was not observed in the Trp extract. Similarly, the mass at 1376.6934 Da is likely a TrcC with two 
1-MeW residues or TrcC (2*1MeW). There appeared to be much lower levels of dimerization of in 
this extract, as well as virtually no readily observable gramicidin production, which is in stark 
contrast to the Trp extract. 
 
 
 
 
 
 
 
 
Table 3.5 List of detected masses for 10 mM supplemented Trp deep-well extracts which could 
be putatively identified based on theoretical masses. Labels correspond to mass-
spectra in Figure 3.10.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1332.6497 TpcB/B' 1332.6893 -30 
1348.6589 TrcC 1348.6842 -19 
1371.6842 TpcC 1371.7002 -12 
1385.6987 TpcC1 1385.7159 -12 
1393.6688 TpcC + Na 1393.6822 -10 
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Figure 3.11 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM 1-
MeWsupplemented deep-well culture extract of strain 5618. A Full spectrum over 
the mass range from 600-6000 Da, B Extracted spectrum showing mass range 
(1300-1450 Da) in which the monomeric peptides would be detected. Refer to 
Table 3.6 for the list possible peptide identities from detected masses above. 
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Figure 3.12 and Table 3.7 represent the ESMS analysis of the 5-MeW supplemented deep-well 
culture extract. Six possible peptide masses were identified. The mass of 1323.6554 Da gives two 
possible theoretical identities, either a TrcB1/B1’ or a TrcB/B’ (1*5MeW), which are unique in the 
since that neither TrcB1/B1’ or TrcB/B’ were readily produced in the Trp supplemented culture. The 
peptide with m/z at1346.6774 is likely a TpcB/B’ (1*5MeW) given that this was readily produced 
in the Trp supplemented culture. The peptide correlating to m/z of 1360.6869 Da could be a 
TpcB1/B1’ (1*5MeW), as its sodium adduct at m/z 1382.6908 was also detected. However, very 
little TpcB1/B1’ is produced in Trp supplemented culture, which could indicate that 5-MeW 
incorporation leads to selective synthesis of the B and B1 type tryptocidine analogues. This extract 
appeared to form fewer dimers than the Trp supplemented culture extract, but more tetramers. Its 
gramicidin content appeared to be similar to that of the Trp supplemented culture extract. 
Due to the complicated nature of dimerization and oligomerisation in the cyclic decapeptide 
mixtures this was not discussed in detail in this chapter. However, a preliminary analysis of the 
possible dimers in the different supplemented extracts is given in the addendum. 
 
Table 3.6 List of detected masses for 10 mM supplemented 1-MeW deep-well extracts which 
could be putatively identified based on theoretical masses. Labels correspond to 
mass-spectra in Figure 3.11, B.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1332.6690 TpcB/B' 1332.6893 -15 
1346.6839 
TpcB/B' (1*1MeW) 
TpcB1/B1' 
1346.7050 
1346.7050 
-16 
-16 
1362.6805 
TrcC (1*1MeW) 
TrcC1 
1362.6999 
1362.6999 
-14 
-14 
1371.7017 TpcC 1371.7002 1 
1376.6934 
TrcC (2*1MeW) 
TrcC1 (1*1MeW) 
1376.7158 
1376.7157 
-16 
-16 
1385.7159# 
TpcC (1*1MeW) 
TpcC1 
1385.7159 
1385.7159 
0 
0 
1399.7188 
TpcC (2*1MeW) 
TpcC1 (1*1MeW) 
1399.7315 
1399.7315 
-9 
-9 
1407.6956 
TpcC (1*1MeW) + Na 
TpcC1 + Na 
1407.6978 
1407.6978 
-2 
-2 
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Figure 3.12 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM 5-MeW 
supplemented deep-well culture extract of strain 5618. A A Full spectrum over the 
mass range from 600-6000 Da, B Extracted spectrum showing mass range (1300-
1450 Da) in which the monomeric peptides would be detected. Refer to Table 3.7 
for the list possible peptide identities from detected masses above. 
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Comparison of Trc production under varying growth conditions using ESMS analysis of extracts: 
Figure 3.13 represents the results of combined analysis of all the Phe and Phe derivative 
supplemented cultures. These deep-well cultures were extracted and analysed by ESMS to 
determine if the growth rate under certain conditions had an effect on both natural and novel Trc 
productions. The % intensity on the in this figure gives an idea of how the signal of Trcs identified 
in the monomer mass range (after MaxEnt 3 processing), using ESMS analysis, changes relative to 
the background of detected compounds, which gives a good estimation of peptide production. 
Concentrations of amino acids were chosen from the middle and high end the concentration range 
used for growth-rate analysis. In addition, urea and sodium sulphate were used at two different 
concentration to determine if their apparent positive effect on growth rate observed in Chapter 2 has 
an effect peptide production.  
 
 
 
 
 
 
Table 3.7 List of detected masses for 10 mM supplemented 5-MeW deep-well extracts which 
could be putatively identified based on theoretical masses. Possible identities 
correspond to mass-spectra in Figure 3.12, B.  
Detected Mass Possible Identities* 
Theoretical 
masses 
ppm 
error 
1323.6554 
TrcB/B' (1*5MeW) 
TrcB1/B1' 
1323.6890 
1323.6890 
-25 
-25 
1346.6774 
TpcB/B' (1*5MeW) 
TpcB1/B1' 
1346.7050 
1346.7050 
-20 
-20 
1360.6869 
TpcB/B' (2*5MeW) 
TpcB1/B1' (1*5MeW) 
1360.7206 
1360.7206 
-25 
-25 
1382.6908 
TpcB/B' (2*5MeW) + Na 
TpcB1/B1' (1*5MeW) + Na 
1382.7026 
1382.7026 
-9 
-9 
1385.6660 
TpcC (1*5MeW) 
TpcC1 
1385.7159 
1385.7159 
-36 
-36 
1399.9634 
TpcC (2*5MeW) 
TpcC1 (1*5MeW) 
1399.7315 
1399.7315 
-27 
-27 
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Figure 3.13, C, compares the Trc production in the Phe supplemented growth media of strain 5618. 
As expected relatively high signal intensities were found for TrcA and PhcA relative to the TGS. 
All Phe supplemented extracts, irrespective of Phe, urea or Na2SO4 concentration produced similar 
signal intensities relative to TGS. Looking at the growth rates for the 5618 strain at 11 mM and 22 
mM (Figure 3.2, D), there was an improvement in growth rate over TGS, but the improvement seen 
in peptide production may not correlate with this. For the Phe derivative 2-FF (Figure 3.13, B), 
TrcA analogues with three and two 2-FF residues were found in the highest % signal intensities 
 
Figure 3.13 Comparison of the medium-throughput deep-well culture extracts for phenylalanine 
and its derivatives supplemented into the growth media of the 5618 strain. The % 
intensity represents the percentage contribution that was observed for each Trc 
analogue under that specific growth condition. The AA in the figure legend is a 
placeholder for the particular amino acid used in that assay, together with the urea 
or Na2SO4 concentration. The F-analogue used is shown at the top-left of each 
graph. The % intensity shown is the mean of two analytical repeats obtained by 
combining six deep-well cultures for each extraction and subsequent analysis. 
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respectively. For these two Trc analogues, TGS together with 10 mM or 20 mM of 2-FF produced 
the highest total signal intensity. Eight other potential Trc analogues containing 2-FF were found 
but at a considerably lower contribution. The addition of either urea or Na2SO4 (irrespective of 
concentration) did appear to improve the production of a TrcB analogue with two 2-FF residues. In 
Figure 3.2, B, supplementation of TGS with 2-FF led to a dampening of growth rate relative to the 
other amino acids tested, but one that was closer to that of TGS. The Phe derivative 4-MeF (Figure 
3.13, D) appeared to be incorporated into the Trcs well under all conditions tested, with the 
exception of a Na2SO4 concentration of 4 g/L together with 20 mM 4-MeF. The 4-CF3F analogue 
only showed one potential novel Trc analogue producing a significant signal, with a mass found 
corresponding to the incorporation of a single 4-CF3F incorporated into a TrcA (Figure 3.13, A)).  
Figure 3.14 shows the Trp and Trp derivative supplemented deep-well extracts, using different 
concentrations of these amino acids together with urea and Na2SO4. For the samples supplemented 
with Trp (Figure 3.14, C)  TpcC (as expected from previous studies (18)) was produced in the 
highest amount, followed by TpcB and TrcC. Looking at the TpcC analogue there is an increase in 
TpcC signal contribution from a 5 mM supplementation to a 10 mM supplementation. There does 
not appear to be any major influence of Na2SO4 or urea on production. Comparing the signal 
contributions to that of the TGS control, it is observed that the TGS produced more appreciable 
amounts of the TrcA, TpcA and TpcA1 analogues, together with some TpcB. The supplementation 
of the growth media with Trp leads to a higher relative production of analogues containing 
tryptophan, particularly TpcC and TrcC.For the direct-injection ESMS results obtained from the Trp 
derivative supplemented extracts (Figure 3.14, A & B) there appears to be incorporation of both the 
1-MeW and 5-MeW analogues for all growth conditions. For the two highest contributions of 
analogues produced, there appeared to be a marginal preference for urea and Na2SO4 at 4 g/L and 
10 mM 1-MeW, Na2SO4 at 1 g/L together with 10 mM 1-MeW, and for TGS alone together with 5 
mM or 10 mM 1-MeW, although observed differences are minimal.  
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Figure 3.14 Comparison of the medium-throughput deep-well culture extracts for tryptophan and its 
analogues supplementation of strain 5618. The % intensity represents the percentage 
contribution that was observed for each Trc analogue under that specific growth condition. 
The AA in the figure legend is a placeholder for the particular amino acid used in that 
assay, together with the urea or Na2SO4 concentration. The Trp-analogue used is shown at 
the top-left of each graph. The % intensity shown is the mean of two analytical repeats 
obtained by combining six deep-well cultures for each extraction and subsequent analysis. 
Letters in bold show represent amino acids used with A: 1-methyl-tryptophan (1-MeW), B: 
5-methyl-tryptophan (4-MeW) and C: tryptophan (W).  
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3.5 Discussion 
Using growth rate analysis under different supplementation conditions has been shown to be a good 
starting point to assess the effect of these altered conditions on the growth of the producer 
organism. It is particularly useful to determine if an amino acid derivative is toxic to the organism. 
This then provides a relatively quick and easy basis by which to select growth conditions for 
analysis of peptide production using a medium-throughput deep-well assay, which in turn provides 
a basis for eventual large-scale production of peptides for detailed analysis and purification of 
individual Trc analogues. 
The relative sensitivity of the producer organisms to certain amino acids has been observed, most 
noticeable is the effect of 1-MeW versus that of 5-MeW on growth rate for all the strains, while 
fluorinated phenylalanine also inhibited growth rate for both the 362 and 5618-strains.  Even though 
there are differences in growth rate between both amino acid type and concentration, almost all the 
conditions tested led to growth rate comparable to the supplemented TGS media, with the only 
exception being the 11 mM and 22 mM 1-MeW supplemented cultures.  
Looking at selected deep-well extracts (Figure 3.6 – Figure 3.12, Table 3.1 – Table 3.7), it is clear 
that the 5618 strain of Brevibacillus parabrevis, and possibly the other strains used in growth rate 
analysis, readily incorporate all the amino acids supplemented into TGS, while only the 4-CF3F 
derivative did not appear to produce the expected production profile of Phe and its other two 
derivatives tested. All the Phe derivatives used appeared to lead to increased levels of 
oligomerisation, particularly the formation of trimers and tetramers. Both the 1-MeW and 5-MeW 
extracts appeared to produce lower oligomers compared to the natural analogue (with the exception 
of an increase in tetramer formation for the 5-MeW extract). Interesting to note is that there is often 
an increase in gramicidin production following supplementation with tryptophan, which was also 
observed for its derivative 5-MeW. Supplementation with 1-MeW, however, appeared to suppress 
gramicidin production, but still allow for the formation of Trcs. 
The direct-injection ESMS analysis of the deep well extracts showed that while both the 2-FF and 
1-MeW amino acid analogues led to inhibited growth in the 5618-strain, they still produced 
detectable Trc analogues. This may indicate that the some analogues may act as antagonists in 
protein synthesis, while still being able to bind to tyrocidine synthetase domains, a result supported 
by Okuda et al. (15).  
Even though an amino acid analogue may inhibit the growth of the producer organism it is still 
possible for the producer organism to synthesise detectable amounts of the cyclic decapeptides over 
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an incubation period of 10 days. This is exemplified by the fact that even though 1-MeW appeared 
to suppress growth at a concentration of 11 mM, using a concentration of 10 mM in the deep-well 
cultures still produced detectable amounts of peptide which were likely incorporated into 
tryptophan analogue. 
The ability of the 5618-strain of Br. parabrevis (and possibly other strains) to incorporate non-
natural amino acids provides even more structural and potential functional diversity to the already 
extensive library of identified Trc analogues. This opens the door for the creation of Trc analogues 
with a higher therapeutic index either on their own or acting synergistically in a formulated 
combination of peptides, as the ability of the monomers to dimerize has been extensively shown. 
Novel Trc analogues retained the ability to form homo- and heterodimers, which could be essential 
for activity. In Chapter 4 the ability of the 5618-strain to produce novel modified cyclodecapeptides 
in the Trc family will be further explored using larger scale production and HPLC purification 
protocols to isolate these novel peptides and assess their antibacterial activity..  
3.6 References 
1.  Mootz, H. D., and Marahiel, M. A. (1997) The tyrocidine biosynthesis operon of Bacillus 
brevis: complete nucleotide sequence and biochemical characterization of functional internal 
adenylation domains. J. Bacteriol. 179, 6843–6850 
2.  Linne, U., Stein, D. B., Mootz, H. D., and Marahiel, M. A. (2003) Systematic and 
quantitative analysis of protein-protein recognition between nonribosomal peptide 
synthetases investigated in the tyrocidine biosynthetic template. Biochemistry. 42, 5114–
5124 
3.  Kopp, F., and Marahiel, M. A. (2007) Macrocyclization strategies in polyketide and 
nonribosomal peptide biosynthesis. Nat. Prod. Rep. 24, 735-749 
4.  Marahiel, M. A. (2009) Working outside the protein-synthesis rules: insights into non-
ribosomal peptide synthesis. J. Pept. Sci. 15, 799–807 
5.  Trauger, J. W., Kohli, R. M., Mootz, H. D., Marahiel, M. A., and Walsh, C. T. (2000) 
Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase. Nature. 
407, 215–218 
6.  Kohli, R. M., Walsh, C. T., and Burkart, M. D. (2002) Biomimetic synthesis and 
optimization of cyclic peptide antibiotics. Nature. 418, 658–661 
Stellenbosch University  https://scholar.sun.ac.za
3-35 
 
7.  Tang, X-J., Thibault, P., and Boyd, R. K. (1992) Characterisation of the tyrocidine and 
gramicidin fractions of the tyrothricin complex from Bacillus brevis using liquid 
chromatography and mass spectrometry. Int. J. Mass Spectrom. Ion Process. 122, 153–179 
8.  Spathelf, B. (2010) Qualitative structure-activity relationships of the major tyrocidines , 
cyclic decapeptides from Bacillus aneurinolyticus. Ph.D. thesis, Stellenbosch University, 
http://hdl.handle.net/10019.1/4001 
9.  Marques, M. A., Citron, D. M., and Wang, C. C. (2007) Development of tyrocidine A 
analogues with improved antibacterial activity. Bioorg. Med. Chem. 15, 6667–6677 
10.  Spathelf, B. M., and Rautenbach, M. (2009) Anti-listerial activity and structure-activity 
relationships of the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus. 
Bioorganic Med. Chem. 17, 5541–5548 
11.  Leussa, A. N. yango N., and Rautenbach, M. (2014) Detailed SAR and PCA of the 
tyrocidines and analogues towards leucocin A-sensitive and leucocin A-resistant Listeria 
monocytogenes. Chem. Biol. Drug Des. 84, 543–557 
12.  Loll, P. J., Upton, E. C., Nahoum, V., Economou, N. J., and Cocklin, S. (2014) The high 
resolution structure of tyrocidine A reveals an amphipathic dimer. Biochim. Biophys. Acta. 
1838, 1199–1207 
13.  Munyuki, G., Jackson, G. E., Venter, G. a., Kövér, K. E., Szilágyi, L., Rautenbach, M., 
Spathelf, B. M., Bhattacharya, B., and Van Der Spoel, D. (2013) β-sheet structures and dimer 
models of the two major tyrocidines, antimicrobial peptides from Bacillus aneurinolyticus. 
Biochemistry. 52, 7798–7806 
14.  Qin, C., Zhong, X., Bu, X., Ng, N. L. J., and Guo, Z. (2003) Dissociation of antibacterial and 
hemolytic activities of an amphipathic peptide antibiotic. J. Med. Chem. 46, 4830–4833 
15.  Okuda, K., Edwards, G. C., and Winnick, T. (1962) Biosynthesis of gramicidin and 
tyrocidine in the Dubos strain of Bacillus brevis I. Experiments with growing cultures. J. 
Bacteriol. 85, 329–338 
16.  Mach, B., Reich, E., and Tatum, E. L. (1963) Separation of the biosynthesis of the antibiotic 
polypeptide tyrocidine from protein biosynthesis*. Proc. Natl. Acad. Sci. U. S. A. 50, 175–
181 
 
Stellenbosch University  https://scholar.sun.ac.za
3-36 
 
17.  Ruttenberg, M. A, and Mach, B. (1966) Studies on amino acid substitution in the 
biosynthesis of the antibiotic polypeptide tyrocidine. Biochemistry. 5, 2864–2869 
18.  Vosloo, J. A., Stander, M. A., Leussa, A. N. N., Spathelf, B. M., and Rautenbach, M. (2013) 
Manipulation of the tyrothricin production profile of Bacillus aneurinolyticus. Microbiol. 
(United Kingdom). 159, 2200–2211 
19.  Vosloo, J. A. (2016) Optimised bacterial production and characterisation of natural 
antimicrobial peptides with potential application in agriculture. Ph.D. thesis, University of 
Stellenbosch, scholar.sun.ac.za/handle/10019.1/98411, pp 3.7 -3.13 
20.  Mach, B., and Tatum, E. L. (1964) Environmental control of amino acid substitutions in the 
biosynthesis of the antibiotic polypeptide tyrocidine. Proc. Natl. Acad. Sci. U. S. A. 52, 876–
884 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
3-37 
 
3.6 Addendum 
The incorporation of the non-natural amino acids used in the deep-well extracts leads to a wide 
array of novel tyrocidine, tryptocidine and some phenycidine analogues. The increase in the 
diversity of monomers incorporating non-natural amino acid derivatives leads to an even more 
diverse array of dimers, which the Trcs have been shown to readily form. In this addendum a 
breakdown of the dimers observed for both Trp and Phe supplemented cultures, as well as their 
non-natural derivatives, is given. The extracted spectrums are shown covering the expected dimer 
ranges from the mass-spectra in Figures 3.6 to 3.12.  
Figures 3.16 to 3.21 depict the extracted mass-ranges for the expected dimers, generated using the 
MaxEnt 3 function. Figures 3.8 to 3.21 show the detected masses in this range as well as their 
possible identities (i.e. their monomer constituents). The dimers are putatively identified by the 
monomers positively identified for the extracts, whose theoretical masses were combined and 
compared against the detected masses. The theoretical dimer masses and detected dimer masses are 
protonated masses (no adducts were tested for). The theoretical dimer identity can be determined by 
looking at the masses highlighted in yellow in the theoretical dimer mass tables. The corresponding 
monomer identities in the first column and top row represent the constituent monomers. 
For a full list of theoretical monomer masses for observed Trcs, see addendum of chapter 4. 
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Figure 3.15  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM Phe 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.9 for % signal contribution of 
detected masses to this spectrum and Table 3.8 for possible dimer identities. 
Stellenbosch University  https://scholar.sun.ac.za
3-38 
 
Table 3.8  Theoretical dimer masses 
and constituent monomers determined from 
combinations of detected monomers in Phe 
extract. Highlighted masses are theoretical 
dimer masses which correspond with 
detected masses in Table 3.9.  
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Table 3.9  Detected MaxEnt 3 masses in 
dimer range for Phe supplemented culture 
contributing over 2% to total signal in this 
range. 
Detected  
Mass (Da) 
% Total  
Signal 
2540.4319 33.55 
2524.4316 16.87 
2554.4407 11.92 
2563.4446 6.78 
2578.4519 5.29 
2509.4465 2.47 
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Table 3.10 Detected MaxEnt 3 
masses in dimer range for 2-FF 
supplemented culture contributing 
over 2% to total signal in this 
range. 
Detected  
Mass (Da) 
% Total 
 Signal 
2651.3958 10.47 
2648.3943 9.82 
2671.4058 9.53 
2654.4143 5.79 
2630.3945 5.55 
2613.4077 3.66 
2692.4167 2.96 
2694.4170 2.84 
2675.4302 2.69 
2668.4072 2.50 
2687.4155 2.45 
2663.4016 2.41 
2707.3921 2.30 
2645.4121 2.14 
 
mass
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%
0
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2648.3943
2630.3945
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2616.4187
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2671.4058
2654.4143
2668.4072
2692.4167
2675.4302
2707.3921
2729.3772
2714.4236 2751.3789
2735.4221
2767.3586 2788.3687
2-FF 
Figure 3.16  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 2-FF 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.10 for % signal contribution of 
detected masses to this spectrum and Table 3.11 for possible dimer identities. 
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Table 3.11 Theoretical dimer masses and constituent 
monomers determined from combinations of detected 
monomers in 2-FF extract. Highlighted masses are 
theoretical dimer masses which correspond with detected 
masses in Table 3.10. 
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Table 3.12  Detected 
MaxEnt 3 masses in dimer 
range for 4-MeF 
supplemented culture 
contributing over 2% to 
total signal in this range. 
Detected 
Mass (Da) 
% Total  
Signal 
2596.5005 10.34 
2619.5308 6.28 
2622.5415 5.47 
2623.5383 3.14 
2594.5200 3.07 
2649.5342 2.77 
2636.5396 2.70 
2605.5212 2.61 
 
mass 
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%
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2608.5310 
2611.5134 
2633.5269 
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2645.5354 
2649.5342 
2657.5269 
2671.5369 
2681.5142 
2693.5081 2772.5520 2745.5107 2707.5071 2729.5034 2786.5615 
2-MeF 
Figure 3.17 ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 2-MeF 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.12 for % signal contribution of 
detected masses to this spectrum and Table 3.13 for possible dimer identities. 
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Table 3.13 Theoretical dimer masses and constituent monomers 
determined from combinations of detected monomers in 4-MeF 
extract. Highlighted masses are theoretical dimer masses which 
correspond with detected masses in Table 3.12. 
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Table 3.14 Detected MaxEnt 3 
masses in dimer range for 4-CF3F 
supplemented culture contributing 
over 2% to total signal in this 
range. 
Detected 
Mass (Da) 
% Total  
Signal 
2709.4724 6.75 
2686.4714 6.75 
2680.4951 6.46 
2641.4854 6.20 
2657.4792 5.64 
2670.4668 5.30 
2647.4534 4.16 
2748.488 3.35 
2724.4707 3.13 
2699.4724 3.05 
2738.4604 2.87 
2694.4988 2.78 
2715.4607 2.56 
2720.4976 2.46 
2664.5044 2.42 
2703.5002 2.34 
2733.4934 2.26 
2602.4814 2.06 
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Figure 3.18   ESMS mass-spectra generated using the MaxEnt 3 algorithm for 20 mM 4-CF3F 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.14 for % signal contribution of 
detected masses to this spectrum and Table 3.15 for possible dimer identities. 
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Table 3.15 Theoretical dimer masses and constituent 
monomers determined from combinations of detected 
monomers in 4-CF3F extract. Highlighted masses are 
theoretical dimer masses which correspond with 
detected masses in Table 3.14. 
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Table 3.16  Theoretical dimer masses and constituent monomers determined 
from combinations of detected monomers in Trp extract. 
Highlighted masses are theoretical dimer masses which 
correspond with detected masses in Table 3.17. 
Peptide 
Abbreviation 
TpcB TrcC TpcC TpcC1 
TpcB 2664.3708       
TrcC 2680.3657 2696.3607     
TpcC 2703.3817 2719.3767 2742.3926   
TpcC
1 2717.3974 2733.3923 2756.4083 2770.4239 
 
 
Table 3.17 Detected MaxEnt 
3 masses in dimer range for 
Trp supplemented culture 
contributing over 2% to total 
signal in this range. 
Detected 
Mass (Da) 
% Total  
Signal 
2742.3086 36.12 
2756.3259 13.22 
2703.3040 10.64 
2717.3206 4.75 
2719.3125 3.92 
2772.3308 2.28 
2758.3206 2.25 
2680.3152 2.11 
 
mass 
2600 2610 2620 2630 2640 2650 2660 2670 2680 2690 2700 2710 2720 2730 2740 2750 2760 2770 2780 2790 2800 2810 2820 2830 2840 2850 2860 2870 2880 2890 2900 
%
 
0 
100 2742.3086 
2703.3040 
2680.3152 
2717.3206 
2719.3125 
2733.3301 
2756.3259 
2772.3308 
Trp 
Figure 3.19  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM Trp 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.16 for % signal contribution of detected 
masses to this spectrum and Table 3.17 for possible dimer identities. 
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Table 3.18  Detected MaxEnt 3 
masses in dimer range for 1-
MeW supplemented culture 
contributing over 2% to total 
signal in this range. 
Detected 
Mass (Da) 
% Total 
Signal 
2731.5222 12.08 
2746.5376 9.84 
2784.5576 9.79 
2770.5388 7.91 
2708.5100 7.13 
2761.5452 6.87 
2799.5833 6.11 
2717.5115 5.73 
2723.5247 5.11 
2692.5164 4.49 
2776.5486 3.65 
2757.5217 3.07 
 
mass 
2600 2610 2620 2630 2640 2650 2660 2670 2680 2690 2700 2710 2720 2730 2740 2750 2760 2770 2780 2790 2800 2810 2820 2830 2840 2850 2860 2870 2880 2890 2900 
%
 
0 
100 2731.5222 
2708.5100 
2692.5164 
2685.5000 
2683.0469 
2717.5115 
2746.5376 2784.5576 
2770.5388 
2761.5452 
2799.5833 
2806.5002 
2880.4880 2815.5632 
1-MeW 
Figure 3.20  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM 1-MeW 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.18 for % signal contribution of detected 
masses to this spectrum Table 3.19 for possible dimer identities. 
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Table 3.19 Theoretical dimer masses and constituent 
monomers determined from combinations of detected 
monomers in 1-MeW extract. Highlighted masses are 
theoretical dimer masses which correspond with detected 
masses in Table 3.18. 
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Table 3.20 Detected MaxEnt 3 
masses in dimer range for 5-MeW 
supplemented culture contributing 
over 2% to total signal in this range. 
Detected 
Mass (Da) 
% Total 
Signal 
2720.3491 13.13 
2759.3652 11.03 
2683.3374 9.70 
2706.3440 8.17 
2745.3455 4.63 
2722.3613 4.22 
2721.3516 4.21 
2708.3269 2.56 
2669.3127 2.45 
2744.3364 2.14 
2733.3340 2.02 
 
mass 
2600 2620 2640 2660 2680 2700 2720 2740 2760 2780 2800 2820 2840 2860 2880 2900 2920 2940 
%
 
0 
100 2720.3491 
2683.3374 
2669.3127 
2646.3174 
2617.3638 2631.2505 2666.3608 
2706.3440 
2697.3418 
2759.3652 
2745.3455 
2722.3613 
2744.3364 
2783.3347 
2772.3633 
2798.3296 
2880.3384 2818.2656 2832.3452 
2855.2014 2862.2727 2927.5674 2898.2341 
5-MeW 
Figure 3.21  ESMS mass-spectra generated using the MaxEnt 3 algorithm for 10 mM 5-MeW 
supplemented deep-well culture extract of strain 5618 depicting mass-range for 
dimers and detected masses. Refer to Table 3.20 for % signal contribution of 
detected masses to this spectrum and Table 3.21 for possible dimer identities. 
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Table 3.21 Theoretical dimer masses and 
constituent monomers determined from 
combinations of detected monomers in 1-MeW 
extract. Highlighted masses are theoretical dimer 
masses which correspond with detected masses 
in Table 3.20. 
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Chapter 4  
Medium scale production and characterisation of tyrocidine analogues containing 
non-natural aromatic amino acids  
4.1 Introduction 
As discussed in the introduction of the previous chapter, the producer organism Br. parabrevis has 
the ability to produce a diverse array of non-ribosomally synthesized peptides. This occurs as a 
result of a lack of specificity of specific of modules 3,4,7 and 9 in the tyrocidine synthetase system 
for a single amino acid, resulting in the large array of cyclic decapeptides with the sequence cyclo-
f1P2X3x4N5Q6X7V8X9L10 (variable residues depicted by X, lower case letters represent D-amino 
acids) observed by Tang et al. (1). 
Vosloo et al. (2) adapted a media from Lewis et al. (3), termed TGS, consisting of tryptone, glucose 
and inorganic salts, as a base media for use in supplementation tyrocidine producer cultures with 
specific amino acids. Using the producer organism Br. parabrevis ATCC 10068 it was found that 
supplementation of the growth media with 5.5 mM Phe led to a marked increase in the more 
hydrophobic tyrocidine A-analogues with Phe at residue positions three and four, while 
supplementation of the growth media with 11 mM Trp led to a marked increase in more hydrophilic 
tyrocidine C-analogues (having Trp at positions 3 and 4) (2), as well as tryptocidines with Trp at 
position 7 (4). Modelling the incorporation of Trp and Phe into the tyrocidines and their analogues 
as a function of their concentration in the media gave an indication of the affinity of the adenylation 
domains at modules 3, 4 and 7 in the tyrocidine synthetase system (4). All these positions have a 
preference for Trp, but position four has the highest affinity for Phe relative to positions 3 and 7, 
being the first to incorporate Phe as its concentration in the growth media is increased, followed by 
position 3 then 7 (4). 
 The shift in production of crude extracts towards more A (F3f4) analogues or more B (F3w4/W3f4) 
and C (W3w3) analogues also leads to alterations in antibacterial activity against Micrococcus luteus 
(2). Extracts from 5.5 mM Phe supplemented cultures, containing predominantly A and B 
analogues, gave an MIC (minimum inhibitory concentration) of 3.125 μg/mL compared to extracts 
from 5.5 mM Trp supplemented culture containing predominantly B and C-analogues together with 
higher gramicidin A production, yielding an MIC of 6.25 μg/mL. At very high Phe supplementation 
concentrations of 27.5 mM there was four-fold increase in the MIC.  Supplementation with 5.5 mM 
Trp, as well as 2.5 mM Phe led to a high production of TrcB, which were previously shown to be 
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one of the most active analogues against Gram-positive bacteria (5, 6). For more detail refer to the 
introduction of Chapter 3 that highlights the differences in activity of six major tyrocidine 
analogues against three microorganisms. As mentioned in Chapter 3, synthetic modification of a 
TrcA led to alterations in its structure-activity relationship, with some modifications leading to 
enhanced activity against M. luteus together with reduced haemolytic activity, indicative of the 
ability to improve the selectivity of the tyrocidines and analogues for pathogens (7).  There has been 
little work done on the ability of Br. parabrevis to incorporate non-natural amino acids into 
tyrocidine analogues, with the exception of work by Okuda et al. (8) who observed incorporation of 
β-2-thienylalanine using isotopic labelling and Ruttenberg et al. (9), where the preferential 
incorporation of allo-isoleucine over isoleucine was observed.  
In earlier years the most commonly used methods to determine the incorporation of an amino acids 
into non-ribosomally synthesized peptides was through the use of radiolabelled tracers, but modern 
electrospray ionisation mass spectrometry (ESI-MS or ESMS) and improved nuclear magnetic 
resonance (NMR) spectrometry has greatly aided in the identification and characterisation of 
peptides (10). High-resolution mass-spectrometry can now provide accurate identification of 
peptides based on the detected m/z ratios, with ppm (parts per million) errors of 2-10 being achieved 
by the high resolution ESMS utilised in our group. Ultra-performance liquid chromatography 
(UPLC®) linked to ESMS (UPLC-MS) is also a valuable tool in calculating purity of tyrocidine 
extracts as well as estimating the concentration of the peptides present in the tyrothricin complex 
using a commercially available standard. 
High performance liquid chromatography (HPLC) is an important tool in both the purification and 
analysis of peptides. In the case of the tyrocidines and analogues semi-preparative purification, as 
well as analysis of peptides is best achieved using reverse-phase separation, where the tyrocidines 
and analogues are separated based on interaction of their hydrophobic amino acid residues with the 
stationary phase (C18 matrix) together with a polar solvent as the mobile phase, in this case 
acetonitrile. UPLC provides enhanced separation via smaller matrix particle sizes (having a larger 
analyte interaction surface) and higher operating pressures, providing improved separation and 
analysis of complex compounds such as the peptide complexes in this study. In the case of the 
tyrocidines and analogues, small differences in amino acid chemistry (such as the CH2 difference 
between Lys and Orn variants) and sequence (Trc analogues with a F3w4 or W3f4 configuration) can 
make them difficult to separate via analytical HPLC, in which case UPLC-ESMS provides the best 
available too for analysis. 
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Semi-preparative HPLC is useful for isolating individual peptides for testing in isolation in terms of 
biological activity (6) and biophysical properties, such as levels of aggregation (4). In this way 
individual peptides can be compared to one another and to the mixture as a whole for optimising 
peptide compositions for use against different organisms. In addition, the isolation of pure peptide 
eases the process of determining its primary structure through tandem MS. 
This chapter reports the utilisation of semi-preparative HPLC, UPLC-MS and biological activity to 
partially characterise novel tyrocidine analogues in medium scale extracts of Br. parabrevis cultures 
supplemented with Phe, Trp and their selected, non-natural, derivatives. 
4.2 Materials 
The producer organisms Br. parabrevis 5618 originate from the Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ) in Braunschweig, Germany. M. luteus NCTC 8340 
was obtained from the UK National Collection of Type Cultures in Porton Down (Salisbury, 
England). Tryptic soy broth (TSB), LB (Luria Bertani) media, tryptone, agar, glucose, ethanol 
(EtOH), hydrochloric acid (HCl), sodium chloride (NaCl), were from Merck (Darmstadt, Germany). 
Commercial tyrothricin, gramicidin S (GS), triflouroacetic acid (TFA, > 98% purity), and resazurin 
dye and were obtained from Sigma-Aldrich (St. Louis, USA). Acetonitrile (ACN, far UV cut-off, > 
98% purity) was obtained from Romil Ltd (Cambridge, UK). Analytical grade, deionised water was 
obtained by filtering reverse osmosis water through a Milli-Q® water purification system from 
Merck Millipore (Burlington, Massachusetts, USA). The modified amino acid 2-
flourophenylalanine (2-FF) was from GL Biochem Ltd (Shanghai, China). L-Tryptophan (Trp), 5-
methyl-DL-tryptophan (5-MeW) and L-phenylalanine (Phe) were from Sigma-Aldrich (Steinheim, 
Germany). TrcA, TrcB, PhcA, TpcB and TpcC (purity above 90% as determined by UPLC-ESMS) 
were donated by W Laubscher and JA Vosloo, and the tyrocidine mixture (>95% purity in terms of 
cyclodecapeptide content) was from the BIOPEPTM peptide library. 
Falcon® tubes were from Corning (Corning, NY). The Acquity UPLC® BEH Phenyl column (2.1 
mm × 100 mm, 1.7 μm particle size) and semi-preparative NovaPak HR C18 column (6 μm particle 
size, 7.8 mm X 300 mm) and 0.22 µm polycarbonate syringe filters were from Waters (Milford, 
MA, USA). Microplate readers utilised in the study were a Model 680 Microplate reader from Bio-
Rad Laboratories (Hercules, California, United States) and the Spark 10M multimode plate reader 
from Tecan (Männedorf, Switzerland) 
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4.3 Methods 
4.3.1 Medium-scale culturing and extraction using selected, non-natural amino acids 
Medium-scale culturing of producer organism: The selected producer organism (Br. parabrevis 
5618) was streaked out from frozen glycerol stocks onto TSA (3% (m/v) tryptic soy broth, 1.5% 
(m/v) agar) agar plates and incubated for 48 hours to allow for the formation of individual colonies. 
An individual colony was then used to inoculate 20 mL a starter culture containing TSB broth (3% 
(m/v) TSB in analytical grade water) in a 50 mL Falcon® tube to allow for incubation for 16 hours 
while shaking at 37 ⁰C where an OD595 of 0.6-0.9 was reached. This culture was then used to 
inoculate a medium-scale 200 ml cultures containing TGS (tryptone, glucose and inorganic salts, 
exact composition cannot be disclosed due to an existing non-disclosure agreement with the 
BIOPEP® group) media in a 200 mL Erlenmeyer flask. One percent of the volume of the medium-
scale culture is used from the starter culture (i.e. 2 mL starter culture in 200 mL TGS). For Trp and 
5-MeW supplemented TGS cultures, a final concentration 10 mM of the amino acid was used. For 
the Phe and 2-FF supplemented TGS cultures, a final concentration of 20 mM of the amino acid 
was used. Following inoculation, cultures were incubated at 37 ⁰C in stationary cultures for a period 
of 10 days.  
Extraction of medium-scale culture: Following the 10-day incubation period, the cultures were 
acidified using HCl to pH of 4 and allowed to stand overnight. The cultures were then extracted 
using an organic solvent, followed by a precipitation step and treatment with activated carbon 
(details cannot be cannot be disclosed due to a non-disclosure agreement). 
4.3.2 Purification of medium-scale extracts 
Semi-preparative HPLC of extracts: Medium-scale extracts were subjected to semi-preparative 
reverse phase HPLC following the methodology of Eyeghe-Bickong (11) and Rautenbach et al. (5), 
utilising the same a Waters® HPLC system to purify individual Trc analogues or subsets of 
analogues. Extracts were dissolved in 75% (v/v) ACN in analytical grade water to a concentration of 
either 10, 15 or 20 mg/mL. Dissolved culture extracts were then centrifuged at 2000 × g for 5 
minutes to remove particulate and all preparations and collection of fractions were done in clean 
(pyrolised) glassware. All extracts were initially injected at 10 mg/mL and concentrations were 
increased if it had no observable effect on the separation and peak shape that generally occurs due 
to aggregation of the peptides. A semi-preparative NovaPak C18 column (6 μm particle size, 7.8 mm 
× 300 mm) was used at a temperature of 37 ⁰C and chromatograms were generated by monitoring 
absorbance at 254 nm using a Waters Model 440 UV-detector at a wave length of 254 nm. A two-
solvent system was used, with eluent A containing 0.1 % TFA in analytical quality water and eluent 
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B consisting of 90% HPLC grade ACN and 10% eluent A (v/v). Injections of 100 uL were made 
and chromatographed using the gradient program depicted in Table 4.1 developed by Eyeghe-
Bickong (11) and Rautenbach (5). All fractions collected via HPLC were freeze dried in preparation 
for later analysis via ESMS and UPLC-MS.   
   
 
4.3.2 ESMS Analysis of Trcs and analogues 
Direct-injection ESMS analysis: Both crude and purified samples were analysed via direct-injection 
ESMS analysis. Samples were made up to 1.00 mg/mL (for crude extracts) and 0.500 mg/mL for 
purified extracts in 75% ACN (%v/v) and centrifuged for 10 minutes 8600 × g to remove insoluble 
material and particulate. Three microliters of sample were then injected and analysed on a Waters® 
Synapt G2 mass spectrometer using the same conditions as in Chapter 2. 
UPLC-ESMS analysis: Crude and purified samples were made up in 75% ACN (v/v) in analytical 
grade water and diluted down to a final concentration of 1.00 mg/mL for crude extracts and 0.50 
mg/mL for purified samples and an ACN concentration of 2.5 % (v/v). Three microliters of sample 
were injected and chromatographed via ultra-performance liquid chromatography (UPLC) on an 
Acquity UPLC® instrument utilising a BEH Phenyl UPLC column at flow rate of 300 L/min. 
Column temperature of 60 ⁰C was used together with a two-solvent system (eluent A: 1% (v/v) 
formic acid in analytical grade water, eluent B: 100% (v/v) ACN) profile at a flow rate of 0.3 
mL/min and chromatography was conducted using the gradient program given in Table 4.2. 
 
Table 4.1  Gradient program used for reverse phase semi-preparative HPLC purification of 
modified peptides from the crude culture extracts. The flow rate was 3.00 mL/min for 
steps 1-5. Gradient type 5 and 6 refers to the Waters® gradient with type 6 being a 
linear gradient and type 5 being a non-linear concave-type gradient  
Step % Eluent B  
Start 
% Eluent B 
End 
Time 
interval 
(min) 
Gradient 
Type Comment 
1 40 60 0.5 - loading sample 
2 40 100 0.5 - 27 5 Separation of peptides 
3 100 100 27 - 29 6 Cleaning of column 
4 40 60 29 - 30 6 Return to starting 
conditions 
5 40 60 30 - 35 6 Condition column 
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ESI-MS monitoring of the chromatography was done inline (i.e. UPLC-MS) on a Waters Synapt G2 
QTOF mass spectrometer in positive mode at a capillary voltage of 3.0 kV together with a sample 
cone voltage of 15 V. The source temperature was 120 ⁰C and the flow rate of desolvation gas (N2) 
was 650 L/hour with a desolvation temperature of 275 ⁰C. Data acquisition took place over a mass-
to-charge (m/z) range of 300 to 2000 in continuum mode at a rate of 0.2 scans per second.  All 
ESMS data was analysed using the Waters® MassLynx 4.01 software package.  
4.3.3 Growth inhibition against M. luteus 
Preparation of peptides for use in spot plate and growth inhibition assay: Selected novel cyclic 
decapeptide analogues with unnatural aromatic residues, enriched from the crude extract following 
semi-preparative HPLC, were used for the spot plate and growth inhibition assays. In addition to the 
novel analogues, equivalent natural purified tyrocidine, phenycidine and tryptocidine analogues 
were also tested. Selected purified peptides and enriched peptide fractions were analytically 
weighed and made up to 2.500 mg/mL in 50% (v/v) DMSO.  
For the spot plate assay on nutrient agar, the stock solutions were added to the first column in a 300 
μL round-bottom microtiter plate, in which analytical quality water had already been added, to 
dilute the peptide down to 0.050 mg/mL and a DMSO concentration of 1% (v/v). A series of five-
fold dilutions were then made, using 1% (v/v) DMSO, starting at a concentration of 0.050 mg/mL 
going down to 2.00 μg/mL (3 dilutions). In addition to the selected peptides, a commercially 
available mixture of tyrocidine analogues (TrcMix) as well as gramicidin S (GS) were used as 
control and diluted in the same manner. A solvent control was also made up using 1% (v/v) DMSO 
alone.  
Table 4.2 UPLC linear gradient program used for separation of peptides during the UPLC-MS 
analysis of crude extracts and purified fractions 
Step % eluent B  
Start 
% eluent B 
 End 
Time interval 
(min) 
1 0 0 0 - 0.5 
2 0 30 0.5 - 1 
3 30 60 1 - 10 
4 60 80 10 - 15 
5 80 100 15 – 15.1 
6 100 100 15.1-18 
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For the growth inhibition assay in culture broth, the 2.500 mg/mL peptide stock solution in 50% 
(v/v) DMSO was added to the first column in a 300 μL round bottom plate (dilution plate) in which 
analytical-grade water had already been added, to achieve a final peptide concentration of 0.500 
mg/mL and a DMSO concentration of 10% (v/v). A series of five-fold dilution was then done in the 
wells using 10% (v/v) DSMO for a concentration range from 0.500 mg/mL to 20.0 μg/mL (3 
dilutions). The TrcMix as well as gramicidin S (GS) were used as control and diluted in the same 
manner. A solvent control consisting of only 10% (v/v) DMSO was also made.  
Spot plate assay: The spot plate method used was adapted from Du Toit and Rautenbach (12). A 
colony of previously grown M. luteus, grown on TSA agar plates (3% (m/v) TSB, 1.5% (m/v) agar) 
was used to inoculate 20 mL of LB (1% (m/v) tryptone, 0.5% (m/v) yeast extract, 1% (m/v) NaCl) 
media which was then incubated for 16 hours at 37 ⁰C while shaking to allow for the formation of 
an OD595 of between 0.6-0.9 to reached. Following this initial incubation period, a sub-culture was 
done by inoculating 20 mL of TSB broth (3% (m/v) TSB) with 500 μL of the LB culture, and 
allowed to grow to an OD595 of 0.6 (between 3.5 to 4.5 hours, checking periodically). An OD595 of 
0.625 was reached and diluted using TSB down to an OD595 of 0.6. Seven-hundred microliters of 
this culture was then added on top of TSB-agar plates, which had been pre-warmed to 37 ⁰C, and 
spread evenly across the surface by tilting the plate, any excess culture was poured off and the 
plates were allowed to dry. Five microliters of each peptide at each dilution was spotted onto the 
plates using a pipette and allowed to dry. Commercial GS and TrcMix were used at a concentration 
of 10 μg/mL as positive controls while 1% (v/v) DSMO was used as a negative solvent control. The 
plates were incubated at 37 ⁰C for 24 hours after which pictures were taken to display zones of 
inhibition of growth. 
Turbidimetric growth inhibition assay: The growth inhibition assay was adapted from Du Toit  and 
Rautenbach (12). Cultures of M. luteus were prepared in the same manner as for the spot plate 
assay, only once the subculture of M. luteus reached an OD595 of 0.6, it was diluted down to an 
OD595 of 0.2 using TSB (3% (m/v)) broth. Ninety microliters of this diluted culture were then added 
to the wells of a 200 μL flat-bottomed 96-well plate, with the exception of four wells which were 
left open for sterile TSB alone, to serve as a negative growth control. Ten microliters of the 
previously prepared peptide dilutions in 10% (v/v) DMSO was then added on top of the 90 μL of 
target organism, meaning a ten-times dilution of peptide was made from the preparatory dilution 
plate, resulting in a final dilution series in the flat-bottomed plate starting at 50.0 μg/mL and going 
down to 0.20 μg/mL with a final DMSO concentration of 1% (v/v). Ten microliters of 10% (v/v) 
DMSO was added to negative and the positive controls, with the positive control used to determine 
Stellenbosch University  https://scholar.sun.ac.za
4-8 
 
maximal growth without any influence of peptide. Following the addition of the peptide, the plates 
were incubated at 37 ⁰C for 16 hours and the OD595 was then measured using a Model 680 
BioRad™ microplate reader, following shaking of the plate, to determine % growth inhibition.  Four 
analytical repeats were done per peptide per dilution (n=4). Percentage growth inhibition was done 
using the following equation: 
% Growth inhibition = 100 −  
100 x (OD595 of well − Mean OD595 of Blank)
Mean OD595 of growth control −  Mean OD595 of Blank
 
Metabolic inhibition assay: This assay was adapted from the Alamar Blue assay® developed by O’ 
Brien et al (13). The dye resazurin, commonly used in the Alamar Blue® assay, can be used to 
assess the effects of a given compound, in this case peptides, on cell metabolism and viability (14). 
Following incubation of the plate used to measure growth inhibition (for 16 hours), and an 
additional nine hours at room temperature, 10 μL of resazurin (which is reduced to resorufin by 
actively metabolising cells) was added to the wells and incubated for 37 ⁰C for an hour. Following 
incubation, the emitted fluorescence (F) of the wells was measured using an excitation wavelength 
of 530 nm and an emission wavelength of 590 nm (at which resorufin fluoresces). The percentage 
inhibition of metabolic activity is determined using the same equation as for the turbidimetric assay, 
but using the fluorescence values instead of optical density at 595 nm. The fluorescence was 
determined using a Tecan™ Spark 10M multimode microplate reader, together with the 
SparkControl™ software suite.  
4.4 Results 
4.4.1 Medium-scale culturing and extraction using selected, non-natural amino acids 
extracts 
The extract mass of each of the crude extracts were determined by weighing the freeze-dried mass 
following extraction with organic solvent. The extract mass per litre of the culture ranged from 
1.523 g for the 10 mM 2-FF supplemented culture to 3.546 g for the 10 mM Trp supplemented 
culture. The grams extract mass per litre media was less for the non-natural Phe analogue 2-FF, 
while the tryptophan analogue 5-MeW produced a marginally lower crude extract yield per liter 
compared to tryptophan. 
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4.4.2 ESMS Analysis of crude extracts of Trcs and analogues 
ESMS analysis of medium-scale 5-MeW extract: Figure 4.1 shows the UPLC chromatograms for the 
Trp and 5-MeW supplemented medium-scale extracts as well as the major detected m/z values for 
the major peptide in each peak. The letters in bold above the peaks in Figure 4.1, A, correspond 
with the extracted peaks of this extract in Figure 4.2. UPLC-ESMS analysis of the 10 mM 5-MeW 
supplemented crude extract revealed extensive incorporation of this analogue into the tyrocidines. 
Analogues were identified by tracking and extracting the relevant doubly charged m/z value in each 
UPLC-MS profile (see addendum at end of thesis for a list of theoretical monomer masses) (Figure 
4.2). Methylated tyrocidine analogues of TrcC, TpcC, TrcB/B’, TrcB1/B1’ and TpcB1/B1’ were 
observed. In some cases, it was difficult to determine the identity of a peptide as its m/z matched 
exactly with another non-natural analogue. This overlap of masses occurred due to the fact that the 
mass gained by the addition of an extra CH2 in the case of an ornithine to lysine substitution is same 
as the mass gained by the substitution of a methyl group for a hydrogen group on 5-MeW. As a 
result, one could not readily tell the difference between a TpcC incorporating two 5-MeW 
analogues or a Tpc incorporating one 5-MeW analogue and having a lysine instead of an ornithine 
at position 9. 
 
 
 
 
 
 
Table 4.3 Summary of the Extract masses obtained for combined cultures following two rounds 
of extraction with organic solvent 
Amino Acid 
(AA) 
AA Concentration 
(mM) 
Total Culture 
Volume (mL)* 
Combined Crude 
Extract mass (mg) 
Extract mass (g) per 
litre of culture 
2-FF 10 400 609.4 1.523 
Phe 10 400 1051.9 2.630 
5-MeW 10 400 1401.5 3.504 
Trp 10 600 2127.8 3.546 
*Individual cultures of 200 mL were combined, hence total culture volume/200 gives the number of cultures combined 
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Figure 4.1  UPLC-ESMS base-peak chromatograms of large scale extracts. A, 5-MeW 
supplemented extract (letters correspond with m/z values and peptide identified 
in Figure 4.2) B, Trp supplemented extract showing major peptides identified 
by doubly charged m/z values [M+ 2H]2+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the case of a masses overlapping between an analogue which theoretically contains no 5-MeW 
analogues, and one which does (e.g. a TrcC1 versus a TrcC(1*5-MeW)), the peptide identity could 
be determined on the basis of differences in retention times between the natural and non-natural 
analogues. Here it can be seen that the peptide observed in Figure 4.2, B, is a TrcC incorporating a 
single 5-MeW residue and not a TrcC1 due to the large difference in retention time, with the non-
natural analogue being retained longer and having an apparent more hydrophobic nature as 
determined by its retention time (9.96 min versus 9.43 min for TrcC seen in Figure 4.1, B). This 
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Figure 4.2  UPLC-MS analysis of 5-MeW supplemented culture extract. A Base peak 
chromatogram (BPC) of the crude extract, B-I,extracted m/z chromatogram 
component peaks ([M+2H]2+) in the culture extract indicating the proposed 
main analogue in the extracted peak, retention time (Rt) in minutes, 
theoretical m/z (T) and observed m/z (O). See thesis addendum for a list of 
theoretical masses 
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principle could also be used to identify a TpcC(1*MeW) versus a TpcC1, a TpcB/B’(1*5MeW) 
versus as TpcB1/B1’ and lastly a TrcB/B’(1*5MeW) versus a TrcB1/B1’ (not observed in Trp 
supplemented extract, determined by comparison with commercial TrcMix).  
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Looking at the crude extract in Figure 4.2, A, and assuming a similar response factor for all the 
tyrocidine analogues, it appears that the analogues produced in the highest abundance are a TrcB/B’ 
incorporating a single 5-MeW residue and either a TpcB1/B1’ incorporating a single 5-MeW residue 
or a TpcB/B’ incorporating two 5-MeW residues, respectively (Figure 4.2, D & H). In some cases, 
there are two major peaks for an extracted m/z value, as observed for TrcC1(1*5MeW) in Figure 
4.2, B. Here, the peak at 11.72 minutes has a different overlapping isotope peak profile with a 
monoisotopic m/z of 680.8643 mapping it to a TpcB1/B1’(1*5MeW) or a TpcB/B’(2*5MeW) (as 
identified in Figure 4.2, H). In such cases the retention time (Rt) shown beneath the theoretical (T) 
and observed (O) masses indicates which peak is being referred to by the peptide identity and mass. 
In cases where there are two retention times shown (e.g. Figure 4.2, C), this indicates that there are 
two similar peptides with the same m/z and isotopic peak profiles, but with different retention times. 
ESMS analysis of medium-scale 2-FF extract: Figure 4.3 compares the 2-FF and Phe supplemented 
cultures. The letters in bold above the peaks in Figure 4.3, A, correspond with the extracted peaks 
of this extract in Figure 4.4. This shows the similar retention time of the fluorinated analogues to 
the natural analogues. The peptide produced in the highest abundance in both extracts was a TrcA 
in the Phe supplemented culture extract and TrcA with three or two fluorinated residues in the 2-FF 
supplemented culture extract (Figure 4.4, F and G respectively). The TrcA(3*2-FF) analogues had a 
retention time that was only 0.03 minutes longer than its natural counterpart, indicating a similar 
hydrophobicity, while the TrcA (2*2-FF) produced two peaks. The two peaks are like likely due to 
different incorporation sites, as there as three possible positions (1, 3 and 4) for incorporation of the 
2-FF residue in TrcA. 
 In Figure 4.4 we can see the breakdown of the UPLC-MS analysis of the crude 2-FF supplemented 
extract. This fluorinated Phe analogue was readily incorporated into the tyrocidines and analogues 
with observable amounts of TrcB/B’, TrcB1/B1’, TpcB/B’, TpcB1/B1’, TrcA, TrcA1, PhcA and 
TpcA incorporating one or more 2-FF residue (see thesis addendum for a list of theoretical 
monomer masses). Fortunately, the substitution of a fluorine for a hydrogen in these analogues did 
not produce overlapping masses, making their identification based on m/z ratios an easier process 
relative to peptides incorporating the 5-MeW analogue. Looking at Figure 4.4, A & G, it appears 
that a TrcA incorporating three 2-FF residues was produced in the highest relative amount (again 
assuming similar response factors), with TrcB/B’(2*2-FF) and TpcA(3*2-FF) also being produced 
in significant amounts (Figure 4.4, B & K respectively).  
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Figure 4.3  UPLC-ESMS base-peak chromatograms of large scale extracts. A, 2-FF 
supplemented extract (letters correspond with m/z values and peptide 
identified in Figure 4.2 (*Retention time not displayed, letter* placed 
approximately where peptide elutes). B, Phe supplemented extract showing 
major peptides identified by their doubly charged m/z values [M+ 2H]2+  
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Figure 4.4 UPLC-MS analysis of 2-FF supplemented culture extract. A. BPC of the crude extract, B-L, extracted 
m/z chromatograms of component peaks ([M+2H]2+) in the culture extract indicating the proposed main 
analogue in the extracted peak, Rt in minutes, theoretical m/z (T) and observed m/z (O) 
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Figure 4.5  A representative chromatogram showing the semi-preparative HPLC and 
fractions collected for 5-MeW supplemented culture extract. Numbers in 
bold above x-axis indicate the fraction number and numbers above the 
vertical lines are the retention time cut-offs of the fractions 
4.4.3 Reverse-phase semi-preparative HPLC purification and ESMS analysis of fractions 
Purification and ESMS analysis of medium-scale 5-MeW extract fractions: Figure 4.5 represents the 
HPLC chromatogram produced by separation of the peptides in the extract based on 
hydrophobicity. Eight fractions were collected in total (2-9). These fractions were then analysed via 
UPLC-MS. Based on UPLC-MS analysis, fractions 3 and 8 were chosen for further analysis and use 
in biological activity testing.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6, A, represents the UPLC-MS analysis of fraction 3 showing the integration of the 
observed peaks to determine the area-under-curve (AUC) for these peaks. The peak at 10.73 
minutes, together with the shoulder at 10.81 minutes were the only peaks observed containing 
tyrocidine analogues, with the peak at 11.69 contained unidentifiable compounds and the peak at 
14.59 minutes also containing contaminants together with trace amounts of gramicidins, which were 
not analysed further. Figure 4.6, B & C, represent the isolated peaks selected using the predominant 
peptide m/z in the peak and shoulder respectively. These peaks were then combined and analysed 
further using the MaxEnt 3 algorithm. Table 4.4 shows the % total AUC for the peak and shoulder 
determined by the contribution of their AUCs to the total AUCs for all the peaks integrated. 
MaxEnt 3 analyses of the peak and shoulder indicated an impure peptide preparation enriched in 
certain peptide analogues. The % signal intensity was determined for the enriched peptide analogue 
preparations. This % signal intensity represents the contribution of these peptides to the total ESMS 
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signal for all the compounds in this peak, only considering the monomer signals and assuming 
comparable response factors. The peak at 10.73 minutes is enriched for a TrcB analogue containing 
a single 5-MeW residue (TrcB/B’(1*5MeW)), with a sodium adduct also present giving a total % 
signal intensity of 33.4%. This analogue proved to have a very similar retention time to a TpcC 
analogue containing two 5-MeW residues (TpcC(2*5MeW)), which partially co-eluted with this 
analogue. The shoulder at 10.8 minutes contained a higher percentage of this tryptocidine analogue, 
producing a % signal intensity of 38.1% (including the TpcC(2*5MeW) sodium adduct). Again, due 
to the partially resolved peak separation, TrcB(1*5MeW) is also observed. Taking both AUC and % 
signal intensity together, fraction 3 contains the highest relative amount of TrcB/B’(1*5MeW). The 
possible structures for this peptide are shown in Figure 4.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time
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%
0
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739.8
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B 
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Figure 4.6  UPLC-MS analysis of semi-preparative reverse phase HPLC fraction 3 of 5-MeW 
supplemented extract. A, BPC (Base Peak Chromatogram) of integrated peaks 
together with area-under-curve (AUC) below retention time. Extracted mass 
chromatograms B & C show peak at 10.73 minutes (m/z = 1323.6958) and shoulder 
at 10.80 minutes (m/z = 1399.7439) respectively 
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Table 4.4  Mass analysis of peak and shoulder from HPLC fraction 3 containing 5-MeW 
tyrocidine analogues showing the % contribution to the total AUC of all integrated 
peaks. MaxEnt 3 analysis was used to determine the % signal contribution of the 
analogues in the peak and shoulder which contributed to over 10% of the total signal 
intensity as well as their mass and identity 
Peak 
Rt 
(min) 
% 
Total 
AUC 
MaxEnt Spectra 
Peptide  
(Theor. mass/Obs. 
Mass) 
% Signal 
Intensity 
10.73 52.98 
 
TrcB/B’ 1*5MeW) 
1323.6890/1323.6847 
TrcB/B’(1*5MeW)[Na] 
1345.6709/1345.6666 
TpcC(2*5MeW) 
1399.7315/1399.7251 
17.66 
 
15.74 
 
10.96 
10.80 10.98 
 
TpcC(2*5MeW) 
1399.7315/1399.7299 
TpcC(2*5MeW)[Na] 
1421.7166/1421.7135 
TrcB/B’(1*5MeW) 
1323.6890/1323.6878 
24.38 
 
13.72 
 
13.35 
 
mass
1300 1325 1350 1375 1400 1425 1450 1475 1500 1525 1550 1575
%
0
100
1323.6847
1345.6666
1399.7251
1367.6450 1421.7089
1443.6884
1457.6592
1525.62651465.6696
mass
1300 1350 1400 1450 1500 1550
%
0
100
1399.7299
1323.6874
1345.6669
1367.6451
1421.7166
1443.6904
1465.6710
1533.66371511.6903
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TrcB(1*5MeW) TrcB’(1*5MeW) 
Figure 4.7  Possible structures for novel TrcB/B’ analogue containing a single 5-MeW 
residues enriched for in fraction 3  
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Figure 4.8, A, represents the UPLC chromatogram for fraction 8 showing the AUCs and retention 
times for the major peaks. Here the peaks were better resolved, with no major overlap. The peak at 
11.40 minutes (Figure 4.8, B) contained majority TpcB/B’(1*5MeW) while the peak at 11.73 
minutes (Figure 4.8, C) was enriched for TpcB/B’(2*5MeW), as shown by the % signal intensities 
in Table 4.5. With the peak at 11.73 minutes giving the highest % total AUC and containing 
predominantly TpcB/B’(2*5MeW), this fraction is enriched primarily for this peptide. Figure 4.9 
shows the possible structures for this peptide. 
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Figure 4.8  UPLC-MS analysis of semi-preparative reverse phase HPLC fraction 8 of 5-MeW 
supplemented extract. A, BPC of integrated peaks together with area-under-curve 
(AUC) below retention time. B & C show extracted mass chromatograms with 
peaks at 11.40 minutes (m/z = 1346.7039) and 11.73 minutes (m/z = 1360.7295) 
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Table 4.5 Mass analysis of UPLC peaks from Fraction 8 containing 5-MeW tryptocidine 
analogues showing the % contribution to the total AUC of all integrated peaks. 
MaxEnt 3 analysis was used to determine the % signal contribution of the analogues in 
the peak and shoulder which contributed to over 10% of the total signal intensity as 
well as their mass and identity 
Peak 
Rt 
(min) 
% 
Total 
AUC 
MaxEnt Spectra 
Peptide  
(Theo. mass/Obs. 
Mass) 
% Signal 
Intensity 
11.40 25.58 
 
TpcB/B’(1*5MeW) 
1346.7050/1346.6976 
70.89 
11.73 74.42 
 
TpcB/B’(2*5MeW) 
1360.7206/1360.7102 
TpcB1/B1’(2*5MeW) 
1374.7363/1374.7269 
70.22 
 
14.23 
 
 
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1346.6976
1364.7104
1368.6854
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1360.7102
1374.7269
TpcB(2*5MeW) TpcB’(2*5MeW) 
Figure 4.9  Possible structures for novel TpcB/B’ analogue containing two 5-MeW residues 
enriched for in fraction 8 
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Purification and ESMS analysis of medium-scale 2-FF extract fractions: Figure 4.10 shows the 10 
fractions collected (2-11) for the 10 mM 2-FF supplemented crude extract. Following UPLC-MS 
analysis of these fractions, fractions 8 and 9 were selected for further analysis. 
 
 
 
 
 
 
 
 
 
 
Figure 4.11, A, shows the UPLC-MS analysis and AUCs for integrated peaks of fraction 8. The 
peak present at 14.39 minutes contained a contaminant with an m/z of 317.115, possibly a 
potassium adduct of dibutyl-phthalate, a common plasticiser from laboratory plastic ware, such as 
micropipette tips, Falcon® tubes and Eppendorf® tubes. Three major peaks were detected with 
retention times of 10.87, 10.99 and 11.11 minutes respectively (Figure 4.11, B-D). The peak at 
10.87 minutes contains predominantly TrcA1 incorporating three 2-FF residues, with a % signal 
intensity of 20.75% (Table 4.6). The peak at 10.99 minutes has the largest % total AUC at 74.6%. 
The predominant peptide in this peak is a TrcA incorporating three 2-FF residues, with a % signal 
intensity of 65.5%. The predominant peptide in the peak at 11.11 minutes is also a TrcA 
incorporating three 2-FF residues. One would expect the TrcA(3*2-FF) peptide to only elute as one 
peak, given that if all the sites for 2-FF incorporation are occupied, only one structural 
configuration is possible and therefore should interact with the UPLC-column in the same manner. 
However, looking in detail at the extracted peaks for this analogue from the crude 2-FF extract in 
Figure 4.4, G, we also see another small peak eluting immediately after the main peak. The high 
levels of oligomerisation of the 2-FF extracts (as observed in Chapter 3) means that it is possible 
that the TrcA(3*2-FF) analogue is undergoing high levels of oligomerisation with of the TrcA(2*2-
​ ​
3
.9
​ ​
8
.1
​ ​
1
0
.7
​ ​
1
1
.4
​ ​
1
3
.4
​ ​
1
6
.7
​ ​
1
9
.4
​ ​
2
1
.4
​ ​
2
2
.5
​ ​
2
3
.8
5
​ ​
2
6
.7
​ ​
2
8
.9
​
0
5
10
15
20
25
30
35
40
45
50
0 5 10 15 20 25 30
R
e
sp
o
n
se
 a
t 
2
5
4
 n
m
Retention Time (min)
2 3 4 5 6 7 8 9 10 11
A
Figure 4.10  A representative chromatogram showing the semi preparative HPLC and 
fractions collected for 2-FF supplemented culture extract. Numbers in bold 
above x-axis indicate the fraction number and numbers above the vertical 
line are the retention time cut-offs of the fractions 
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Figure 4.11  UPLC-MS analysis of semi-preparative reverse phase HPLC fraction 8 of 2-FF 
supplemented extract. A, BPC of integrated peaks together with AUC below 
retention time. B-D show extracted mass chromatograms with peaks at retention 
times 10.87 (m/z = 669.8222), 10.99 (m/z = 1324.6333) and 11.11 minutes (m/z = 
1306.6410) respectively 
Time
8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
%
0
100
10.99
1671.2
10.87
138.3
11.11
165.7
14.39
265.8
Time
8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
%
0
100
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Time
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%
0
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Time
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0
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11.11
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   Fraction 8 
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FF) analogue that elutes at 11.09 minutes (Figure 4.4, F). It is regularly observed in our research 
group with TrcA purification that more than one peak corresponds to TrcA, particularly in purer 
samples, where more oligomerisation is expected. The two peptide containing peaks with the largest 
% total AUC both contain TrcA(3*2-FF) in the highest relative amounts. This fraction can therefore 
be considered to be enriched for this peptide, but also containing some TrcA1 and TrcA with 
varying levels of incorporation of 2-FF residues, ranging from one to three. The fluorinated TrcA 
analogues observed in this fraction have very similar retention times to the natural analogue, as is 
can be seen in Figure 4.3. Proposed structure for the enriched peptide in this fraction, TrcA(3*2-
FF), is given in Figure 4.12. 
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Figure 4.13, A, shows the UPLC-MS analysis and integrated peaks for fraction 9. The peak at 14.40 
minutes is the same contaminant that is present in fraction 8, with an m/z of 317.115. This fraction 
had six peaks that could clearly be observed. The major peak at 11.04 minutes contributed most to 
the % total AUC, with a contribution of 54.26%. The predominant peptide in this peak is a TrcA 
containing two 2-FF residues (Table 4.7), which is also found to be the major peptide in the peaks at 
10.84 and 10.97 minutes, meaning that this fraction is enriched for this peptide. TpcA(2*2-FF) 
(with a sodium adduct) and PhcA(3*2-FF) were detected in the remaining peaks (Table 4.7). From 
the peak and signal analysis it was deduced that fraction 9 of the 2-FF extract is enriched for the 
TrcA analogues with two 2-FF residues, denoted TrcA(2*2-FF), whose possible structural 
configurations are shown in Figure 4.14. 
 
 
 
 
TrcA(3*2-FF) 
Figure 4.12  Structure for novel TrcA analogue containing three 2-FF residues 
enriched for in fraction 8  
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Table 4.6 Mass analysis of peaks from HPLC Fraction 8 containing 2-FF tyrocidine analogues 
showing the % contribution to the total AUC of all integrated peaks. MaxEnt analysis 
was used to determine the % signal contribution of the analogues in the peak and 
shoulder which contributed to over 10 % of the total signal intensity as well as their 
mass and identity  
Peak Rt 
(min) 
% 
Total 
AUC 
MaxEnt Spectra Peptide  
(Theo. mass/Obs. Mass) 
% Signal 
Intensity 
10.87 6.2 
 
TrcA1(3*2-FF) 
1338.6498/1338.6426 
TrcA1(2*2-FF) 
1320.6592/1320.6508 
TrcA(2*2-FF) 
1306.6436/1306.6379 
TrcA(1*2-FF) 
1288.6530/1288.6473 
20.75 
 
15.44 
 
15.04 
 
13.03 
10.99 74.6 
 
TrcA(3*2-FF) 
1324.6342/1324.6246 
TrcA(2*2-FF) 
1306.6436/1306.6376 
65.50 
 
13.96 
11.11 7.4 
 
TrcA(3*2-FF) 
1324.6342/1324.6246 
TrcA(2*2-FF) 
1306.6436/1306.6375 
45.07 
 
20.25 
 
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1338.6426
1320.65081306.6379
1288.6473
1270.6576
1360.6183
1376.6012
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1324.6246
1306.6376
1288.6460 1338.6418
1346.6115
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100 1324.6246
1306.6375
1288.6467 1338.6420
1346.6008
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Figure 4.13 UPLC-MS analysis of semi-preparative reverse phase HPLC fraction 9 of 2-
FFsupplemented extract. A, BPC of integrated peaks together AUC below 
retention time. B-G show extracted peaks at retention times 10.84 (m/z = 
660.8342), 10.89 (m/z = 1288.6462), 11.04 (m/z = 1306.6410), 11.44 (m/z = 
676.3248), 11.58 (m/z = 1308.6464) and 11.69 (m/z = 1326.6366) minutes at 
respectively  
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Table 4.7 Mass analysis of peaks from HPLC fraction 9 containing 2-FF tyrocidine analogues 
showing the % contribution to the total AUC of all integrated peaks. MaxEnt analysis was 
used to determine the % signal contribution of the analogues in the peak and shoulder 
which contributed to over 10 % of the total signal intensity as well as their mass and 
identity 
Peak 
Rt 
(min) 
% 
Total 
AUC 
MaxEnt Spectra Peptide  
(Theo. mass/Obs. Mass) 
% Signal 
Intensity 
10.84 2.53 
 
TrcA(2*2-FF) 
1306.6436/1306.6378 
TrcA(1*2-FF) 
1288.6530/1288.6464 
TrcA1(2*2-FF) 
1320.6592/1320.6482 
TrcA(3*2-FF) 
1324.6342/1324.6248 
19.4 
 
14.7 
 
13.7 
 
12.2 
10.89 8.09 
 
TrcA(2*2-FF) 
1306.6436/1306.6379 
TrcA(1*2-FF) 
1288.6530/1288.6469 
TrcA(3*2-FF) 
1324.6342/1324.6246 
32.39 
 
16.05 
 
15.09 
11.04 54.26 
 
TrcA(2*2-FF) 
1306.6436/1306.6379 
TrcA(3*2-FF) 
1324.6342/1324.6246 
TrcA(1*2-FF) 
1288.6530/1288.6462 
36.17 
 
21.03 
 
14.92 
11.44 4.49 
 
TpcA(2*2-FF)[Na] 
1351.6415/1351.6371 
TpcA(1*2-FF)[Na] 
1333.6509/13336512 
TpcA(2*2-FF) 
1329.6596/1329.6570 
40.75 
 
18.16 
 
11.03 
11.58 10.30 
 
PhcA(3*2-FF) 
1308.6393/1308.6313 
PhcA(4*2-FF) 
1326.6298/1326.6233 
26.14 
 
13.59 
11.69 3.53 
 
Phc(3*2-FF) 
1308.6393/1308.6315 
PhcA(4*2-FF) 
1326.6298/1326.6246 
22.00 
 
9.95 
 
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1306.6378
1288.6464
1270.6573
1320.6482
1324.6248
1338.6373
1342.6173
1360.6140
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1306.6379
1288.6469
1270.6573
1324.6246
1338.6370
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1306.6379
1288.6464
1270.6567
1324.6246
1345.6116
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1351.6371
1333.6512
1329.6570
1315.6622
1273.6458
1352.6605
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1308.6313
1290.6387
1326.6233
1330.6277
1347.6188
mass
1260 1280 1300 1320 1340 1360 1380 1400 1420 1440
%
0
100
1308.6315
1290.6382
1272.6530
1326.6246
1329.6451
1330.6349
1351.6141
1364.5654
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A 
B 
C 
Figure 4.14  Possible structural configurations for novel TrcA analogue containing two 
2-FF residues enriched for in fraction 9. A-C represent the three different 
possible structural configurations based on theoretical sites of incorporation 
for phenylalanine 
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4.3.4 Growth inhibition against M. luteus 
For the HPLC fractions used in the biological activity assay, the fraction number will no longer be 
used, but rather the identity of the peptide present in the largest relative amount as determined by 
ESMS analysis. The 5-MeW fractions 3 and 8 were denoted TrcB(1*5MeW) and TpcB(2*5MeW) 
respectively. The 2-FF fractions 8 and 9 were denoted TrcA(3*2-FF) and TrcA(2*2-FF) 
respectively.  
Spot plates against M. luteus: Figure 4.15 shows the effects of the selected HPLC fractions and 
selected natural analogues spotted on top of a lawn of M. luteus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
1 2 
4 
5 
6 
3 
B 
1 2 
7 
8 
3 
C 
1 2 
9 
10 
11 
3 
D 
2 
12 
13 
14 
3 
50 
μg/ml 
10 
μg/ml 
2 μg/ml 
50 
μg/ml 
10 
μg/ml 
2 μg/ml 
50 
μg/ml 
10 
μg/ml 
2 μg/ml 
1 
1) 10 μg/ml TrcMix  
2) 10 μg/mlS 
3) 1% DMSO 
4) TrcA(3*2-FF) 
5) TrcA(2*2-FF) 
6) 2-FF Crude  
7) TrcA  
8) PhcA 
9) TpcB(2*5MeW) 
10) TrcB(1*5MeW) 11) 5-
MT Crude  
12) TpcC 
13) TpcB 
14) TrcB 
Figure 4.15  Spot plates of selected HPLC fractions for 5-MeW and 2-FF. A volume of 
5μL was spotted for all samples. Fractions and controls (TrcMix, GS and 
solvent) were all tested against M. luteus  
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In Figure 4.15, A, there were no clear zones of inhibition against the target organism by either of 
the 2-FF fractions or the crude extract. The positive controls (spotted in duplicate at positions 1 and 
2) did not all have very clear zones of inhibition relative to the other plates (Figure 4.15, B-D) 
indicating that the organism concentration was slightly too high on parts of the plate. This is 
possibly due to uneven spreading and growth over the plate. The natural analogues (Figure 4.15, B) 
represented by spots at 7 and 8 (TrcA and PhcA), only showed zones of inhibition at the highest 
concentration of 50 μg/mL (spot to the furthest left).  
For the 5-MeW analogues, only the spot at 10 (Figure 4.15, C-10, TrcB(1*5MeW)) showed a zone 
of inhibition at 50 μg/mL. Only the natural analogue of this peptide (Figure 4.15, D-14, TrcB) 
showed some inhibition of growth, also at 50 μg/mL. It was previously found by Troskie (15) that 
solid media such as agar can influence the activity of tyrocidines against certain fungi. To overcome 
the problem of uneven spreading of the indicator organism on the assay plate and the possible effect 
that agar can have on the activity of the peptides, the activity assay was repeated in a liquid culture 
broth.  
Turbidimetric growth inhibition assay: Figure 4.16 A and B represent the % growth inhibition of M. 
luteus by determining the optical density (OD) or turbidity produced by the dividing bacterial cells 
in solution after 16 hours of incubation. Figure 4.16, A, represents the peptides % growth inhibition 
of the selected natural and non-natural analogues against the target organism at the highest 
concentration used of 50 μg/mL. All peptides showed very good inhibition of growth at this 
concentration, with the exception of PhcA showing only about 30% growth inhibition. Figure 4.16, 
B, compares the activity of the same peptides at a five-fold lower concentration of 10 μg/mL. Here 
again most peptides show good inhibition of growth after 16 hours, again with the exception of 
PhcA, but also TpcC, having a marked decrease in growth inhibition, inhibiting only about 35% of 
bacterial growth. 
Resazurin growth inhibition assay: Figure 4.12, C and D, represent the loss of actively metabolising 
cells, which can reduce the dye resazurin to resorufin, due to cell death by the peptide preparations. 
The % inhibition of metabolism (or % cell death) by the peptide preparations at 50 μg/mL (Figure 
4.12, C) is similar to the % growth inhibition produced by the peptides tested at the same 
concentration. However, at a lower concentration of 10 μg/mL, the % inhibition of metabolic 
activity decreased markedly for most peptides, as surviving cells will metabolise the dye. If a 
peptide inhibits cell growth effectively, but there are still actively metabolising cells (surviving cells 
as determined by Alamar Blue® assay), it is a more bacteriostatic peptide, whereas if a there is loss 
in cell growth and metabolism, it is a more bactericidal peptide (acting either through disruption of 
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the cell wall and/or other mechanisms) (16). These results indicated that 10 μg/mL was below the 
MIC and below the minimum bacteriocidal concentration (MBC) of these peptides. MIC is defined 
as the lowest concentration at which visible inhibition of growth is observed using OD 
measurements, whereas MBC is defined by the minimum concentration at which over a 99% 
percent loss in cell viability occurs (usually as a result of lysis of the bacterial membrane) (17). The 
commercial TrcMix, commercial GS, TrcB and its non-natural analogue TrcB(1*5MeW), and the 
fluorinated TrcA analogue TrcA(3*2-FF) did not show such a decrease in activity, indicating that 
10 μg/mL is close to their MICs and/or MBCs. 
 
 
 
 
Figure 4.16 Activity of selected peptides against M. luteus showing. A and B show the 
percentage inhibition of bacterial growth as a function of decrease in OD595 
following 16 hours of incubation. C and D show inhibition of metabolic activity as a 
function of increase in fluorescence at 590 nm after 25 hours by incubating the 
plates for an hour after adding resazurin dye then taking the reading. 
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4.5 Discussion 
The non-natural amino acid analogues 2-flouro-phenylalanine and 5-methyl-tryptophan have been 
shown to be readily incorporated into tyrocidine-analogues by the producer organism Br. 
parabrevis DSMZ 5618 in TGS media. Preliminarily analysis of extracts of cultures supplemented 
with the 1-methyl-L-tryptophan and 4-methyl-L-phenylalanine also showed incorporation of these 
analogues into peptides produced by this organism (Chapter 3), indicating the ability of the 
tyrocidine peptide synthetase complex to incorporate unnatural aromatic amino acid derivatives of 
Phe and Trp. 
The increased incorporation of certain amino acid residues by supplementation in the growth media 
is supported by Vosloo et al. (2) who showed that the production profile of Br. parabrevis ATCC 
10068 could be shifted towards analogues containing enriched in either Trp or Phe residues. These 
results indicate a promising avenue for the biosynthesis of novel tyrocidines, tryptocidines and 
phenycidines. 
Like the natural analogues incorporated into the variable positions, the non-natural analogues also 
have variable incorporation into different sites, as is evident by certain non-natural tyrocidine 
analogues having two different retention times as observed by UPLC analysis. In Figure 4.1, B, 
there are two peaks which contain significant proportions of a peptide corresponding to TpcC with 
one 5MeW residue (TpcC(1*5MeW)), indicating that there are likely only two favourable positions 
of incorporation (of the three theoretically available). Given the fact that position 4 in any 
tyrocidine analogue contains a D-amino acid residue that is converted from L to D configuration by 
the epimerase activity in the E-domain, it seems more likely that the 5-MeW residue is incorporated 
into either position 3 or position 7, resulting in a different retention time for the two analogues. The 
double peak phenomenon is also observed for the 2-FF-containing tyrocidine analogues. For 
example, Figure 4.6, F, shows two clear peaks with different retention times both containing TrcA 
with two 2-FF residues (TrcA (2*2-FF)), indicating that there are two possible sites of 
incorporation. Given that this analogue only contains three likely sites for incorporation of a Phe 
analogue, it would seem likely that the 2-FF residue can be incorporated at positions 1 and/or 3 
and/or 4, with both positions 1 and 4 having a D-configuration. This implies that a 2-FF residue 
could be epimerised by the E-domain, or at the very least can still be incorporated at this module in 
the NRPS.  
The purification of single peptides from a mixture of non-natural analogues proved to be difficult 
due to the extra level of structural diversity provided by the incorporation of non-natural amino acid 
residues at different positions, as well as the possible increased levels of aggregation resulting from 
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changes in structure and hydrophobicity. An emphasis should be placed on optimising semi-
preparative HPLC purification of these peptides, either using lower concentrations, exploring 
different solvent systems, alternative chromatographic matrix/HPLC program or driving the 
production profile towards one or two major analogues using specific amino acid supplementation 
concentrations during incubation. This could also involve the creation of a mathematical model 
determining the levels of productions of certain analogues as a function of supplemented amino acid 
concentration in a manner similar to that done by Vosloo et al (2). It would also be essential to 
confirm the amino acid sequence of novel peptide(s) in the purified/enriched fractions utilising 
tandem mass spectrometry (MS/MS). In MS/MS the collisional induced dissociation (CID) of a 
novel cyclic decapeptide and comparing the fragment spectra with that of the natural analogue 
would allow validation of our current identification of the different peptides.   
Of particular interest would be the purification of single analogues with fluorinated aromatic amino 
acid residues for use in fluorine-NMR studies, possibly to explore the interaction of these residues 
with model membranes. The incorporation of a fluorinated tryptophan would potentially allow for 
the production of various tyrocidine analogues with all the aromatic amino acid residues being 
fluorinated. Using TrcA as an example, the similar retention times of fluorinated analogues of TrcA 
(Figure 4.8) with the natural analogue, together with their similar levels of inhibition of bacterial 
growth (Figure 4.11, A & B) indicate that the incorporation of 2-FF residues into TrcA does not 
significantly alter its structure-activity relationship. The modified TrcA with 2-FF residue(s) can 
therefore be an NMR traceable analogue of TrcA in biological systems. In terms of inhibition of 
metabolic activity, the fluorinated TrcA analogues (TrcA(3*2-FF) and TrcA(2*2-FF), appear to be 
more active at lower concentrations, where the anti-metabolic activity of the natural TrcA 
disappeared completely. It is possible that these analogues depress cell growth by causing cell death 
(i.e. have lower MBCs), rather than just causing reversible inhibition of cell growth (bacteriostatic 
action).   
The incorporation of 5-MeW into the tyrocidines resulted in an increase in the hydrophobicity of 
these peptides as determined by the increase in their retention times compared to the natural 
analogues (Figure 4.1). The incorporation of this analogue did not appear to have any marked effect 
on inhibition of microbial growth (Figure 4.16, A and B). Both TrcB and TrcB(1*5MeW) appeared 
to be strong inhibitors of bacterial growth, as is evident by the zones of inhibition on the spot plates 
in Figure 4.11 C and D. Both these analogues were also relatively good inhibitors of bacterial 
metabolism retaining over 70% inhibition of bacterial metabolic activity at the lower concentrations 
of 10 μg/ml (Figure 4.12, D), indicating a more bacteriostatic nature (as discussed earlier for TrcA 
and its analogues). Of all the peptides tested these therefore appear to be the most active against M. 
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luteus, a result supported by Spathelf and Ruatenbach (6) and Leussa and Rautenbach (18). Both 
TpcB and TpcB(2*5MeW) showed similar levels of inhibition of bacterial growth and bacterial 
metabolic activity. For these analogues, the lack of inhibition of metabolism at a concentration of 
10 μg/mL (Figure 4.16, D) indicates that these are less active peptides.  
This work shows a promising avenue for the biosynthesis of a wide array of novel Trc analogues, 
with the possibility of developing novel anti-microbial peptides with unique structure-activity 
relationships, which is becoming ever more important as the efficacy of existing antibiotics is 
rapidly dwindling. In addition, the cost of production is lower compared to synthetic synthesis, 
implying a higher feasibility for large-scale production of these novel peptides if they prove to have 
practical applications in clinical and industrial settings. 
Future work would include improving the purification process of these peptide to characterise 
individual analogues, sequencing novel peptides using MS fragmentation, testing a more diverse 
array of amino acid analogues for incorporation, testing biological activity against a wider variety 
or organisms (particular to observe if activity against Gram negative bacteria occurs) and  looking 
at production of novel peptides in producer organisms which also synthesize subsets of structurally 
similar peptides using non-ribosomal peptide synthesis.  
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Chapter 5 
Summary, conclusions and future work 
5.1 Introduction 
The Tcn extract produced by the producer organism, Brevibacillus parabrevis, contains a diverse 
array of cationic cyclodecapeptides, such as the tyrocidines, tryptocidines and phenycidines, as well 
as the neutral linear pentadecapetides, the gramicidins. The different structural analogues arise as a 
result of the non-ribosomal synthesis process of these peptides, where the tyrocidine peptide 
synthetases enzymatically incorporate amino acids, with certain domains having the ability to 
incorporate more than one amino acid (1).  These peptides are produced in varying amounts within 
the Tcn extract depending on a variety of factors, including the producer strain (2) used and media 
compositions (3). In addition, it has been found that supplementing the growth media with Phe 
and/or Trp can drive the production towards different subsets of Trcs incorporating more of these 
amino acids at their variable positions (4). The activity of the individual Trcs isolated from these 
mixtures against Gram-positive bacteria (5) and Plasmodium falciparum (6) varies depending on 
their structure and biophysical characteristics, which effect their hydrophobicity and their levels of 
oligomerisation (3, 7). 
The goal of this study was to make use of the ability of the producer organism to incorporate 
different amino acids into the Trcs, specifically to determine whether non-natural derivatives of Phe 
and Trp could be incorporated, to produce novel Trcs. In order to achieve this, different strains of 
the producer organism were first analysed in terms of their Trc production profiles without amino 
acid supplementation under varying conditions (Chapter 2). Following this, the strains were 
assessed on their ability to grow in the presence of the selected non-natural amino acid derivatives 
and to determine their production profiles (using a selected strain) following supplementation with 
these amino acids under various growth conditions (Chapter 3). In chapter 4 large scale productions 
using the selected strain was done using supplementation with the selected amino acid derivatives in 
an attempt to purify and partially characterise novel Trcs. 
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5.2 Summary of findings and future work 
5.2.1 Strain production profile characterisation and optimisation of carbon, nitrogen and 
sulphate sources 
Initially, extracts of large scale cultures of the four available Br. parabrevis strains (DSMZ 5618, 
DSMZ 362, ATCC 8185 and ATCC 10068) were characterised using UPLC-ESMS analysis to 
determine differences in their production profiles. These cultures were grown in TGS media 
(combinations tryptone, glucose and inorganic salts) as used in cultures by Vosloo (4) based on a 
media composition developed by Lewis et al (8). UPLC-MS analysis revealed differences in the 
production profiles of the major Trc analogues, which is likely given differences in the production 
of the structurally similar GS observed between different producer strains (9, 10).The major Trcs 
detected in the extracts (based previous extracts done in our lab) were identified and their 
contributions to the production profiles were calculated. Here it was observed that the 5618-strain 
gave the best production of C-analogues, with TpcC and TrcC1 being the predominant analogues. 
There was no strain with a clear preference for production of B-analogues, but the 362-strain did 
produce the highest relative amounts of TpcB1 and TrcB1, indicating a higher level production of 
Lys9 containing analogues. The 362-strain showed the best overall production of A-analogues. 
The effects of altering nitrogen, sulphate and carbon sources (using TGS as a base media) on the 
growth rates of the 5618, 8185 and 362 strains were also determined using various combinations 
and concentrations of urea (CO(NH2)2), sodium sulphate (Na2SO4), ammonium sulphate 
((NH4)2SO4), glucose and glycerol. The nitrogen and sulphate containing compounds were well 
tolerated by all the strains as determined by their growth rates relative to TGS. Urea appeared to 
produce a slightly higher growth rate (either on its own or in combination with sodium sulphate) for 
the 5618 and 362 strains compared to TGS. Some of the tested nutrient conditions also had an effect 
on the nature of the growth of the strain, producing multi-auxic (more than one apparent 
exponential growth phase) growth curves and varying lag times. 
In terms of the carbon sources tested (using TGS as a base media), glycerol appeared to be an 
overall poor supporter of growth for all strains, with a clear preference for glucose shown by all the 
strains tested. When testing combinations of these carbon sources the results were more ambiguous, 
with the combination of glucose and glycerol sometimes producing higher or lower growth rates 
(and not for all concentrations) compared to either glucose or glycerol alone. Glucose alone at a 
concentration of 30 g/L produced the highest growth rates for all carbon source concentrations and 
combinations tested. Like the nitrogen and sulphate sources, different glucose and glycerol 
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concentrations and compositions also had an observable effect on lag times and number of apparent 
exponential growth phases. 
Selected concentrations of urea (since it had the largest apparent improvement in on growth rate 
compared to all other nutrient conditions tested) were selected for used in deep-well extracts to 
determine its effects on Trc production on the 5618, 362 and 8185 strains. In terms of the ratio of 
cell mass to extract mass, the 5618 and 8185 strains showed the best production of peptide with 
added urea. For the 5618-strain the addition of 8 g/L urea to TGS produced the best cell mass to 
extract mass ratio compared to all other strains and conditions, but with an improvement in this 
ratio of 0.11 over TGS, it is dubious whether this difference would be statistically significant and 
ultimately lead to a significant in production of peptide. 
In terms of production profiles following urea supplementation, the 5618-strain showed the best 
production in the sense that it produced all the major Trc analogues tested for in readily detectable 
amounts (with the exception of TpcC, which was supressed by the addition of urea to TGS). The 
relationship between growth rate and peptide production is unclear, with variable relationships 
between growth rate, extract masses and peptide signals. 
The 5618-strain was chosen going forward for subsequent chapters based on the fact that it was the 
best producer of TrcC-analogues (but also had an all-round good production of other analogues). 
This was initially of interest as the first non-natural analogue initially tested for incorporation into 
the Trcs was the Trp derivative 5-MeW. The strain was then chosen for testing with other amino 
acid derivatives for the sake of simplicity and comparison of production of Trcs by this strain under 
different conditions. 
Future studies of this nature would benefit from a more comprehensive growth curve experiment in 
which more data in captured in an individual experiment. This means that following the 
determination of growth rate in the microtiter plates, incubation of these plates should be done for a 
longer period to allow for Trc synthesis. Following this incubation small-scale extraction can be 
done in the wells and the supernatant can be tested for Trc production in a higher throughput 
manner using any number of assays or combinations of assays, including antimicrobial growth 
inhibition assays, assays to determine peptide aggregation, as well as haemolysis assays. In this way 
the one can directly determine the effect of growth rate and growth conditions on peptide 
productions before selecting conditions for deep-well assays. 
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5.2.2 Determination of the incorporation of non-natural amino acids into  
the tyrocidines and analogues 
As described previously, the mechanism of Trc synthesis allows for the production of a variety of 
cyclo-decapeptide analogues thanks to variable amino acid incorporation (4). This provides the 
primary basis for exploring the possibility of incorporation of the selected non-natural amino acid 
derivatives. Some work has been done on the effect of non-natural amino acids on growth rates of 
different producer organisms as well as Trc production (but not looking at incorporation of the 
tested amino acid into the produced Trcs) (11), with some non-natural amino acids inhibiting 
protein synthesis by the producer organism. Little work, however, has been done on testing for the 
incorporation of non-natural amino acids into the Trcs, with the exception of some work by 
Ruttenberg et al. (12). The possibility of the producer organism to incorporate non-natural amino 
acids provides a promising avenue for the creation of novel antimicrobial peptides, which may help 
in the fight against antimicrobial resistance. 
This chapter aimed to determine the effects of selected non-natural amino acids on the growth rate 
of the 5618, 362 and 8185 strains and to characterise the production of Trcs by the 5618-strain 
following supplementation with Phe and Trp as well as their non-natural derivatives 2-FF (2-flouro-
phenyalanine), 4-MeF (4-methyl-phenylalanine), CF3F (4-triflouro-phenyalanine), 1-MeW (1-
methyl-trpytophan) and 5-MeW (5-mehtyl-trpytophan).  
Supplementation of TGS with the selected amino acids at varying concentrations produced both 
improved and reduced growth rates relative to TGS alone. There was generally an inhibitory effect 
on growth as amino acid concentration was increased, with some strains showing no change, 
particularly at the maximum concentration tested of 22 mM. Increasing Trp concentration led to an 
improvement in growth rate for the 5618-strain. The 5-MeW derivative was best tolerated by the 
5618-srain while the 1-MeW derivative was best tolerated by the 362-strain. For the phenylalanine 
derivatives, the 8185-strain appeared to be the most tolerant to increasing concentrations of all the 
Phe derivatives, with the exception of the CF3F derivative, which showed increasing toxicity with 
an increase in growth rate for all the strains. 
Medium-throughput small scale cultures were done using the 5618-strain, which was selected as it 
had already been used for initial deep-well cultures with Trp and 5-MeW (for which it gave the best 
growth rates and production profiles).  Analysis of these deep-well culture extracts, using ESMS, 
showed extensive incorporation of all the amino-acid analogues tested (with the exception of the 
CF3F derivative). Identification of novel peptides was done based on comparing the detected versus 
the theoretical masses (see addendum at end of thesis) if amino acids had been incorporated. In 
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addition, levels of oligomerisation were analysed, and found to vary from natural to non-natural 
analogues. All the non-natural Phe derivative extracts showed increased formation of higher order 
oligomers (trimers and tetramers) relative to the Phe extract, while there was a marginal increase in 
tetramer formation for the non-natural Trp derivatives relative to Trp.  
The relative quantification of natural and non-natural peptides produced under varying incubation 
conditions was done following extraction of deep-well cultures to assess differences in production 
profiles as well as any possible correlation between growth rates under varying conditions and Trc 
production under varying conditions. For Phe and its derivatives, there was no clear correlation 
between a growth rates at amino acid supplementation concentrations of 11 and 22 mM, and peptide 
production at 10 and 20 mM, with the exception of the CF3F derivative, which showed both 
decreasing growth rates and peptide production as its concentration increased.  There was no clear 
effect of sodium sulphate and urea supplementation and concentration on peptide production, with 
some peptides showing increased production relative to TGS alone and some having decreased 
production relative to TGS alone. The same is true for quantification of peptides in Trp and Trp-
derivative supplemented samples. It may be possible than some amino acid derivatives are selective 
inhibitors or protein synthesis but not Trc synthesis. 
Production of novel Trcs by incubation of the producer organism with non-natural amino acids 
proved to be successful. Future work would include testing a wider variety of non-natural amino 
acids for incorporation. The process of peptide identification and quantification would benefit from 
automated identification and quantitation of peptides using ESMS mass spectra. In addition, the use 
of ion-mobility analysis linked to ESMS would aid in the identification of novel Trcs (when there 
are too many samples to be processed by UPLC-MS), which have overlapping masses with natural 
Trcs, on the basis of differing drift-times (as determined by ion-mobility analysis). Ion mobility 
would also aid in the analysing levels of oligomerisation and deconvoluting oligomers and 
monomers with overlapping m/z values to aid in the determination of masses using MaxEnt 3 
analysis. 
5.2.3 Medium scale production and characterisation of tyrocidine analogues containing 
non-natural aromatic amino acids  
Medium-scale in-culture production of Trcs allows for subsequent extraction, purification and 
analysis of both the crude extract and individual Trc analogues. This is achieved using a large-scale 
extraction process to maximise the purity of the Trcs before further purification and analysis. 
UPLC-MS is a valuable tool which is then used to analyse the extracts for quantification and 
identification or peptides within the mixture using its high degree of sensitivity. Semi-preparative 
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reverse-phase HPLC can be used to purify or enrich certain analogues within the crude extract, 
which can then be further characterised in a number of ways, including their activity against 
selected microorganisms and their unique biophysical characteristics.  
In this chapter we aimed to produce, purify and partially characterise novel Trcs isolated following 
incubation of the producer organism with the Phe derivative 2-FF and the tryptophan derivative 5-
MeW. 
Both 2-FF and 5-MeW were readily incorporated into the Trcs to produce a host of novel cyclo-
decapeptides. Identification was achieved by comparing the detected masses of these analogues to 
their theoretical masses (given in thesis addendum) and comparison of production profiles and 
UPLC retention times for extracts supplemented with Phe and Trp. In the case of the 2-FF 
supplemented extract, a TrcA incorporating three fluorinated phenylalanine residues produced the 
largest signal, and with a similar retention time to TrcA (differing by 0.03 minutes), indicating a 
very similar hydrophobicity. In the 5-MeW supplemented extract a TpcB/B’ incorporating a single 
5-MeW residue produced the highest signal and a retention time of 11.73 minutes, but was 
significantly more hydrophobic than its natural counterpart which eluted at 10.86 minutes. The 
UPLC analyis of the 5-MeW analogues indicated an increase in retention time for all methylated  
analogues, indicating the more hydrophobic nature of these analogues.  
Semi-preparative reverse-phase HPLC purification of individual peptides proved to be difficult. 
This was primarily due to the large increase in structural diversity of Trc analogues produced when 
incorporating an additional amino acid. This increases the odds of creating peptides with 
overlapping retention times. As a result, it was only possible to enrich HPLC fractions for a certain 
peptide (as determined by UPLC-MS analysis). For the 2-FF extract two fractions were used for 
subsequent analysis, one enriched for a TrcA incorporating three fluorinated phenyl residues 
(TrcA(3*2-FF)), and one incorporating two (TrcA(2*2-FF)). In the case of the HPLC fractions of 
the 5-MeW supplemented culture extract, two fractions were also used for subsequent analysis, one 
enriched for a TrcB/B’ incorporating single 5-MeW residue (TrcB/B’(1*5MeW)) and one a 
TpcB/B’ incorporating two 5-MeW residues (TpcB/B’(2*5MeW)). 
The peptide enriched for in these fractions were then characterised by testing them against the 
Gram-positive target organisms Micrococcus luteus, together with their natural equivalents as well 
as PhcA and TpcC. An initial spot plate assay indicated that the most active peptides were the 
natural analogues TrcA, PhcA and the non-natural analogue TrcB(1*5MeW), however further tests 
were required. Growth inhibition and metabolic activity inhibition assays were done against M. 
luteus to give a more in-depth idea of their activity. All peptides tested appeared to be good 
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inhibitors of bacterial growth (±80% - 90% growth inhibition) at concentrations of 50 μg/mL (with 
the exception of PhcA) and 10 μg/mL (with the exception of PhcA and TpcC). The % inhibition of 
metabolic activity by the selected peptides at 50 μg/mL were also good (±80% - 90%), again with 
the exception of PhcA. At a concentration of 10 μg/mL the inhibition of metabolic activity 
decreased for TrcA, TpcB, TpcC and TpcB(2*5MeW) and decreased less, but still considerably, for 
TrcA(2*2-FF). This indicates that the MBC (minimum bactericidal concentration) for these 
peptides is above 10 μg/mL, while TrcB, TrcA(3*2-FF) and TrcB(1*5MeW) retained good 
inhibition of bacterial metabolism, making them more potent bactericidal peptides. The large 
increase in % metabolic inhibition by the TrcA(3*2-FF) peptide, and to a lesser degree the 
TrcA(2*2-FF) peptide, indicates that these non-natural derivative are more active than TrcA. TpcB 
and TrcB and their non-natural analogues had similar growth and metabolic activity inhibition, with 
TrcB and its non-natural analogues being more active than TpcB and its analogues. 
5.3 Last word 
Growth curve analysis can be rapidly used to determine the viability of certain culture conditions 
and non-natural amino acid supplementations on cell growth. Medium throughput deep-well assays 
can then be used to test for the levels of peptide production, as well as the identification of novel 
peptides, under selected conditions. This can be scaled up even further to allow for the production, 
isolation and characterisation of novel Trcs. 
This study has shown that it is possible to create novel Trcs using simple in-culture methodology 
and this may prove to be an exciting avenue in the development of novel antimicrobial peptides for 
use in clinical and industrial settings. 
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Table 1  List of theoretical monomer masses and primary structures for natural Trcs 
and Grcs (1). For this and subsequent tables, Mr = theoretical mass, [M+H]
1+ 
= (Mr + hydrogen)/1 (singly charged m/z), [M+2H]
2+ = (Mr + 2 hydrogens)/2 
(doubly charged m/z), [M+Na]1+ = mass + sodium adduct, [M+Na+H]2+ = (Mr 
+ hydrogen + sodium/2 (doubly charged m/z) 
 
Abbreviations Primary structure Mr [M+H]1+ [M+2H]2+ [M+Na]1+ [M+Na+H]2+ 
A analogues 
      
PhcA Cyclo-(fPFfNQFVOL) 1253.6597 1254.6675 627.8377 1276.6495 638.8286 
PhcA1 Cyclo-(fPFfNQFVKL) 1267.6753 1268.6832 634.8455 1290.6651 645.8365 
TrcA Cyclo-(fPFfNQYVOL) 1269.6546 1270.6624 635.8351 1292.6444 646.8261 
TrcAv1 Cyclo-(fPFfNQYVOV) 1255.6390 1256.6468 628.8273 1278.6287 639.8183 
TrcA1 Cyclo-(fPFfNQYVKL) 1283.6703 1284.6781 642.8430 1306.6600 653.8339 
TpcA Cyclo-(fPFfNQWVOL) 1292.6706 1293.6784 647.3431 1315.6604 658.3341 
TpcA1 Cyclo-(fPFfNQWVKL) 1306.6862 1307.6941 654.3509 1329.6760 665.3419 
B analogues 
      
PhcB2 Cyclo-(fPWfNQFVOL) 1292.6706 1293.6784 647.3431 1315.6604 658.3341 
TrcB Cyclo-(fPWfNQYVOL) 1308.6655 1309.6733 655.3406 1331.6553 666.3316 
TrcB' Cyclo-(fPFwNQYVOL) 1308.6655 1309.6733 655.3406 1331.6553 666.3316 
TrcB1 Cyclo-(fPWfNQYVKL) 1322.6812 1323.6890 662.3484 1345.6709 673.3394 
TrcB1' Cyclo-(fPFwNQYVKL) 1322.6812 1323.6890 662.3484 1345.6709 673.3394 
TpcB Cyclo-(fPWfNQWVOL) 1331.6815 1332.6893 666.8486 1354.6713 677.8395 
TpcB' Cyclo-(fPWfNQWVOL) 1331.6815 1332.6893 666.8486 1354.6713 677.8395 
TpcB1 Cyclo-(fPWfNQWVKL) 1345.6971 1346.7050 673.8564 1368.6869 684.8474 
TpcB1' Cyclo-(fPFwNQWVKL) 1345.6971 1346.7050 673.8564 1368.6869 684.8474 
C analogues 
      
PhcC2 Cyclo-(fPWwNQFVOL) 1331.6815 1332.6893 666.8486 1354.6713 677.8395 
TrcC Cyclo-(fPWwNQYVOL) 1347.6764 1348.6842 674.8460 1370.6662 685.8370 
TrcC1 Cyclo-(fPWwNQYVKL) 1361.6921 1362.6999 681.8539 1384.6818 692.8448 
TpcC Cyclo-(fPWwNQWVOL) 1370.6924 1371.7002 686.3540 1393.6822 697.3450 
TpcC1 Cyclo-(fPWwNQWVKL) 1384.7080 1385.7159 693.3618 1407.6978 704.3528 
Gramicidins (Grcs) 
      
VGA VGAlAvVvW-lWlWlW 1881.0783 1882.0862 941.5470 1904.0681 952.5380 
VGB VGAlAvVvW-lFlWlW 1842.0674 1843.0753 922.0415 1865.0572 933.0325 
VGC VGAlAvVvW-lYlWlW 1858.0624 1859.0702 930.0390 1881.0521 941.0300 
IGA IGAlAvVvW-lWlWlW 1895.0940 1896.1018 948.5548 1918.0838 959.5458 
IGB IGAlAvVvW-lFlWlW 1856.0831 1857.0909 929.0494 1879.0729 940.0403 
IGC IGAlAvVvW-lYlWlW 1872.0780 1873.0858 937.0468 1895.0678 948.0378 
1 Very rarely detected in Trc extracts using ESMS  
2 Never detected in ESMS extracts using ESMS 
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Table 2 List of theoretical monomer masses for Trcs incorporating Phe derivative 2-FF. The F 
residues with the a, b, c and d superscripts show the modification sites of F to 2-FF. In 
the cases of a single 2-FF substitution, ‘a’, ‘b’, ‘c’ and ‘d’ show the possible sites of 
modification from most to least likely (assuming a preference for the natural analogue 
over 2-FF).  If there is more than one possible sequence due to more than one 2-FF 
substitution in a Trc analogue, the possible sequences are shown by corresponding 
superscripts in the structure e.g. PhcA(2*2-FF) = Cyclo-(fbPFafbNQFbVOL), where Fa 
is the most likely modification to a 2-FF residue, and subsequent modifications are at 
any of the positions with the ‘b’ subscript. The order of incorporation of modified Phe 
residues (from most to least likely), is based on the work of Vosloo (2) using Phe 
Abbreviations1 Primary  structure/s No. of theoretical sequences2 Mr [M+H]
1+
 [M+2H]
2+
 [M+Na]
1+
 [M+Na+H]
2+
 
A analogues 
       
PhcA(1*2-FF) Cyclo-(fdPFafbNQFcVOL) 4 1271.6503 1272.6581 636.8330 1294.6400 647.8239 
PhcA(2*2-FF) Cyclo-(fbPFafbNQFbVOL) 6 1289.6409 1290.6487 645.8283 1312.6306 656.8192 
PhcA(3*2-FF) Cyclo-(fbPFafaNQFbVOL) 4 1307.6314 1308.6393 654.8235 1330.6212 665.8145 
PhcA(4*2-FF) Cyclo-(faPFafaNQFaVOL) 1 1325.6220 1326.6298 663.8188 1348.6118 674.8098 
PhcA1(1*2-FF) Cyclo-(fdPFafbNQFcVKL) 4 1285.6659 1286.6737 643.8408 1308.6557 654.8318 
PhcA1(2*2-FF) Cyclo-(fbPFafbNQFbVKL) 6 1303.6565 1304.6643 652.8361 1326.6463 663.8270 
PhcA1(3*2-FF) Cyclo-(fbPFafaNQFbVKL) 4 1321.6471 1322.6549 661.8314 1344.6368 672.8223 
PhcA1(4*2-FF) Cyclo-(faPFafaNQFaVKL) 1 1339.6377 1340.6455 670.8267 1362.6274 681.8176 
TrcA(1*2-FF) Cyclo-(fcPFafbNQYVOL) 3 1287.6452 1288.6530 644.8304 1310.6350 655.8214 
TrcA(2*2-FF) Cyclo-(fbPFafbNQYVOL) 3 1305.6358 1306.6436 653.8257 1328.6255 664.8167 
TrcA(3*2-FF) Cyclo-(faPFafaNQYVOL) 1 1323.6264 1324.6342 662.8210 1346.6161 673.8120 
TrcAv(1*2-FF)3 Cyclo-(fcPFafbNQYVOV) 3 1273.6295 1274.6374 637.8226 1296.6193 648.8136 
TrcAv(1*2-FF)3 Cyclo-(fbPFafbNQYVOV) 3 1291.6201 1292.6280 646.8179 1314.6099 657.8089 
TrcAv(1*2-FF)3 Cyclo-(faPFafaNQYVOV) 1 1309.6107 1310.6185 655.8132 1332.6005 666.8041 
TrcA1(1*2-FF) Cyclo-(fcPFafbNQYVKL) 3 1301.6608 1302.6687 651.8382 1324.6506 662.8292 
TrcA1(2*2-FF) Cyclo-(fbPFafbNQYVKL) 3 1319.6514 1320.6592 660.8335 1342.6412 671.8245 
TrcA1(3*2-FF) Cyclo-(faPFafaNQYVKL) 1 1337.6420 1338.6498 669.8288 1360.6318 680.8198 
TpcA(1*2-FF) Cyclo-(fcPFafbNQWVOL) 3 1310.6612 1311.6690 656.3384 1333.6509 667.3294 
TpcA(2*2-FF) Cyclo-(fbPFafbNQWVOL) 3 1328.6518 1329.6596 665.3337 1351.6415 676.3247 
TpcA(3*2-FF) Cyclo-(faPFafaNQWVOL) 1 1346.6423 1347.6502 674.3290 1369.6321 685.3200 
TpcA1(1*2-FF) Cyclo-(fcPFafbNQWVKL) 3 1324.6768 1325.6846 663.3462 1347.6666 674.3372 
TpcA1(2*2-FF) Cyclo-(fbPFafbNQWVKL) 3 1342.6674 1343.6752 672.3415 1365.6572 683.3325 
TpcA1(3*2-FF) Cyclo-(faPFafaNQWVKL) 1 1360.6580 1361.6658 681.3368 1383.6477 692.3278 
B analogues 
  
     PhcB(1*2-FF)4 Cyclo-(fcPWfaNQFbVOL) 3 1310.6612 1311.6690 656.3384 1333.6509 667.3294 
PhcB(2*2-FF)4 Cyclo-(fbPWfaNQFbVOL) 3 1328.6518 1329.6596 665.3337 1351.6415 676.3247 
PhcB(3*2-FF)4 Cyclo-(faPWfaNQFaVOL) 1 1346.6423 1347.6502 674.3290 1369.6321 685.3200 
TrcB(1*2-FF) Cyclo-(fbPWfaNQYVOL) 2 1326.6561 1327.6639 664.3359 1349.6459 675.3268 
TrcB(2*2-FF) Cyclo-(faPWfaNQYVOL) 1 1344.6467 1345.6545 673.3312 1367.6364 684.3221 
TrcB'(1*2-FF) Cyclo-(fbPFawNQYVOL) 2 1326.6561 1327.6639 664.3359 1349.6459 675.3268 
TrcB’ (2*2-FF) Cyclo-(faPFawNQYVOL) 1 1344.6467 1345.6545 673.3312 1367.6364 684.3221 
TrcB1(1*2-FF) Cyclo-(fbPWfaNQYVKL) 2 1340.6717 1341.6796 671.3437 1363.6615 682.3347 
TrcB1(2*2-FF) Cyclo-(faPWfaNQYVKL) 1 1358.6623 1359.6701 680.3390 1381.6521 691.3300 
TrcB1'(1*2-FF) Cyclo-(fbPFawNQYVKL) 2 1340.6717 1341.6796 671.3437 1363.6615 682.3347 
TrcB1'(2*2-FF) Cyclo-(faPFawNQYVKL) 1 1358.6623 1359.6701 680.3390 1381.6521 691.3300 
TpcB(1*2-FF) Cyclo-(fbPWfaNQWVOL) 2 1349.6721 1350.6799 675.8439 1372.6618 686.8348 
TpcB(2*2-FF) Cyclo-(faPWfaNQWVOL) 1 1367.6627 1368.6705 684.8392 1390.6524 695.8301 
TpcB'(1*2-FF) Cyclo-(fbPFawNQWVOL) 2 1349.6721 1350.6799 675.8439 1372.6618 686.8348 
TpcB'(2*2-FF) Cyclo-(faPFawNQWVOL) 1 1367.6627 1368.6705 684.8392 1390.6524 695.8301 
TpcB1(1*2-FF) Cyclo-(fbPWfaNQWVKL) 2 1363.6877 1364.6955 682.8517 1386.6775 693.8427 
TpcB1(2*2-FF) Cyclo-(faPWfaNQWVKL) 1 1381.6783 1382.6861 691.8470 1404.6681 702.8379 
TpcB1'(1*2-FF) Cyclo-(fbPFawNQWVKL) 2 1363.6877 1364.6955 682.8517 1386.6775 693.8427 
TpcB1’(2*2-FF) Cyclo-(faPFawNQWVKL) 1 1381.6783 1382.6861 691.8470 1404.6681 702.8379 
C-analogues 
  
     PhcC(1*2-FF)4 Cyclo-(fbPWwNQFaVOL) 2 1349.6721 1350.6799 675.8439 1372.6618 686.8348 
PhcC(2*2-FF)4 Cyclo-(faPWwNQFaVOL) 1 1367.6627 1368.6705 684.8392 1390.6524 695.8301 
TrcC(1*2-FF) Cyclo-(faPWwNQYVOL) 1 1365.6670 1366.6748 683.8413 1388.6568 694.8323 
TrcC1(1*2-FF) Cyclo-(faPWwNQYVKL) 1 1379.6826 1380.6905 690.8491 1402.6724 701.8401 
TpcC(1*2-FF) Cyclo-(faPWwNQWVKL) 1 1388.6830 1389.6908 695.3493 1411.6727 706.3403 
TpcC1(1*2-FF) Cyclo-(faPWwNQWVOL) 1 1402.6986 1403.7064 702.3571 1425.6884 713.3481 
1 
The number followed by the * indicated the number of residues of the non-natural amino acid (shown after *) in that structure 
2 Shows the structural configurations possible given the same sites of incorporation for Phe in the natural equivalent of the analogue 
3 Natural analogue (TrcAv) very rarely detected in Trc extracts using ESMS 
4
 Natural analogues (PhcB and PhcC) not detected in Trc extracts using ESMS 
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Table 2 List of theoretical monomer masses for Trcs incorporating Phe derivative 4-MeF. The 
F residues with the a, b, c and d superscripts show the modification sites of F to 4-
MeF substitution. In the cases of a single 4-MeF substitution, ‘a’, ‘b’, ‘c’ and ‘d’ 
show the possible sites of modification from most to least likely (assuming a 
preference for the natural analogue over 4-MeF).  If there is more than one possible 
sequence due to more than one 4-MeF substitution in a Trc analogue, the possible 
sequences are shown by corresponding superscripts in the structure e.g. PhcA(2*4-
MeF) = Cyclo-(fbPFafbNQFbVOL), where Fa is the most likely modification to a 4-
MeF residue, and subsequent modifications are at any of the positions with the ‘b’ 
subscript. The order of incorporation of modified Phe residues (from most to least 
likely), is based on the work of Vosloo (2) using Phe 
Abbreviations1 Primary  structure/s 
No. of theoretical 
sequences2 
Mr [M+H]
1+
 [M+2H]
2+
 [M+Na]
1+
 [M+Na+H]
2+
 
A analogues 
       
PhcA(1*4-MeF) Cyclo-(fdPFafbNQFcVOL) 4 1267.6863 1268.6941 641.8643 1290.6760 652.8552 
PhcA(2*4-MeF) Cyclo-(fbPFafbNQFbVOL) 6 1281.7129 1282.7207 655.8908 1304.7026 666.8818 
PhcA(3*4-MeF) Cyclo-(fbPFafaNQFbVOL) 4 1295.7394 1296.7473 669.9174 1318.7292 680.9084 
PhcA(4*4-MeF) Cyclo-(faPFafaNQFaVOL) 1 1309.7660 1310.7738 683.9440 1332.7558 694.9350 
PhcA1(1*4-MeF) Cyclo-(fdPFafbNQFcVKL) 4 1281.7019 1282.7097 648.8721 1304.6917 659.8630 
PhcA1(2*4-MeF) Cyclo-(fbPFafbNQFbVKL) 6 1295.7285 1296.7363 662.8987 1318.7183 673.8896 
PhcA1(3*4-MeF) Cyclo-(fbPFafaNQFbVKL) 4 1309.7551 1310.7629 676.9252 1332.7448 687.9162 
PhcA1(4*4-MeF) Cyclo-(faPFafaNQFaVKL) 1 1323.7817 1324.7895 690.9518 1346.7714 701.9428 
TrcA(1*4-MeF) Cyclo-(fcPFafbNQYVOL) 3 1283.6812 1284.6890 649.8617 1306.6710 660.8527 
TrcA(2*4-MeF) Cyclo-(fbPFafbNQYVOL) 3 1297.7078 1298.7156 663.8883 1320.6975 674.8793 
TrcA(3*4-MeF) Cyclo-(faPFafaNQYVOL) 1 1311.7344 1312.7422 677.9149 1334.7241 688.9058 
TrcAv(1*4-MeF)3 Cyclo-(fcPFafbNQYVOV) 3 1269.6656 1270.6734 642.8539 1292.6553 653.8449 
TrcAv(1*4-MeF)3 Cyclo-(fbPFafbNQYVOV) 3 1283.6921 1284.7000 656.8805 1306.6819 667.8714 
TrcAv(1*4-MeF)3 Cyclo-(faPFafaNQYVOV) 1 1297.7187 1298.7265 670.9071 1320.7085 681.8980 
TrcA1(1*4-MeF) Cyclo-(fcPFafbNQYVKL) 3 1297.6968 1298.7047 656.8695 1320.6866 667.8605 
TrcA1(2*4-MeF) Cyclo-(fbPFafbNQYVKL) 3 1311.7234 1312.7312 670.8961 1334.7132 681.8871 
TrcA1(3*4-MeF) Cyclo-(faPFafaNQYVKL) 1 1325.7500 1326.7578 684.9227 1348.7398 695.9137 
TpcA(1*4-MeF) Cyclo-(fcPFafbNQWVOL) 3 1306.6972 1307.7050 661.3697 1329.6869 672.3607 
TpcA(2*4-MeF) Cyclo-(fbPFafbNQWVOL) 3 1320.7238 1321.7316 675.3963 1343.7135 686.3873 
TpcA(3*4-MeF) Cyclo-(faPFafaNQWVOL) 1 1334.7503 1335.7582 689.4229 1357.7401 700.4138 
TpcA1(1*4-MeF) Cyclo-(fcPFafbNQWVKL) 3 1320.7128 1321.7206 668.3775 1343.7026 679.3685 
TpcA1(2*4-MeF) Cyclo-(fbPFafbNQWVKL) 3 1334.7394 1335.7472 682.4041 1357.7292 693.3951 
TpcA1(3*4-MeF) Cyclo-(faPFafaNQWVKL) 1 1348.7660 1349.7738 696.4307 1371.7557 707.4217 
B analogues 
       
PhcB(1*4-MeF)4 Cyclo-(fcPWfaNQFbVOL) 3 1306.6972 1307.7050 661.3697 1329.6869 672.3607 
PhcB(2*4-MeF)4 Cyclo-(fbPWfaNQFbVOL) 3 1320.7238 1321.7316 675.3963 1343.7135 686.3873 
PhcB(3*4-MeF)4 Cyclo-(faPWfaNQFaVOL) 1 1334.7503 1335.7582 689.4229 1357.7401 700.4138 
TrcB(1*4-MeF) Cyclo-(fbPWfaNQYVOL) 2 1322.6921 1323.6999 669.3672 1345.6819 680.3581 
TrcB(2*4-MeF) Cyclo-(faPWfaNQYVOL) 1 1336.7187 1337.7265 683.3937 1359.7084 694.3847 
TrcB'(1*4-MeF) Cyclo-(fbPFawNQYVOL) 2 1322.6921 1323.6999 669.3672 1345.6819 680.3581 
TrcB’ (2*4-MeF) Cyclo-(faPFawNQYVOL) 1 1336.7187 1337.7265 683.3937 1359.7084 694.3847 
TrcB1(1*4-MeF) Cyclo-(fbPWfaNQYVKL) 2 1336.7077 1337.7156 676.3750 1359.6975 687.3660 
TrcB1(2*4-MeF) Cyclo-(faPWfaNQYVKL) 1 1350.7343 1351.7421 690.4016 1373.7241 701.3925 
TrcB1'(1*4-MeF) Cyclo-(fbPFawNQYVKL) 2 1336.7077 1337.7156 676.3750 1359.6975 687.3660 
TrcB1'(2*4-MeF) Cyclo-(faPFawNQYVKL) 1 1350.7343 1351.7421 690.4016 1373.7241 701.3925 
TpcB(1*4-MeF) Cyclo-(fbPWfaNQWVOL) 2 1345.7081 1346.7159 680.8752 1368.6978 691.8661 
TpcB(2*4-MeF) Cyclo-(faPWfaNQWVOL) 1 1359.7347 1360.7425 694.9017 1382.7244 705.8927 
TpcB'(1*4-MeF) Cyclo-(fbPFawNQWVOL) 2 1345.7081 1346.7159 680.8752 1368.6978 691.8661 
TpcB'(2*4-MeF) Cyclo-(faPFawNQWVOL) 1 1359.7347 1360.7425 694.9017 1382.7244 705.8927 
TpcB1(1*4-MeF) Cyclo-(fbPWfaNQWVKL) 2 1359.7237 1360.7315 687.8830 1382.7135 698.8739 
TpcB1(2*4-MeF) Cyclo-(faPWfaNQWVKL) 1 1373.7503 1374.7581 701.9096 1396.7401 712.9005 
TpcB1'(1*4-MeF) Cyclo-(fbPFawNQWVKL) 2 1359.7237 1360.7315 687.8830 1382.7135 698.8739 
TpcB1’(2*4-MeF) Cyclo-(faPFawNQWVKL) 1 1373.7503 1374.7581 701.9096 1396.7401 712.9005 
C-analogues 
       
PhcC(1*4-MeF)4 Cyclo-(fbPWwNQFaVOL) 2 1345.7081 1346.7159 680.8752 1368.6978 691.8661 
PhcC(2*4-MeF)4 Cyclo-(faPWwNQFaVOL) 1 1359.7347 1360.7425 694.9017 1382.7244 705.8927 
TrcC(1*4-MeF) Cyclo-(faPWwNQYVOL) 1 1361.7030 1362.7108 688.8726 1384.6928 699.8636 
TrcC1(1*4-MeF) Cyclo-(faPWwNQYVKL) 1 1375.7186 1376.7265 695.8804 1398.7084 706.8714 
TpcC(1*4-MeF) Cyclo-(faPWwNQWVKL) 1 1384.7190 1385.7268 700.3806 1407.7087 711.3716 
TpcC1(1*4-MeF) Cyclo-(faPWwNQWVOL) 1 1398.7346 1399.7424 707.3884 1421.7244 718.3794 
1 
The number followed by the * indicated the number of residues of the non-natural amino acid (shown after *) in that structure 
2 Shows the structural configurations possible given the same sites of incorporation for Phe in the natural equivalent of the analogue 
3 Natural analogue (TrcAv) very rarely detected in Trc extracts using ESMS 
4
 Natural analogues (PhcB and PhcC) not detected in Trc extracts using ESMS 
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Table 3  List of theoretical monomer masses for Trcs incorporating Trp derivatives 5- or 1-
mehtyl-tryptophan (5/1-MeW). The W residues with the ‘a’ anf ‘b’ superscripts show 
the modification sites of W to 5/1-MeW. In the cases of a single 5/1-MeW 
substitution, ‘a’ and ‘b’ show the possible sites of modification from most to least 
likely (assuming a preference for the natural analogue over 5/1-MeW).  If there is 
more than one possible sequence due to more than one 5/1-MeW substitution in a Trc 
analogue, the possible sequences are shown by corresponding superscripts in the 
structure e.g. TpcC(2*5/1-MeW)) = Cyclo-(fPWbwaNQWbVOL)), where Wa is the 
most likely modification to a 5/1-MeW residue, and subsequent modifications are at 
any of the positions with the ‘b’ subscript. The order of incorporation of modified Trp 
residues (from most to least likely), is based on the work of Vosloo (2) using Trp 
Abbreviations1 Primary structure/s 
No. of theoretical  
sequences2 
Mr [M+H]1+ [M+2H]2+ [M+Na]1+ [M+Na+H]2+ 
A analogues 
       
TpcA(1*5/1-MeW) Cyclo-(fPFfNQWaVOL) 1 1306.6864 1307.6942 654.3511 1329.6762 665.3420 
TpcA1(1*5/1-MeW) Cyclo-(fPFfNQWaVKL) 1 1320.7020 1321.7099 661.3589 1343.6918 672.3498 
A analogues 
       
PhcA(1*5/1-MeW)3 Cyclo-(fPWafNQFVOL) 1 1306.6863 1307.6941 654.3510 1329.6760 665.3419 
TrcA(1*5/1-MeW) Cyclo-(fPWafNQYVOL) 1 1322.6812 1323.6890 662.3484 1345.6709 673.3394 
TrcA'(1*5/1-MeW) Cyclo-(fPFwaNQYVOL) 1 1322.6812 1323.6890 662.3484 1345.6709 673.3394 
TrcA1(1*5/1-MeW) Cyclo-(fPWafNQYVKL) 1 1336.6968 1337.7046 669.3563 1359.6866 680.3472 
TrcA1'(1*5/1-MeW) Cyclo-(fPFwaNQYVKL) 1 1336.6968 1337.7046 669.3563 1359.6866 680.3472 
TpcA(1*5/1-MeW) Cyclo-(fPWafNQWbVOL) 2 1345.6972 1346.7050 673.8564 1368.6869 684.8474 
TpcA(2*5/1-MeW) Cyclo-(fPWafNQWaVOL) 1 1359.7128 1360.7206 680.8643 1382.7026 691.8552 
TpcA'(2*5/1-MeW) Cyclo-(fPfWaNQWaVOL) 1 1359.7128 1360.7206 680.8643 1382.7026 691.8552 
TpcA'(1*5/1-MeW) Cyclo-(fPfWaNQWbVOL) 2 1345.6973 1346.7051 673.8565 1368.6871 684.8474 
TpcA1(1*5/1-MeW) Cyclo-(fPWafNQWbVKL) 2 1359.7128 1360.7206 680.8643 1382.7026 691.8552 
TpcA1(2*5/1-MeW) Cyclo-(fPWafNQWaVKL) 1 1373.7284 1374.7363 687.8721 1396.7182 698.8630 
TpcA1'(1*5/1-MeW) Cyclo-(fPFwaNQWbVKL) 2 1359.7129 1360.7208 680.8643 1382.7027 691.8553 
TpcA1’(2*5/1-MeW) Cyclo-(fPFwaNQWaVKL) 1 1373.7287 1374.7366 687.8722 1396.7185 698.8632 
C analogues 
       
PhcC(1*5/1-MeW)3 Cyclo-(fPWbwaNQFVOL) 2 1345.6973 1346.7051 673.8565 1368.6871 684.8474 
PhcC(2*5/1-MeW)3 Cyclo-(fPWawaNQFVOL) 1 1359.7131 1360.7209 680.8644 1382.7029 691.8553 
TrcC(1*5/1-MeW) Cyclo-(fPWbwaNQYVOL) 2 1361.6922 1362.7000 681.8540 1384.6820 692.8449 
TrcC(2*5/1-MeW) Cyclo-(fPWawaNQYVOL) 1 1375.7080 1376.7158 688.8619 1398.6978 699.8528 
TrcC1(1*5/1-MeW) Cyclo-(fPWbwaNQYVKL) 2 1375.7079 1376.7157 688.8618 1398.6976 699.8527 
TrcC1(2*5/1-MeW) Cyclo-(fPWawaNQYVKL) 1 1389.7237 1390.7315 695.8697 1412.7134 706.8606 
TpcC(1*5/1-MeW) Cyclo-(fPWbwaNQWbVOL) 3 1384.7081 1385.7159 693.3619 1407.6978 704.3528 
TpcC(2*5/1-MeW) Cyclo-(fPWbwaNQWbVOL) 3 1398.7237 1399.7315 700.3697 1421.7135 711.3606 
TpcC(3*5/1-MeW) Cyclo-(fPWawaNQWaVOL) 1 1412.7394 1413.7472 707.3775 1435.7291 718.3685 
TpcC1(1*5/1-MeW) Cyclo-(fPWbwaNQWbVKL) 3 1398.7237 1399.7315 700.3697 1421.7135 711.3606 
TpcC1(2*5/1-MeW) Cyclo-(fPWbwaNQWbVKL) 3 1412.7393 1413.7472 707.3775 1435.7291 718.3685 
TpcC1(3*5/1-MeW) Cyclo-(fPWawaNQWaVKL) 1 1426.7550 1427.7628 714.3854 1449.7448 725.3763 
1 The numaer followed ay the * indicated the numaer of residues of the non-natural amino acid (shown after *) in that structure 
2 Shows the structural configurations possiale given the same sites of incorporation for Trp in the natural equivalent of the analogue 
3 Natural analogues (PhcA and PhcC) not detected in Trc extracts using ESMS 
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